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palavras-chave 
 
Ftalocianinas, fulerenos (C60), nanotubos de carbono (CNT), nanofolhas de 
grafeno, química supramolecular, matrizes supramoleculares, assembleias 
dador-aceitador, transferência de energia, terapia fotodinâmica (PDT), 
fotossensibilizador, células de cancro de bexiga humana UM-UC-3, 
fotoinativação de micorganismos (PDI). 
resumo Esta dissertação descreve a síntese e caracterização de diferentes derivados 
de ftalocianina (Pc), assim como de algumas porfirinas (Pors), para interação 
supramolecular com diferentes nanoestruturas de carbono para potencial 
aplicação em nanodispositivos eletrónicos. Igualmente, é também reportado a 
preparação e avaliação biológica de interessantes conjugados de Pc para a 
terapia fotodinâmica (PDT) de cancro e para a fotoinativação de 
microrganismos (PDI). 
Neste trabalho científico são discutidas as propriedades gerais das Pcs e 
metodologias sintéticas usadas na sua preparação, bem como algumas das 
suas importantes aplicações. 
Os precursores ftalonitrilo foram preparados a partir de ftalonitrilos comerciais 
por substituições nucleofílicas de grupos -NO2, -Cl ou -F, presentes no núcleo  
ftalonitrilo, por unidades tiol ou piridilo. As correspondentes Pcs foram 
preparadas por ciclotetramerização dos ftalonitrilos, previamente sintetizados, 
na presença de um sal metálico a temperaturas elevadas. Uma segunda 
estratégia envolveu a pós-funcionalização na periferia do macrociclo da 
ftalocianina hexadecafluor de zinco(II) com unidades de mercaptopiridina ou 
ciclodextrina. 
Os diferentes compostos foram caracterizados estruturalmente por diversas 
técnicas espectroscópicas, nomeadamente espectroscopia de ressonância 
magnética nuclear de 
1
H, 
13
C e 
19
F (atendendo à composição elementar de 
cada estrutura), espectroscopia de absorção e de emissão, e espectrometria 
de massa. Para estudos fotofísicos específicos foram também usadas a 
caracterização electroquímica, espectroscopia de femtossegundo e raman, 
microscopia de transmissão eletrónica e de força atómica. Foi realizado a 
derivatização não covalente de nanoestruturas de carbono, principalmente 
nanotubos de carbono de parede simples (SWNT) e nanofolhas de grafeno, 
com os conjugados de ftalocianina preparados, para dessa forma estudar as 
propriedades fotofísicas dessas nanoassembleias supramoleculares. Também, 
a partir de Pors-piridilo e ftalocianinas de ruténio (RuPcs) foram realizadas 
matrizes de Por-RuPcs via química de coordenação. Os resultados obtidos 
mostraram interessantes interações eletrónicas doador-aceitador e podem ser 
considerados candidatos atrativos para diversos dispositivos nanotecnológicos. 
Por outro lado, os conjugados anfifílicos de ftalocianina-ciclodextrina (Pc-CD) 
foram testados em ensaios biológicos para avaliar a sua capacidade de inibir 
células cancerígenas UM-UC-3 da bexiga humana. Os resultados obtidos 
demonstraram que estes conjugados fotoativos são altamente fototóxicos 
contra este tipo de células, mostrando-se bastante promissores como agentes 
em PDT. 
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abstract 
 
This dissertation describes the synthesis and characterization of different 
phthalocyanine (Pc) derivatives, as well as some porphyrins (Pors), for 
supramolecular interaction with different carbon nanostructures, to evaluate 
their potential application in electronic nanodevices. Likewise, it is also reported 
the preparation and biological evaluation of interesting phthalocyanine 
conjugates for cancer photodynamic therapy (PDT) and microorganisms 
photodynamic inactivation (PDI). 
The phthalonitrile precursors were prepared from commercial phthalonitriles by 
nucleophilic substitution of -NO2, -Cl, or -F groups, present in the phthalonitrile 
core, by thiol or pyridyl units. After the synthesis of these phthalonitriles, the 
corresponding Pcs were prepared by ciclotetramerization using a metallic salt 
as template at high temperatures. A second strategy involved the post-
functionalization of hexadecafluorophthalocyaninato zinc(II) through the 
adequate substituents of mercaptopyridine or cyclodextrin units on the 
macrocycle periphery. 
The different compounds were structurally characterized by diverse 
spectroscopic techniques, namely 
1
H, 
13
C and 
19
F nuclear magnetic resonance 
spectroscopies (attending the elemental composition of each structure); 
absorption and emission spectroscopy, and mass spectrometry. For the 
specific photophysical studies were also used electrochemical characterization, 
femtosecond and raman spectroscopy, transmission electron and atomic force 
microscopy. It was highlighted the noncovalent derivatisation of carbon 
nanostructures, mainly single wall carbon nanotubes (SWNT) and graphene 
nanosheets with the prepared Pc conjugates to study the photophysical 
properties of these supramolecular nanoassemblies. Also, from pyridyl-Pors 
and ruthenium phthalocyanines (RuPcs) were performed Por-RuPcs arrays via 
coordination chemistry. The results obtained of the novel supramolecular 
assemblies showed interesting electron donor-acceptor interactions and might 
be considered attractive candidates for nanotechnological devices. 
On the other hand, the amphiphilic phthalocyanine-cyclodextrin (Pc-CD) 
conjugates were tested in biological trials to assess their ability to inhibit UM-
UC-3 human bladder cancer cells. The results obtained demonstrated that 
these photoactive conjugates are highly phototoxic against human bladder 
cancer cells and could be applied as promising PDT drugs. 
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Chapter 1 
General Introduction 
 
 
 3 
1.1 Phthalocyanines: General considerations 
 
The term phthalocyanine was suggested by Linstead, in 1933, to describe a class of 
blue-green pigments. This term comes from the combination of the prefix phthalo, 
highlighting the origin from phthalic anhydride and derivatives, and cyanine due to their 
dominating blue colour.
1 
 Phthalocyanines are a class of compounds of synthetic origin, 
structurally close to the analogous porphyrins (Pors), but with a core constituted by four 
isoindole units linked through aza bridges (H2Pc, Figure 1.1).
1
 
 
  
Figure 1.1 Structure of free-base phthalocyanine H2Pc. 
 
Pcs are one of the most widely used and studied classes of chromophores, as 
revealed by the plethora of applications were they are included.
1-3
  
The vast number of publications since their discovery
4
 and a high interest in the 
physical-chemical properties characterization attracted many researchers from 20
th
 
century.
5-13
 In 1907, Braun and Tscherniak detected the formation of a small amount of a 
blue compound when heated the o-cyanobenzamide.
14
 In 1927, Diesbach and von der Weid 
of the University de Fribourg described a high stable blue material during the chemical 
reaction of 1,2-dibromobenzene with copper cyanide in pyridine under reflux.
15-17
 
However, these researchers proposed an incorrect molecular formula of C26H18N6Cu.
15
 Six 
years later, in 1933, Linstead continued this investigation and identified the compounds as 
being the free and the Cu(II) complex of phthalocyanine. In the same period, Scottish Dyes 
Ltd. detected a highly stable and insoluble blue impurity when their employees were trying 
to produce phthalimide from phthalic anhydride and ammonia; this compound showed a 
high potential to be used as a pigment. In 1929, the economic interest of this pigment leads 
 4 
to create a patent, even without knowing the exact structure.
18
 In this sense, the company 
decided to send some quantity of this sample to Linstead. Finally, between 1933 and 1934, 
this researcher proved that the blue compound was the Fe(II) complex of phthalocyanine 
and the structure was confirmed by Robertson using the X-ray crystallography.
19-23
 
Following the Linstead study, the first one to use the name of phthalocyanine, two distinct 
synthetic routes were described to prepare phthalocyanines: one of them involved the use 
of o-cyanobenzamide as starting material, and the other the use of phthalonitrile 
precursors.
24-27
 With these developments, in 1935, the Cu(II) phthalocyanine was 
synthesized at industrial scale and used as a blue pigment until nowadays. The Linstead 
investigations were encouraging for the paint industry, but in case of the scientific areas 
the insolubility of these pigments limited their use. 
Only in the 60s, when Lukyanets tried to continue the Pcs investigation and 
reported the synthesis of highly soluble Pc derivatives, the phthalocyanine chemistry won 
importance among many synthetic organic researchers. In the period of 1965-2001, over 
5000 works on Pcs and their derivatives, including research papers and patents, concerning 
the synthesis, characterization and applications were published.
28
 Interestingly, in 1983, 
Frank H. Moser and Arthur L. Thomas published two volumes on Pcs
29,30
 dedicating a 
especial chapter focused on the physical properties of these dyes with information related 
to the effects of temperature, pressure, electromagnetic radiation and particle impact on 
Pcs. These books also cover the properties of the Pcs in solutions and on surfaces, 
experimental techniques and analytical methods used for their characterization, and also 
theoretical calculations.
1
 
In 2000, it was also published a concise review of the physical properties of Pcs 
written by Lobbert
31
 in the Ullmann's Encyclopedia of Industrial Chemistry, which offers 
the information about: density, appearance, sublimation points, solubility and thermal 
stability of Pcs; particle size; colour properties; crystal structure and polymorphism; 
surface and interfacial properties; physical investigations [absorption, fluorescence, 
phosphorescence, nuclear magnetic resonance (NMR), infrared (IR) and Raman spectra; 
determination of electric, photoelectric and magnetic properties; Mossbauer analysis, 
ESCA, inelastic tunnelling spectroscopy, field ion and field electron microscopy].
31
 In the 
last 13 years, from 2002 until 2014, occurred a boom in the phthalocyanine research and 
were published over 12000 works (923 papers per year) in scientific journals which 
considerably reveal the enormous interest of the phthalocyanines until nowadays. 
 5 
However, the evolution of the chemistry of phthalocyanines has not only been 
focused at finding synthetic strategies that provide increasingly “sophisticated” 
phthalocyanine structures. The called analogues of phthalocyanines, namely 
subphthalocyanine, naphtophthalocyanine, tetrapirazinoporphyrazine and 
hemiporphyrazine (Figure 1.2) also represent a number of structural variations of the basic 
macrocycle ring.
32,33
 
 
Figure 1.2 Examples of phthalocyanine analogue structures. 
 
1.2 Aromaticity and optical properties 
 
Phthalocyanines are structurally related with porphyrins but contrarily to the last 
ones do not occur in nature. These aromatic compounds were one of the first macrocycles 
 6 
synthesised in the organic chemistry laboratories. The main attention devoted to these 
structures is correlated with the striking resemblance with the heme group and chlorophylls 
were the phthalocyanines have being used as models for these biomolecules. The aromatic 
structure of the metal-free unsubstituted phthalocyanine molecule is constituted by 18 π-
electron pairs and according with the International Union of Pure and Applied Chemistry 
(IUPAC), all atoms are numbered except the fused carbons between the pyrrole ring and 
the benzene ring (Figure 1.3).
34
 This type of macrocycle formed by four isoindole groups 
can also be called tetrabenzotetraazoporphyrin or tetrabenzoporphyrazine. The macrocycle 
evidences sixteen possible sites for substitution in the four benzo-subunits: eight peripheral 
β-positions (2,3,9,10,16,17,23,24) and eight non-peripheral α-positions 
(1,4,8,11,15,18,22,25). These positions can be substituted by several organic units. 
Substitutions in the α,β-positions improve the solubility of the phthalocyanines in the most 
organic and aqueous solvents depending on the groups.
35
 
 
 
Figure 1.3 IUPAC numeration of the free-base phthalocyanine. 
 
One of the most extraordinary features of the Pc macrocycle core is their versatility 
to incorporate some chemical elements. One of the first systematic studies on the variations 
of nonlinear optic (NLO) properties of modulated Pcs was presented in 1991 and 
concerned the characterization of Pcs having different central metal atoms “M” (Figure 
1.4).
36
 The hydrogen atoms of the central cavity of the Pc may be replaced by more than 
seventy elements of the periodic table giving rise to metallophthalocyanine (MPc), which 
can be regarded as very weak dibasic acid.
37
 Hence, one of the most synthesized MPc in 
large scale was phthalocyaninato Cu(II). 
 
 7 
 
Figure 1.4 a) Disposition of MPc, which symbol “M” can represent monovalent or 
divalent entities. b) Structure of phthalocyaninato Cu(II). 
 
The unsubstituted phthalocyanines exhibit high thermal and chemical resistance, 
which is an important role for the most technological applications. Their major drawback 
lies with the fact of the highly insoluble compounds, are only dissolved in solvents with 
high boiling point such as quinoline, chlorobenzene or 1-chloronaphthalene, or strong 
mineral acids due to their natural tendency to stack (π-π stacking). Also, the versatility of 
these aromatic structures, not only allows the incorporation of specific substituents, in the 
isoindole rings, but also certain central metals can be co-axially functionalized. Usually, 
co-axially functionalized derivatives are highly soluble, since the π-π-stacking is 
drastically decreased.
38-40
 
 
Phthalocyanines and their analogues have been used as components of artificial 
photosynthetic devices, due to their unequivocal photophysical features.
41-47
 In this respect, 
phthalocyanines hold some advantages comparing to other photoactive porphyrinoids. 
Attending to the extended network of conjugated electrons, which are delocalized over 
four isoindole units bridged by eight azamethines, these compounds have subsequently 
high molar absorption coefficients in the red region of the electromagnetic spectrum and 
fast energy and/or electron transfer abilities to electron acceptor counterparts. The 
explanation for this phenomenon is the structural differences of the two tetrapyrrolic 
macrocycles: the higher electronegativity of the nitrogen atoms in the aza bridges than of 
carbon atoms, which attract a self-around the π-electron density and the benzene rings 
fused allow the extend the π-electronic system.48,49 
The typical electronic spectrum of a metal phthalocyanine complex shows a broad 
band around 300-400 nm called Soret-band (S- or B-band) and an intense Q-band situated 
in the range of 600-750 nm (Figure 1.5).
50-52
 This narrow and intense Q-band is responsible 
for the blue-green colour of these dyes. In case of free-base phthalocyanines, the 
macrocycle have less symmetry and consequently show a split of the Q-band (Figure 
 8 
1.5).
49
 The strongest Q-band absorption of H2Pc and ZnPc, can be attributed to the 
absorption of light and consequently excitation of electrons from the highest occupied 
molecular orbital (HOMO), namely the π-transitions, to a transition of the lowest 
unoccupied molecular orbital (LUMO), namely the π*-transitions (Figure 1.6).48,49 
 
 
Figure 1.5 Ultraviolet–visible (UV-Vis) spectra of free-base H2Pc (D2h) and metal 
complex ZnPc (D4h).
53
 
 
 
 
Figure 1.6 Electronic transitions of the Q- and S-bands of the phthalocyanine. 
 
It is also noteworthy, that the position, appearance and intensity of the Q-bands 
depend on the Pc peripheral substituents, metal insertion, solvent and if the macrocycle is 
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aggregate or not. The nature and the oxidation state of the metal ion and the expansion of 
the macrocycle aromatic system can also affect its electronic features.
49 
 
1.3 Synthesis of phthalocyanines 
 
A great variety of precursors can be used in the synthesis of phthalocyanines, such 
as: o-cyanobenzamide, phthalic acid, phthalic anhydride, phthalimide, diiminoisoindoline 
and phthalonitrile (Figure 1.7). One of the most common precursors are the phthalonitriles, 
that depending on the reaction conditions can initially be transformed into a 
diiminoisoindoline derivative via reaction with ammonia, followed of condensation, 
usually in alcoholic solutions at high temperatures. It is noteworthy, that the use of a 
catalytic organic base, for example, 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) or 1,5-
diazabicyclo[4.3.0]non-5-ene (DBN) in pentanol
54,55
 or 2-dimethylaminoethanol (DMAE) 
as solvent, is possible to get many desired Pcs in high yields.
56
 
 
 
Figure 1.7 Synthetic routes for the synthesis of free-base H2Pc. 
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However, reactions with other precursors, like phthalimide, phthalic acid and 
phthalic anhydride require urea as nitrogen donor. In order to prepare free-base Pcs, it is 
common the use of lithium or magnesium, as template, followed by demetallation of the 
obtained Pc complexes in dilute acidic conditions. 
The access to MPcs can involve two different approaches: in one of them the metal 
is inserted directly in the macrocycle during the tetramerization process using a 
phthalonitrile and an adequate metal salt;
57
 and other strategy is by metallation of H2Pc 
previously prepared (Scheme 1.1).
58
 
The synthesis of free-base and metal complex phthalocyanines containing the same 
type of substituents in all four isoindole rings (A4) can be performed by 
cyclotetramerization of the same suitable substituted precursor (Scheme 1.2).
59
 Depending 
on the precursor, nature of the substituents and metal to be inserted into the macrocycle, 
have been used a wide range of reaction conditions: reaction time, temperature, solvent, 
type of atmosphere, base and catalyst selected.
60
 
 
 
Scheme 1.1 
 
To prepare metal complexes of phthalocyanines it is necessary to heat a mixture of 
a phthalonitrile derivative and a metallic salt choosing a solvent with a high boiling point, 
such as DMAE, N,N’-dimethylformamide (DMF) or 1-chloronaphthalene.28 On the other 
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hand, there are procedures that can be carried out at lower temperatures, by using for 
example a basic catalyst such as DBU in pentan-1-ol,
54
 or even at room temperature by 
using lithium in DMAE.
61
 This methodology allows the synthesis of MPcs with different 
metallic salts in specific heating conditions (Schemes 1.1 and 1.2). 
 
 
Scheme 1.2 
 
Taking advantage of established knowledge about synthesis or chemical 
modifications of Pcs
35
 and also about the linkage of some species,
62,63
 different synthetic 
approaches were considered to obtain several conjugates.
35
 In most of those approaches, 
the different suitable groups are incorporated previously in the precursors during the first 
synthetic procedure to allow and simplify the achievement of the desired phthalocyanines. 
In this sense, when chosen a symmetrically disubstituted precursor, the final product is a 
symmetric phthalocyanine derivative with all α- or β-positions completely substituted 
(Figure 1.8).
35
 On the other hand, the use of monosubstituted precursor in the position 3 or 
4 (IUPAC numeration, Figure 1.3) is generated a mixture of four isomers (Figure 1.9) 
which are particularly difficult to separate by chromatography techniques. Nevertheless, 
mono-, di, tri- and tetra-substituted phthalocyanines have interesting applications
35
 and in 
these cases several chromatography techniques have been developed to purify all the 
structural isomers.
64,65
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Figure 1.8 Structural of symmetric phthalocyanines. 
 
 
 
Figure 1.9 Four structural a) β-isomers and b) α-isomers of phthalocyanines performed 
from a monosubstituted precursors. 
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The details of the phthalocyanine mechanism and the exact and unambiguous 
course remain still unclear. A purposed mechanism of the synthesis of MPcs is exemplified 
in Figure 1.10 where it is possible to observe stepwise the formation of potentials 
intermediaries.
28
 
 
 
Figure 1.10 Possible mechanism of the MPc formation with the corresponding 
intermediaries. 
 
The tetramerization of phthalonitriles in the presence of alkali metals, such as Li or 
Na, using an alcohol as solvent with a high boiling point, resulted initially in the specie 
RCH2O
-
 and in the separation of the anionic forms 1.3A and 1.3B. It is noteworthy that the 
obtained structure 1.3A can be formed and preferential favoured in the presence of 
alcohols with a short chain, such as methanol or ethanol, while other alcohols with a larger 
chain favoured the formation of 1.3B. It is possible that both forms are in the reaction as 
intermediates leading the formation of the phthalocyanine in pentan-1-ol at high 
temperature.
28
 Curiously, the intermediate of type 1.4 is formed in good yield when the 
reaction is carried out between the 4-nitrophtalonitrile and lithium methoxide around 120 
°C.
55
 In case of the intermediate 1.5, composed by coordination of two moieties 1.4 with a 
metal ion of Ni(II), was isolated after reaction in pentan-1-ol at reflux. Subsequently, 
heating the obtained complex 1.5 in the same solvent assisted the formation of metallated 
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phthalocyanine with Ni(II) that leads concomitantly pentanol and pentanal liberation.
66
 The 
cyclization of the ring and the corresponding intermediary eventually depends of the 
intermediary 1.6 where the ring closure is driven by the thermodynamic stabilization and 
the aromaticity involved. The formation of 1.6 can also occurs via sequential addition of 
two phthalonitrile molecules or diiminoisoindoline to the intermediate 1.4.
28
 
The synthetic procedures from diiminoisoindoline with addition of an organic base, 
such as DBU, DBN or NH3, provide a tetramerization mechanism similar to the previously 
one described, however the alkoxide RCH2O
-
 is formed by the action of the organic base.
28
 
 
The synthesis of phthalocyanines involves nucleophilic aromatic substitution 
reactions and obviously electrophilic aromatic substitutions. However, when preceded to 
the halogenation, sulphonation or nitration of the phthalocyanine macrocycle results 
inevitably a mixture of compounds with different substitution degrees.
34
 These compounds 
are particularly difficult to dissolve and subsequently their functionalization wins a high 
interest. In this sense, the use of substituted precursors
67
 enables the achievement of 
substituted phthalocyanines with appropriate groups.
28,32
 
 
1.4  Phthalocyanine applications 
 
Phthalocyanines
34
 have also been intensively studied due to their unequivocal 
applications in several scientific areas, namely as: i) biomimetic models of photosynthetic 
primary processes;
34
 ii) catalysts
68,69
 or photocatalysts
68,70
 and iii) photosensitizers (PSs) or 
markers in photomedicine.
71
 More recently they have also been combined with 
nanomaterials to exploit the nanohybrid material features in nanosciences and different 
nanotechnological applications. 
 
1.4.1 Phthalocyanines as electroactive molecules for supramolecular 
interaction with carbon nanostructures 
 
The preparation of supramolecular carbon nanostructures (graphene, single-walled 
carbon nanotubes and fullerenes) with organic compounds present a certain degree of order 
(where it is possible to observe nanoscopic to macroscopic multiple scales), highly 
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desirable with the fast-growing of nanoscience and nanotechnology fields.
72-74
 In this 
perspective, the use of self-assemblies is an attractive strategy for the functionalization of 
organized structures to perform multifunctional systems by efficient noncovalent 
interactions. Among the organic compounds, the π-conjugated phthalocyanine molecules 
are interesting candidates for the construction of such supramolecular arrays due to their 
self-assemble capabilities.
75
 
The interesting organization capability of Pc derivatives and their exceptional 
physicochemical features have prompted their utilization as photoactive components in 
different technological fields, such as nanosensors, molecular photovoltaics, liquid crystals 
and nanotransistors, where the supramolecular organization is considered fundamental for 
an efficient application.
58
 
Among the most important photoactive phthalocyanine features, it is noteworthy 
their redox reactions and their strong extinction coefficients of absorption in the red/near-
infrared (NIR) region of the solar spectrum and also high fluorescence quantum yields, 
which render them attractive candidates for light-harvesting antenna structures. Thus, these 
unequivocal photophysical properties have promoted their utilization as multifunctional 
nanomaterials in donor-acceptor arrays.
74
 In this sense, Pcs have been employed for the 
preparation of covalent and noncovalent donor-acceptor systems based on Pcs with 
graphene, carbon nanotubes (CNTs) or fullerenes (C60). In this approach, the relevant 
synthetic strategies for the preparation of supramolecular heterochromophoric systems, 
based on phthalocyanine derivatives, leads to a large variety of carbon nanostructures 
assemblies. In these systems, the degree of electronic interaction between the components 
is highly dependent on their electronic characteristics, interaction type, and molecular 
topology of the ensemble. 
 
Photoinduced electron process 
 
The process of photoinduced electron transfer (PET) is a key role in supramolecular 
chemistry and/or biology areas.
76
 It is noteworthy that in chemistry during the last century 
have been developed supramolecular-based artificial solar energy harvesting systems with 
ability to absorb light from the sun for convert it to useful and storable forms. In this sense, 
one procedure to store solar energy is in chemical energy form, evidenced efficiently for 
example during photosynthesis of the plants.
77
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For an efficient artificial solar energy converting systems, some requirements are 
needed: i) the light irradiation must be absorbed by antenna molecules as sensitizers, 
leading to excited states; ii) the light absorption must allow the transference of an electron 
to the acceptor unit; iii) the electron transference must be steered; and iv) the lifetimes of 
the excited states must be high for electron transfer. Indeed, the intermolecular PET is just 
an easy process where an electron is transferred from an electron-donor specie (D) to an 
electron-acceptor specie (A), producing the radical cation of the donor (D
•+
) and the radical 
anion of the acceptor (A
•−
), when one of these species is photoexcited upon irradiation.
78,79
 
If these charged species are used as electrons and holes to line up electrical energy or 
provide chemical reactions before back electron transference driving to the initial states of 
the reactants arises (Figure 1.11), which the light energy is converted into electrical or 
chemical energy. A critical factor in PET is evidenced in the successful matching of D and 
A with suitable electrochemical and photophysical characteristics for the existence of an 
exothermic ET.
77,78
 It is important to know that the excited state energies of the 
chromophores and the redox potentials of D and A species are unequivocally an essential 
condition to study PET processes. The main interest on the phthalocyanines 
photochemistry is the challenge to mimic the photosynthetic processes, where 
phthalocyanine derivatives have been extensively used as sensitizers and as electron donor 
system.
80,81
 
 
 
Figure 1.11 Energy diagram of the PET processes in donor-acceptor systems: HT refers to 
hole transfer step in the presence of hole acceptor (H) and EM refers to an electron 
mediation step in the presence of an electron mediator (M). 
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Interesting is that each intramolecular decay step of an excited molecule is 
characterized by their own rate constant and each excited state is evidenced by their 
lifetime. In solution, when the intramolecular deactivation processes are not fast, mainly 
when the lifetime of the excited state is appropriately long, an excited molecule *A may 
have a chance to find a molecule of another solute, B. In this case, specific interactions can 
lead to the deactivation of the excited state by second order kinetic processes. The two 
most important types of interactions in an encounter are those leading to electron or energy 
transfer observed below: 
 
*A + B → A+ + B- oxidative electron transfer (eq. 2.1) 
*A + B → A- + B+ reductive electron transfer (eq. 2.2) 
*A + B → A + •B energy transfer (eq. 2.3) 
 
 It will be emphasized the electronic interactions between carbon nanostructures and 
phthalocyanine derivatives, as well in multichromophoric supramolecular arrays. 
 
A short view of graphene, carbon nanotubes and fullerenes chemistry 
 
In the last years, the nanoscience field has had over the years a considerable growth 
in all areas of research and technologies. A prove of this importance can be obtained from 
Figure 1.12, which show fantastic economic scenarios for nanotechnology. Although the 
forecasts differ significantly from each other they both predict a substantial increase of 
nanotechnological products starting in the early 2010s.
82,83 
 
Figure 1.12 World market forecasts for nanotechnology in billion US Dollar.
84
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The nanotechnology is the conception and exploitation of materials, devices, and 
systems through the control of matter on the nanometer-length scale, i.e., at the level of 
atoms, molecules, and supramolecular structures. This term is applied to describe the 
creation and employment of functional structures with at least one typical dimension 
measured in nanometers (a nanometer is one billionth of the meter – 10-9 m).85 
Carbon nanostructures can be associated with many structures/molecules, such as 
Pors and Pcs by covalent or supramolecular interactions. These porphyrinoids are 
multiconjugated chromophores able to absorb UV-Vis light and can be excellent electronic 
donor-acceptors. With these systems it can be possible to combine the unique optical 
properties of both components; dyes (Por and Pc) and carbon nanostructures, and prepare 
hybrids with interesting properties.
74,86 
The unidirectional and exponential growth of 
materials to create nanostructures has attracted a colossal interest in the middle of 20
th
 
century, with the discovery and proposed term of graphene as a combination of graphite 
and the suffix -ene by Hanns-Peter Boehm.
87
 He described the carbon nanosheets in 
1962,
88,89
 but the structure was just isolated in 2004 by Novoselov.
90,91
 Since the 
pioneering work by Novoselov et al. graphene is one of the first two-dimensional (2D) 
atomic material, which is readily available. This nanostructure revealed interesting 
electrical, mechanical, and thermal features, namely high carrier mobility, ambipolar 
electrical field effect, tunable band gap, room temperature quantum hall effect, high 
elasticity, superior thermal conductivity, etc.
92
 Taking the aforementioned into concert, 
graphene bears great promises to replace existing materials in emerging applications.
93
 In 
Figure 1.13 are represented four kinds of π-conjugated systems of different dimensions, 
namely polyacetylene (Figure 1.13a); a 1D system which can be rolled up to form a series 
of annulenes (Figure 1.13b), each being a quasi-0D system; graphene a 2D system, which 
can be rolled up to perform a series of SWNTs (Figure 1.13c), each being a quasi-1D 
system. 
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Figure 1.13 Four π-conjugated systems of different dimensionalities: a) polyacetylene; b) 
annulenes (cyclobutadiene, benzene, cyclooctatetraene, annulene, etc.); c) graphene; d) 
SWNT. Classical aromatic and antiaromatic structures are painted green and red, 
respectively.
109
 
 
After the discovery of the firsts nanomaterials, fullerenes surged in 1985
94
 followed 
of the CNTs that were immediately discovered in 1991,
95
 and since then the research in 
this exciting field has been in continuous evolution.
96,97
 CNT consist on graphene 
nanosheets, which have been rolled up into a tubular and cylindrical shape generating 
single-walled carbon nanotube (SWNT) and multi-walled carbon nanotube (MWNT), all 
represented in Figures 1.14 and 1.15. 
 
 
Figure 1.14 Graphene as the rudimentary unit of fullerene (0D), carbon nanotubes (1D) 
and graphite (3D).
92 
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Figure 1.15 – Conceptual diagram of a) SWNT and b) MWNT showing typical 
dimensions of length, width and separation distance between graphene rolled layers in 
MWNTs. 
 
It is noteworthy that the length of CNT is in the size of micrometres with diameters 
up to 100 nm. CNT form bundles, which are entangled together in the solid state giving 
rise to a highly complex network. Thus, CNTs can be metallic or semiconducting 
depending on the arrangement of the hexagon rings along the tubular surface. A major 
critical issue toward their widespread application in nanotechnology is the control of their 
electronic properties, in their pristine form, which depends on their diameter and 
chirality.
98,99
 
The concepts of aromaticity, highest occupied molecular orbital (HOMO), and 
lowest unoccupied molecular orbital (LUMO) are of fundamental significance in 
understanding the chemical stability and reactivity of CNTs conductivity, namely of their 
metallic or semiconducting properties. Both metallic and semiconducting carbon nanotubes 
have positive resonance energies, although “metallic” nanotubes are slightly less aromatic 
than the semiconducting ones.
100-102
 This aromaticity confers to both types of nanotubes a 
relative similar thermodynamic stability. On the other hand, the kinetic stability of 
polycyclic aromatic complexes is usually more associated to their HOMO-LUMO energy 
gap than to their resonance energy.
103,104
 Indeed, the effect of the geometric structure of 
CNTs on their electronic arrangement and chemical reactivity can be intuitively 
appreciated by an illustrative analogy between the imaginary process of rolling up a 
polyacetylene to form annulenes and the roll-up of graphene to form SWNTs.
105,106
 Thus, 
semiconducting nanotubes are equivalent to [4n+2]annulenes, which are usually 
considered aromatic by the Hückel rule, whereas metallic nanotubes are corresponding to 
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[4n]annulenes, which are often considered nonaromatic by the Hückel rule, even though 
only small ones, such as cyclobutadiene, have negative resonance energies.
107-109
 
 
Nevertheless, the lack solubility and the complicated handling in any solvents have 
imposed enormous limitations to the use of carbon nanostructures, mainly graphene and 
carbon nanotubes. In fact, when graphene and carbon nanotubes are prepared they are 
insoluble in all organic solvents and aqueous solutions. They can be dispersed in several 
solvents by ultrasonication, but a precipitation occurs immediately when it is interrupted 
the sonication process. On the other hand, it has been demonstrated that these structures 
can interact with diverse classes of compounds.
110-116
 The structure of supramolecular 
complexes allows a better processing of carbon nanostructures toward the fabrication of 
unique and specific nanodevices. More, they can suffer chemical reactions that can provide 
solubility, making easier their integration into inorganic, organic, and biological 
systems.
74,116,117
  
The key approaches to change the physicochemical properties of these carbon 
allotropes can involve the following two approaches: i) covalent derivatization with 
functional groups directly on their skeleton; or ii) noncovalent interactions, through 
adsorption or wrapping with functional molecules. However, in case of CNTs is possible to 
occur an endohedral filling of their internal empty cavity. 
 
1.4.2 Covalent and noncovalent functionalization of carbon nanostructures 
 
The covalent functionalization is based on covalent linkage of functional entities 
onto the carbon nanostructures scaffold. This functionalization can occur on their sidewalls 
of the graphene,
118
 CNTs
119
 and fullerenes,
120
 but also in the termini of the graphene 
nanosheets or nanotubes. Direct covalent sidewall functionalization is related with a 
change of hybridization from sp
2
 to sp
3
 and a simultaneous loss of electronic conjugation. 
It is noted that defect functionalization takes disadvantage of chemical modifications of 
defect sites because it can open ends and holes in the sidewalls, terminated, for example, 
by carboxylic groups, and irregularities in the hexagon graphene framework. Also 
oxygenated sites, formed through oxidative purification, can be considered as defects 
(Figure 1.16).
118-124
 On the other hand, the noncovalent functionalization of the carbon 
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allotropes is principally based on supramolecular assemblies using various adsorption 
forces, such as Van der Waals and π-stacking interactions.118,123,126-129  
 
 
Figure 1.16 Functionalization of carbon allotropes: a) Covalent functionalization of 
fullerenes,
130
 CNTs
131
 and graphene
118
; and b) Noncovalent functionalization of 
fullerenes,
132
 CNTs
131
 and graphene.
133
 
 
Covalent and noncovalent functionalization of carbon nanostructures conjugates 
 
In the case of covalent functionalization sidewalls are directly functionalized by 
oxidation or reduction, and subsequently derivatised with a variety of different molecules, 
and by several addition reactions.
134,135,137
 The outside skeletal functionalization is possible 
using various methodologies, namely: fluorination, ozonolysis, hydrogenation, 
halogenation, cycloadditions, radical additions, electrophilic additions, osmylation, and 
nucleophilic additions.
136-138
 
The structures of graphene and carbon nanotubes can react with different reagents, 
which proportionate the addition of some groups/molecules to the structure side-wall.
118,139
 
Studies of the chemical reactivity of these derivatives had attributed a main role to induced 
local strain, which arises from disruption of the sp
2
-hybridized (trivalent) carbon atoms and 
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π-orbitals misalignment between adjacent carbon atoms.100,118,139,140 This methodology 
represents a chemical view of the electronic structure of carbon nanostructures, which fits 
into the molecular orbitals description of organic reaction mechanisms.
140
 This surface 
modification of the scaffold is important because allows the incorporation of external 
molecules allowing a significantly hydrosolubility when attached to biopolymers, for 
example.
118,119,139-141
 
Moreover, it is necessary to take into account the type of interaction with the 
carbon allotropes, because the global properties of these compounds are modified 
according the covalent or noncovalent attachment.
118,130-132
 Indeed, the photophysical 
properties are different with the incorporation of some molecules such as 
phthalocyanines.
142
 Thus, the advance of novel porphyrinoid-based systems capable to 
absorb a higher scale of the solar emissions evidences an unquestionable importance, 
mainly the functions ranging from light harvesting through most of the visible part of the 
solar spectrum to electron transport.
142
 The redox properties of phthalocyanine derivatives 
can be analysed by electrochemistry or spectroelectrochemistry because the electro donor-
acceptor features are an interesting point for interaction with carbon allotropes. The 
remarkable characteristics of phthalocyanines, as well as porphyrins, can form building 
blocks with carbon allotropes as light-harvesting systems. These planar chromophores 
share important electronic features, mainly the redox conditions and simultaneously 
photoinduced energy and/or electron transfer, which these features can be modified with 
incorporation of different peripheral substituents and metal centres.
92,142
 
An alternative way to render carbon nanostructures soluble in a wide range of 
solvents is based on their noncovalent hydrophobic and π-π stacking interactions with 
interesting phthalocyanine derivatives attending their electronic features. The main goal of 
these carbon allotropes is their functionalization via noncovalent interactions, where the 
aromatic structure and their electronic characteristics are preserved.
133,143,144
 
In this sense, the exfoliation and supramolecular derivatization of graphite was 
achieved, for example, using a zinc phthalocyanine oligomer that is also an electron donor 
(Figure 1.17) as described by Guldi and co-workers.
133
 The Pc derivatives interact tightly 
and reversibly with graphene, performing stable dispersions with high concentrations of 
mono- to few-layer graphene. 
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a) 
 
b) 
 
Figure 1.17 a) Supramolecular exfoliated NG/Pc assembly; b) Electron-transfer pathway 
in the exfoliated NG/Pc hybrid.
133
 
 
In fact, it was observed interesting exfoliated NG/Pc hybrids with strong electronic 
coupling between the single components (Figure 1.17a) that allows characteristic 
absorptions and a close quantitative fluorescence quenching. Moreover, the transient 
absorption measurements determined interactions with electron transfer from the Pc 
derivative to the graphene nanosheets (Figure 1.17b), both in the ground and excited state. 
This methodology was used to prepare individual graphene nanolayers by wrapping on 
their surface several organic Pc molecules and these hybrid materials are constructed as 
active layer and transparent electrode materials for solar-cell systems.  
For example, another supramolecular approach based on π-π stacking interactions 
between pyrene derivatives and SWNTs has also an advantage of being non-destructive sp
2
 
structures with respect to the nanotubes, and consequently is useful for applications where 
the conducting properties of the CNTs are nowadays exploited (Figure 1.18).
145
  
The noncovalent modification of the CNT surface has emerged as a potent and 
viable strategy safeguarding unequivocally the unique electronic, physicochemical and 
mechanical properties of CNTs.
146
 In this context, pyrene derivatives have played a leading 
role to immobilize Por 1.7,
147-150
 chlorins 1.8
151 
or fullerenes 1.9
152
 onto CNTs (Figure 
1.18). 
Interactions between different dyes with planar structures have been showing 
interesting adsorption properties and play a significant role also in supramolecular 
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chemistry.
153
 It has been well documented that different conjugated aromatic units have 
preferences to associate on the SWNT surface by host-guest interactions promoting 
aromatic association.
154-157
 These macrocyclic dyes can be planar or non-planar with a 
flexible or rigid framework
158
 enhances a specific face-to-face orientation around the 
SWNT scaffold.
159
 Depending of these molecules type it’s possible to obtain electronic 
transitions between the aromatic macrocycle and SWNT, establishing potential electronic 
donor-acceptor properties.
152
 The association of SWNT with electron-donors or acceptors 
produces active materials, which are able to generate electrical energy when irradiated.
160
 
Indeed, the development of trustworthy and reproducible procedures to incorporate CNT 
into functional assemblies, like donor/acceptor hybrids to convert sunlight into electrical or 
chemical energy, has emerged as an interesting research area. In this way, phthalocyanines 
and SWNT are promising building blocks in donor-acceptor devices for solar energy 
conversion, which is nowadays an important research topic to produce innovative 
materials, composites, and electronic devices of greatly reduced size. 
 
 
Figure 1.18 Pyrene derivatives as electroactive units for immobilization onto the CNT 
surface. 
 
Guldi and co-workers developed an strategy to immobilize functional Pcs onto the 
SWNT surface without covalent functionalization, using substituted poly(p-phenylene 
vinylene)-oligomers (or PPV-oligomers) with a different electronic character.
161
 The 
complementary use of a series of microscopy and spectroscopy techniques is fundamental, 
particularly to gather a comprehensive representation of the supramolecular interactions. 
After photoexcitation of an SWNT/Pc 1.10 hybrid, it was evidenced a metastable radical 
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ion pair state, namely oxidized Pc and reduced SWNT (Figure 1.19). In this sense, rather 
significant is the ratio of charge separation to charge recombination, specifically near of 3 
orders of magnitude, which is promising to construct photovoltaic cells established, for 
example, on different carbon nanostructures.
161
 
 
a)
 
b)
 
Figure 1.19 a) Pc-oligomer 1.10 derivative; b) Tuning and optimizing the intrinsic 
interactions between phthalocyanine-based oligomers 1.10 and SWNTs toward n-type/π-
type systems. 
 
Likewise, Nyokong have been developed interesting pyridyl Pcs 1.11 due to their 
assembly properties with SWNTs.
162,163
 The authors functionalized covalently SWNTs 
with amine groups using a previously developed diazonium approach, to improve the 
dispersion in organic solvents. The amine functionalized SWNTs showed a significant 
increase in the intensity of the D-band upon amine functionalization, a feature indicative of 
disruption of the sp
2
 carbon hexagonal lattice to sp
3
 bonded carbons. The authors showed a 
sidewall functionalization as a result of the covalent attachment of the ethylamine groups, 
the increased D-band intensity is more accurately expressed with respect to the G-band in 
the form of a D:G ratio (sp
3
:sp
2
 carbon ratio).
162
 After that, was shown a SWNT/Pc 1.11 
supramolecular complex obtained via supramolecular π–π stacking interactions between 
the Pc planar units and the unpristine carbon nanotube surface (Figure 1.20). 
The presence of a covalent bond in the linked form limits the extent of 
decomposition attainable, for the same functional groups. Indeed, rapid deactivation of 
fluorescence was found upon introduction of SWNTs as revealed by the fluorescence 
spectra and showed also low fluorescence quantum yields.
162
 Additionally, it was expected 
that the pyridine groups could coordinate with the central metal of the macrocycle core of 
the neighbouring molecules, and in that way forming a random 3D network able to 
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encapsulate the SWNTs. This strategy could bring closer the Pc macrocycles around the 
SWNTs providing a compact assembly also via coordination chemistry. 
 
 
Figure 1.20 Pc 1.11/SWNT supramolecular complex. 
 
The importance of the presence of pyridyl units in dye derivatives it is a 
methodology to prepare compact supramolecular array as reported by Cook and co-
workers.
164,165
 Pyridyl groups placed at the bay region of a porphyrin coordinate with 
ruthenium phthalocyanine (RuPc) units to perform structural hybrids to promote electronic 
coupling systems. The starting topic of synthetic photosynthesis is an arrangement of light-
induced energy- and electron-transfer reactions. In this way, centres mimicking the light-
harvesting and reaction processes should comprise light-absorbing chromophores, acting as 
antenna molecules and excited-state electron donors, and additional electron acceptors.
166
 
 
Torres and co-workers proved as a versatile approach for designing a novel electron 
donor/acceptor hybrid perylenediimide-[RuPc]4 1.12 via metal coordination, in which four 
pyridines placed at the bay region of a perylenediimide coordinate with four RuPc units 
(Figure 1.21). The structural system was projected to provide electronic coupling between 
the electron donors-acceptors, confirmed by physicochemical properties. Indeed, the 
absorption and electrochemical assays revealed a remarkable redistribution of electron 
density from the electron-donating RuPc to the electron-accepting perylenediimide. It is 
noteworthy, that the RuPc are oxidized and the perylenediimide reduced rendered more 
difficult in the supramolecular array than in the individual building blocks. Therefore, in 
the excited state, strong electronic communication is the inception for a rapid charge-
transfer process in photoexcitation process. 
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a)
 
b)
 
Figure 1.21 a) Structure of perylenediimide-[RuPc]4 1.12; b) Energy-minimized of 
structure 1.12. 
 
1.4.3 Phthalocyanine derivatives as photodynamic therapy agents 
 
In addition to the electronic applications previously described, phthalocyanines 
have also a prominent role in medicine, particularly in photodynamic therapy (PDT)
167,168
 
photodynamic inactivation (PDI)
169
 and as markers.
170
 Since Pcs are photoactive molecules 
that can absorb and emit light in a large range of the UV-Vis spectrum, these 
characteristics make them also useful probes for photodiagnostic applications and/or in the 
study of basic cellular processes.
171
 For all this, in biomedical/environmental applications 
are necessary to guarantee a good solubility in biological media. This can be reached by 
combining different amphiphilic units, such as cationic pyridinium groups
172,173
 or 
cyclodextrin (CD) units
174,175
 to the macrocycle. In presence of molecular oxygen 
3
O2 and 
upon photoexcitation with a specific light, this class of compounds can promote the 
production of reactive oxygen species (ROS), mainly singlet oxygen (
1
O2), which can 
induce cellular dead.
28
 The combination of these characteristics makes them potential 
photosensitizer agents in PDT, PDI and/or fluorescent tags. 
In general, the topical or systemic administration of a PS is initiated by its 
preferential accumulation in cells of rapidly division like neoplastic tissues. Then, the 
target tissue is irradiated with a suitable light that enables the excitation of the PS from its 
singlet ground state (S0) to excited state of higher energy (S1) – Figure 1.22. This excited 
state can then decay through a phenomenon of intersystem crossing (ISC) to a lower 
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energy state with a longer life time, the triplet excited state (T1).
176,177
 The PS, in this 
excited state, can instantaneously respond in two different ways: 
- Type I mechanism which involve reactions of electron transfer from the 
photosensitizer in the triplet excited state to a substrate yielding radical ions. When the 
substrate is the molecular oxygen occurs formation of O2
·-
 species, which easily converts in 
radical species, followed of easily conversion in reactive radical specie of OH
·
. These 
cytotoxic species can subsequently react with other organic substrates yielding a chain of 
oxidative processes.
178
 
- Type II mechanism which involves energy transfer from the triplet state of the PS 
to the triplet ground state of the molecular oxygen (
3
O2) converting into singlet oxygen 
(
1
O2). This reactive cytotoxic specie is able to oxidize biomolecules such as proteins, lipids 
and nucleic acids.
179
 
 
 
Figure 1.22 Jablonski modified diagram representing the excitation and relaxation of a PS, 
and type I and type II photoreactions. S0 = ground singlet state; S1 = first excited singlet 
state; T1 = first excited triplet state. 
 
Probably the two processes act in simultaneous. However, the mechanism of type II 
is predominantly and the singlet oxygen is considered the most important cytotoxic specie 
in the photodynamic process; however mechanism of type I can be more significant in 
environments with low oxygen level. In addition, the ROS in both mechanisms provide 
oxidative reactions that induce cell death and consequently tumour destruction. 
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The increase of pathogenic of resistance microorganisms in infection diseases
180-184
 
and/or in contaminated environments
185,186
 have been exploited by many researchers to 
develop new methodologies to guarantee their well-successful inactivation.
187
 The same 
can be said about the successful development of new methodologies for cancer treatment. 
In both applications, several molecules have been used as PSs,
188-192
 for several infection, 
cancer and environmental problems. 
The emergent antibiotic resistance of pathogenic bacteria has encouraged numerous 
research groups to investigate the principle of PDI as an alternative antimicrobial therapy, 
where the metallated Pcs, upon photoexcitation with light, are able to photoinactivate 
different pathogenic microorganisms and could be an excellent approach to inactivate 
bacteria.
169,193
 
Despite of the existence of medical procedures against cancer cells (surgery, 
chemotherapy and radiotherapy), PDT has the advantage of being a selective treatment for 
early diagnosis and locally identified carcinomas, without harming the surrounding healthy 
tissues. The PS and light can be selectively focused to the damage localization
176
 and the 
high reduced life time of the main cytotoxic oxygen species in biological media, especially 
the singlet oxygen, limit the treatment exclusively to the area to be treated.
194
 The 
photodamage processes, initialized by PDT, lead to necrosis and/or to apoptosis and 
autophagy. The leading mechanism of the cell inactivation depends on the specific 
protocol used, such as the drug and light doses.
179
 
However, PDT efficiency is dependent of several other aspects, such as: the PS 
structure, its subcellular localization at the time of irradiation, irradiation magnitude and 
wavelength, sensitivity of tumour cells, tumour oxygenation level, among others.
178,195-198
 
Indeed, the efficiency of this medical procedure depends on the high light absorption 
features of the PS, mainly at the red region of the visible spectrum, its great selectivity to 
the target cells, minimal dark toxicity, and high singlet oxygen quantum yields formation, 
amphiphilicity features and others.
176,178,199,200
 PDT is considered an excellent strategy for 
the treatment of a large variety of tumours, age-related macular degeneration, and 
promising for the treatment of cardiovascular and infectious diseases.
176,182,201-203
 On the 
other hand, antimicrobial PDT has been suggested for dental applications, burn wounds 
and acne, mainly due to the easy access of the light source to these areas.
180,182,184
 
Amongst the various types of PSs used in PDT, Pors are the most extensively 
studied and the ones firstly approved for clinical applications. However, it is recognized 
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that even the most widely used formulation (Photofrin
®
) is far from being an ideal PS. It 
comprises a mixture of hematoporphyrin oligomeric derivatives, with considerable skin 
accumulation and reduced light absorbance capabilities in the red region of the 
electromagnetic spectrum, where light penetrates deepest into tissues.
202
 Due to this 
disadvantage, it has emerged a second generation of PDT agents based on chlorins
204
 and 
Pcs.
205
 These new PSs have an extraordinary absorbance in the visible red region of the 
electromagnetic spectrum, enabling both phototherapy and imaging to go deeper into 
tissues. However, all these types of macrocycle cores do not have appropriate 
biocompatibility requirements, mainly solubility in physiological fluids. For that, different 
delivery formulations, such as incorporation into liposomes,
206
 biopolymers,
207
 
cyclodextrins
208
 and more recently into dendrimers
209
 have been explored. In fact, the 
different photodynamic activities can be associated to their different extent of cellular 
uptake and aggregation effect. Indeed, the progress of more effective PDT agents has been 
accomplished by appending second generation PSs with “bio”molecular recognition 
motifs, such as: carbohydrates,
63
 polysaccharides,
181
 amino acids,
210
 proteins,
211
 
monoclonal antibodies,
212
 pyridinium
213,214
 and ammonium units,
215
 sulphonate groups,
216
 
polyethylene glycol (PEG) units,
217
 etc. The PSs prepared by the later strategy are known 
as third generation of PSs because these moieties/groups target specific cancer cells.
218
  
The attractive properties of phthalocyanines, namely the strong absorption band 
(e.g. Photosens:  = 110000 M-1 cm-1) in the region of 620-800 nm, which is considered the 
ideal photodynamic therapeutic window. In case of Photosens
®
, that is a PS in the second 
stage of clinical trials by the selection of the water-soluble aluminium sulphonated 
phthalocyanine 1.13, (Figure 1.23) by several Moscow medical institutions (Oncological 
Scientific Centrum, Oncological Institute, Moscow Medical Academy and Institute of 
Laser Surgery). In fact, this PS used as a mixture of regioisomers, is now in the second 
stage of clinical trials for the treatment of malignant and non-malignant tumours, ulcers, 
and festering wounds with very promising results.
219-223
 A review from Lukyanets has been 
published concerning the success of clinical studies using Pcs as PSs.
224
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Figure 1.23 Structures of photosensitizers based on phthalocyanines. 
 
Another promising photosensitizer is the phthalocyaninato silicon(IV) 1.14 (Figure 
1.23) which as a single compound has shown effective feasibility in the treatment of skin 
diseases.
225
 
In order to get an ideal PS, using these photoactive structures, several groups have 
developed synthetic strategies in order to incorporate pyridinium
226
 and cyclodextrin
208
 
units into the Pc core. The new compounds can be excellent alternatives to overcome the 
tremendous limitations of the first and second generation PSs have been prepared and 
studied in order to give their higher solubility in aqueous media and cell/tissue 
recognition.
167,173,227,228
 In fact, phthalocyanine derivatives can open the possibility to build 
smart photoactive molecules by the combination of their unique photophysical and 
photochemical properties.
210,229,230
 
 
Phthalocyanines as photosensitizer drugs against microorganisms 
 
It is well-known that for an efficient photoinactivation of Gram-negative bacteria is 
essential the use of a cationic PS,
231-233
 where the positive charged can interact 
electrostatically with the negative charged of the outer wall (lipoproteins, 
lipopolysaccharides) allowing their binding and relative entrance.
234
 The positive charged 
groups provides a strait electrostatic interaction with negatively charged sites at the outer 
membrane surface of the Gram-negative bacteria, increasing the efficiency of the 
photodynamic activity. Furthermore, inactivation of Gram-positive bacteria is guaranteed 
by neutral, anionic or cationic PSs that quickly cross the cell membrane.
234,235
 
Nevertheless, the typical damages involved in the antimicrobial PDI are not well clarified. 
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For example, Brown and co-workers reported uptake studies using cationic groups 
on the Pc core to perform interesting water-soluble pyridinium zinc phthalocyanine 1.15
236
 
(Figure 1.24) as a powerful photosensitizer able to inactivate Escherichia coli (or E. 
coli).
237
 This PS was applied in the incubation of E. coli cells in the dark, which produced 
modifications in the outer membrane permeability barrier, rendering the bacteria sensitive 
to hydrophobic compounds.
238
 Interesting, is the addition of Mg
2+
 to the medium prior to 
the cells incubation with the PS preventing these modifications in the outer membrane. 
Moreover, the use of Mg
2+
 in the medium also prevents the photoinactivation of E. coli. 
The binding of divalent cations, such as Mg
2+
, prevents electrostatic repulsion of the outer 
leaflet membrane of lipopolysaccharides being responsible for protecting the structure of 
the membrane surface.
239
 
 
 
Figure 1.24 Structure of water-soluble pyridinium zinc(II) phthalocyanine. 
 
However, the authors have reported that the obtained results are consistent where 
the metallated pyridinium phthalocyanines access across the outer membrane of E. coli by 
self-promoted uptake pathway in Gram-negative bacteria.
237
 
Kaliya and co-workers showed the photophysical and photosensitizing properties of 
two octacationic oxotitanium phthalocyanines with pyridiniomethyl 1.16 or cholinyl 1.17 
units (Figure 1.25) that were studied in aqueous and alcohol solutions.
240
  
The phototoxicity of the Pc derivatives has been studied against coliform bacteria 
from a contaminated Moscow River water, by generating singlet oxygen 
1
O2 and hydroxyl 
radicals upon light exposure. It is proposed that both OH and 
1
O2 might be responsible for 
the observed bactericidal effects to achieve the water disinfection. However, the authors 
mentioned that in these conditions it is more difficult to achieve disinfection than on pure 
bacterial cultures. The photodisinfection study was performed in microorganisms, which 
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are standardized in drinking water supply reservoirs, specifically total germs, E. coli, 
spores of sulphite-reducing Clostridium and coliphages.
240 
 
Figure 1.25 Structures of octa-pyridiniomethyl phthalocyanine oxotitanium 1.16 and 1.17. 
 
Phthalocyanines for cancer PDT 
 
A different strategy to obtain soluble Pcs in biological media is to insert different 
carbohydrates (CHs) in the Pc core. The combination of these two characteristics makes 
them possible PS drugs in PDT. Carbohydrates are largely disseminated in all living 
organisms, appearing as monomers, oligomers or polymers and as components of many 
other natural molecules and playing vital roles in metabolic processes.
241,242
 Also, these 
molecules can appear conjugated to other biological components, such as: proteins, lipids 
and nucleic acids. It is well-known that carbohydrates are involved in many cellular 
processes (e.g., cell-substrate and cell-cell recognition, drug transport, etc.).
243-245
 In this 
sense, CH derivatives have been incorporated on the structures of several drugs, to give 
them the adequate physicochemical properties for biomedical proposes. This methodology 
has attracted the search for therapeutic applications in the medical field, being an exciting 
strategy to solve many of the biocompatibility and selectivity problems of several active 
molecules.
243
 
Cavaleiro and co-workers
174
 reported the synthesis of glyco-Pcs with four protected 
D-galactose (GalPro) units linked to the same isoindole by the hydroxyl group located in 
carbon C-6 (Scheme 1.3). The Pc 1.19 was obtained by statistical cross-condensation of 
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glycophthalonitrile 1.18 with an excess of 1,2-dicyanobenzene phthalonitrile, in the 
presence of zinc chloride The reaction was performed in DMAE at 100 ºC, affording the 
desired Pc 1.19 in 30% yield, accompanied by the symmetric zinc Pc formed by self-
condensation of phthalonitrile. The Pc 1.20 was obtained in 85% yield, after removal of the 
CH protecting groups with aqueous trifluoroacetic acid (TFA) and purification by reverse-
phase column chromatography (Scheme 1.3). The UV-Vis spectrum of 1.20, in dimethyl 
sulfoxide (DMSO), indicates the presence of monomeric species. A different situation 
occurs in water where a significant reduction in the Q-band suggests intermolecular 
aggregation due to macrocycles cofacial arrangements. 
 
 
Scheme 1.3 
 
The asymmetric structure of the Pc 1.20 provides an amphiphilic character useful 
for drug administration (hydrophilicity) and membrane crossing (lipophilicity).
246
 In 
addition, considering the specific affinity of carbohydrates for cancer cells and their strong 
influence on the bioavailability of the corresponding conjugates, good perspectives can be 
anticipated for this new generation of photosensitizers based on Pc-carbohydrate 
derivatives.
247-250
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The synthesis of glyco-Pcs where the CH units are linked by a short or a long 
spacer, it was idealized in order to avoid any steric disturbance of the macrocycle in the 
recognition source, and simultaneously to allow multiple carbohydrate recognition.
251
 In 
this context, Cavaleiro and co-workers
227
 reported the synthesis of Pcs with eight galactose 
(Gal) units separated from macrocycle by methylenic (CH2) bridges (Scheme 1.4). The 
synthetic route involved the tetramerization of phthalonitrile 1.21 in DMAE at 140 ºC 
under argon atmosphere for 16 h in the presence of ZnCl2 giving the glyco-Pc 1.22 as a 
dark blue solid in 62% yield. The deprotection of the CH units under acidic conditions 
afforded Pc 1.23 in 87% yield (Scheme 1.4). 
Scheme 1.4 
 
The optical properties of the octa-glycophthalocyanine suggest good perspectives 
for the potential application of such compounds as photosensitizers in PDT depending of 
the specific affinity for tumour tissues. 
Tomé and co-workers
167
 selected also the post glycoconjugation approach to obtain 
the phthalocyanines decorated with sixteen galactose units (Scheme 1.5), where the 
preliminary photophysical and photochemical features of the glycodendrimer conjugates, 
namely their high singlet oxygen production and interaction with human serum albumin 
(HAS) suggest that they might be used as promising PDT agents. In the this publication, 
the authors reported an efficient and elegant access to the glycodendritic unit 1.27 that 
involved in a first step the reaction of 2,4,6-trichlorotriazine 1.24 with the adequate 
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protected galactose 1.25 in the presence of N,N’-diisopropylethylamine (DIPEA) in dry 
toluene. Then, the reaction of intermediate 1.26 obtained in 92%, with propane-1,3-dithiol, 
afforded the glycodendritic unit 1.27 in 89% yield. The synthetic approach involving the 
reaction of the commercial available perfluorinated phthalocyanine ZnPcF16 with the 
dendritic unit 1.27, afforded the protected glycodendrimer 1.28 in 81% yield (Scheme 1.5). 
The hydrolysis of the isopropylidene protective groups with TFA/H2O (9:1) produced the 
unprotected glycodendrimer conjugate 1.29 in 78% yield, as a mixture of α/β 
stereoisomers. 
 
 
Scheme 1.5 
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Cavaleiro and co-workers synthesized the first water-soluble phthalocyanine-β-
cyclodextrin conjugate via a statistical cross condensation of a 4-(β-
cyclodextrin)phthalonitrile with known phthalonitriles.
174
 The purpose work was to obtain 
stable water solutions of Pcs using a covalent linkage to the β-cyclodextrin (Figure 1.26). 
The use of the CD moiety was related with the high amphiphilicity character to the 
performed water soluble hybrids. The exterior hydrophilic properties of the CD combined 
with its hydrophobic cavity in the centre allow the solubilisation of these Pcs in water. 
Moreover, the CDs have the capacity of inclusion of small molecules in their cavity.
252
 
 
 
Figure 1.26 Water-soluble phthalocyanine-β-cyclodextrin conjugates 1.30 and 1.31. 
 
In the same context, Ng and co-workers developed a series of symmetrical and 
unsymmetrical silicon(IV) phthalocyanines based on permethylated β-cyclodextrin units or 
on this unit combined with a sugar or a diamino moiety as the axial substituents.
253,254
 In 
Scheme 1.6 are shown the structures of unsymmetrical phthalocyanines 1.35 and 1.36 as 
examples of this series of Pcs, which were obtained in yields ranging from 10 to 14% . 
The photodynamic activities for 1.35 and 1.36 were investigated against HT29 
human colorectal carcinoma and HepG2 human hepatocarcinoma cells, showing IC50 
between 21-36 nM; it was also highlighted that 1.35 has a greater photocytotoxicity and 
efficiency to generate ROS than 1.36. 
The extension of the previous studies to the tetra-ethyleneglycol-linked 1,2:5,6-di-
O-isopropylidene-α-D-glucofuranose unit 1.34 allowed to prepare the glucoconjugated 
silicon(IV) phthalocyanines 1.38 and 1.39 (Scheme 1.7).
229
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Scheme 1.6 
 
The diglucosylated phthalocyanine 1.38 was obtained in 13% yield after refluxing 
in toluene 1.34 with the readily available silicon(IV) phthalocyanine dichloride 1.32 in the 
presence of sodium hydride (NaH) for 48 h, followed by chromatographic purification. The 
authors highlighted that the purification must be performed by column chromatography 
using neutral alumina followed by gel permeation chromatography, due to the 
susceptibility of the compound towards silica gel acidic nature to its decomposition.
229
 
The silicon 2,3-dichlorophthalocyanine dichloride 1.37, used as precursor of 1.39, 
(Scheme 1.7) was prepared via a “3+1” mixed cyclisation involving 1,3-
diiminoisoindoline, dichloro-1,3-diiminoisoindoline and SiCl4 and was performed in reflux 
quinoline. The authors mentioned that the crude 1.37 owing to its poor solubility was 
treated directly with the protected glucose derivative 1.34 and NaH. The A3B-type 
silicon(IV) phthalocyanines 1.39 was isolated in 3.1% after a similar chromatographic 
process described for 1.38.
229
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Scheme 1.7 
 
Both compounds 1.38 and 1.39 show high solubility in common organic solvents 
and exhibit substantial solubility in water. The in vitro photodynamic activities of both 
compounds showed highly photocytotoxicity against HepG2 human hepatocarcinoma and 
HT29 human colon adenocarcinoma cells, principally the nonchlorinated Pc 1.38 due to its 
smaller tendency to aggregate in biological media when compared with 1.39. The studies 
indicated also that Pc 1.38 presents a highly selective subcellular localization property 
targeting the lysosomes of HT29 cells. 
 
For all aforementioned, in the next five chapters it will be emphasized the 
preparation of novel phthalocyanine derivatives with suitable groups on their periphery for 
different applications: electronic supramolecular interactions (Chapters 2-4), 
microorganisms PDI (Chapter 5) and cancer PDT (Chapter 6). 
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Objectives 
 
The global goal of this project comprise the synthesis and characterization of 
innovative compounds/materials based on neutral and cationic phthalocyanines (Pcs) and 
to study their potential in electron donor-acceptor and biomedical applications.  
To achieve that goal, new phthalocyanine derivatives were prepared with adequate 
motifs and suitable units on their periphery in order to study their interactions with carbon 
nanostructure and their use as photosensitizers (PSs) in photodynamic therapy (PDT) of 
cancer cells and in the photodynamic inactivation of microorganisms (PDI). 
 So, the present PhD work is divided in the 5 specific aims summarized below: 
 
 
Specific Aim 1 – Develop suitable substituted precursors to prepare the corresponding 
thiopyridyl Pc derivatives and it will be studied their supramolecular interactions with 
graphene nanosheets (GN) – Figure 1.27. 
 
 
Figure 1.27 Example of one of the targets thiopyridyl-Pc/graphene nanohybrids  
 
 
Specific Aim 2 – Synthesis and characterization of new cationic Pcs, based on 
thiopyridinium motifs, to interact with single wall carbon nanotubes (SWNTs) in water 
media. It will be analysed the photophysical properties of the possible supramolecular 
systems (Figure 1.28). 
 
 42 
 
Figure 1.28 Example of one of the targets thiopyridinium-Pc/SWNT nanohybrid. 
 
 
Specific Aim 3 – Develop new supramolecular arrays from coordination of ruthenium 
phthalocyanine (RuPc) and thiopyridylporphyrins to perform multichromophoric 
assemblies (RuPc-PorSPy, Figure 1.29).  The photophysical characterization of the 
supramolecular arrays it will be analysed. 
 
Figure 1.29 Example of synthesised supramolecular RuPc-PorSPy pentads. 
 
 
Specific Aim 4 – Synthesis and characterization of new amphiphilic phthalocyanines, 
based on methoxypyridinium derivatives to be evaluated as potential 
“photoantibiotics”/photoactive molecules against antibiotic resistant microorganisms. The 
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new Pc-pyridinone molecules initially prepared will be subsequently methylated to yield 
the corresponding target cationic Pcs (Figure 1.30). The biological screen on Gram-
negative bacteria (Escherichia coli) performed in collaboration with the microbiology 
group of the University of Aveiro, it will be investigated to evaluate the potential of these 
compounds in the photoinactivation of Gram-negative bacteria. 
 
 
Figure 1.30 Example of a cationic Pc used as PS agent. 
 
 
Specific Aim 5 – Synthesis and characterization of novel photosensitizing agents, based on 
phthalocyanine-cyclodextrin (Pc-CD) conjugates. In this project, the particular concern is 
to design and synthesize new asymmetric Pc-CD formulations covalently conjugated, 
which may show water solubility and marked selectivity towards UM-UC-3 human 
bladder cancer cells (Figure 1.31). The physicochemical and photobiological properties 
will be assessed and the in vitro studies on bladder cancer cells examined to select the most 
effective PSs. 
 
 
Figure 1.31 Example of target Pc-CD conjugates. 
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Chapter 2 
Decorating Graphene Nanosheets with Electron Accepting Pyridyl 
Phthalocyanines 
 
63 
2.1 Overview 
 
Since the pioneering work of Novoselov et al. graphene is one of the first 
two-dimensional (2D) atomic crystals, which is readily available.
1,2
 An 
overwhelming number of its properties including mechanical stiffness,
3,4 
strength 
and elasticity – a Young’s modulus of 1 TPa and intrinsic strength of 130 GPa5,6, 
electrical and thermal conductivity, above 3,000 W mK
-1
,
7
 among others, are simply 
outstanding, especially when compared to conventional materials. Taking the 
aforementioned features together, graphene bears great promises to replace existing 
materials in emerging applications.
8
 
To meet the full potential of graphene in general, and the requirements for 
specific applications in particular, dozens of methods for preparing graphene 
featuring various dimensions, shapes and quality, are either in use or under 
development.
9
 A leading example is the micromechanical exfoliation of graphite, 
which yields high-quality single-layer graphene with room-temperature electron and 
hole mobility up to 15000 cm
2
/Vs,
10
 but comes short of scalability. 
Alternatively, bottom-up fabrication strategies of graphene by means of, for 
example, epitaxial growth
11
 and/or chemical vapour deposition
12
 opened the doors 
for technological applications. This approach can be used to prepare transparent 
conductive layers
13
 for photonics
14
 and nanoelectronic systems.
15
 Only a few 
substrates such as copper and others are, however, suitable for the growth of 
graphene films and a fairly problematic transfer step is required to facilitate 
combination with other materials.
16
 
In stark contrast, liquid-phase exfoliation of graphite is a widespread method 
that bears great potential for mass-production of graphene.
17
 Liquid-phase 
exfoliation is currently been conducted in the area of coatings,
18
 composites,
19
 
conductive inks,
20
 transparent conductive layers,
21
 and energy generation/storage.
22
 
As such, it is based on bringing graphite with the aid of sonication into contact with 
a solvent, which, in turn, assists in disintegrating graphite into individual platelets. 
Exfoliation efficiencies and yields are, however, rather moderate in pure solvents, 
due to high activation barrier and high thermodynamic stability of graphite.
17,23 
Somewhat related is the approach of transforming graphite into graphite 
oxide by means of harsh oxidation, dispersing the resulting flakes by sonication, and 
64 
re-reducing it back to graphene.
24
 Although this method guarantees processability on 
one hand, and covalent functionalization on the other, it comes along with a 
significant alteration of the physicochemical properties of pristine graphene.
25-27 
To 
avoid such setbacks and to secure the efficient exfoliation of graphite the necessity 
of employing molecular building blocks in the form of amphiphilic intercalators has 
evolved.
28,29 
One key aspect in graphene research is to tune its electronic properties by chemical 
doping with molecular building blocks, while preserving its unique band structure.
30
 
Importantly, covalent methodologies affect the electronic structure of graphene and in that 
way potentially reduce the charge carrier mobility. On the contrary, noncovalent strategies 
not only tune the electronic properties of graphene but also minimize the damage to the 
sp
2
-conjugated lattice.
31
 Here, relevant advances are particularly in the area of self-
ordering/self-assembling,
32,33
 π-stacking,34,35 as well as charge transfer36,37 interactions. 
Such approach is particularly useful to link photo- and/or redoxactive chromophores to 
graphene, and, thereby, adding light harvesting and electron transfer features. To this date, 
a fairly large number of molecular building blocks, such as porphyrins,
27
 porphycenes,
30
 
phthalocyanines (Pcs),
31
 perylenes,
38,39
 among others, have successfully been immobilized 
onto the basal plane of graphene. 
In the current study, we focus on Pc/graphene nanohybrids
40
 as promising electron 
donor-acceptor building blocks in, for example, solar energy conversions schemes. This 
constitutes a contemporary research topic, especially in terms of producing innovative 
materials of greatly reduced sizes.
41
 In this context, we report herein the immobilization of 
pyridyl-appended Pcs 2.6-2.8 (Figure 2.1) onto graphene. The unique absorption features 
of Pcs throughout the solar spectrum render them well suited for our proposal.
42,43
 
Furthermore, in contrast to the standard tetra-tert-butyl phthalocyanines (ZnPcs), the newly 
synthesized pyridyl Pcs show electron accepting properties. 
Usually, phthalocyanines are poorly soluble and tend to aggregate in many solvents. 
Nevertheless, a careful selection of peripheral substituents may minimized/overcome these 
disadvantages. The synthesis of all the target compounds follows previous procedures 
already reported by us.
44
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Figure 2.1 Structures of thiopyridylphthalocyanines 2.6-2.8. 
 
2.2 Syntheses of thiopyridylphthalocyanines 
 
The thiopyridylphthalocyanines 2.6-2.8 were chosen for the proposed study not 
only due to the unique optical features of this type of macrocycles covering a large range 
of the UV-Vis spectrum, but also due to the presence of the mercaptopyridyl groups, which 
can favour noncovalent interactions with the metal present in the macrocycle core of 
neighbour molecules.
45
 These interactions can approach the Pc macrocycles around the 
graphene nanosheets providing a compact assembly, not only due to the approximation of 
these molecules but also by the π-π stacking interactions between the macrocycle and 
graphene structure. 
 
2.2.1 Syntheses of mono- and di-thiopyridylphthalonitrile precursors 
 
The access to the innovative pyridyl-phthalocyanines 2.6 and 2.7 required the 
previous synthesis of the adequate the thiopyridylphthalonitriles 2.3 and 2.5 (Scheme 2.1). 
The mono-thiopyridylphthalonitrile 2.3 was obtained by nucleophilic substitution of the 
nitro group in 4-nitrophthalonitrile 2.1 by the sulphanyl group of the mercaptopyridine 2.2. 
The reaction was carried out in dimethylformamide (DMF) under basic conditions for 5 h 
at 60 ºC. The evolution of the reaction was followed by thin-layer chromatography (TLC) 
and the desired product 2.3 (70 % yield) was directly obtained from the reaction medium 
by addition of water. 
A similar procedure was used in the synthesis of the di-thiopyridylphthalonitrile 2.5 
but the coupling involved 4,5-dichlorophthalonitrile (2.4) and 4-mercaptopyridine (Scheme 
2.1). In this case, the reaction was carried out at room temperature and after stirring for 2 h, 
66 
it was confirmed by TLC the presence of the di-thiopyridylphthalonitrile 2.5. The crude 
product was precipitated from the reaction medium with water, filtered and washed several 
times with water. Finally, product 2.5 was isolated in 50% of yield, after crystallization 
from a mixture of MeOH/CH2Cl2. 
 
 
Scheme 2.1 
 
The thiopyridylphthalonitrile 2.3 was previously characterized by 
1
H, 
13
C NMR, 
and mass spectroscopy (MS) using electrospray (ESI) in positive mode. The 7 aromatic 
protons distributed between both aromatic rings appear at  7.35, 7.91, 8.15, 8.28 and 8.53 
ppm (Figure 2.2). The pyridyl protons ortho-H
d
 and meta-H
e
 appear as two doublet of 
doublets at  7.35 and 8.53 ppm, respectively, due to the different shielding influenced 
mainly by the nitrogen atom. 
Figure 2.3 shows the 
1
H NMR spectrum of the symmetrical phthalonitrile 2.5, 
where the resonance signals of the pyridyl protons ortho-H
b
 and meta-H
c 
appear as two 
doublet of doublets respectively at  7.25 and 8.67 ppm. The resonances of the 
phthalonitrile ring H
a
 are situated as a singlet at  7.57 ppm. The structures of the 4-
thiopyridylphthalonitrile (2.3) and 4,5-dithiopyridylphthalonitrile (2.5) were also 
confirmed by ESI-MS presenting, respectively, the molecular ion peaks [M+H]
+
 at m/z 237 
and 347. 
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Figure 2.2 
1
H NMR spectrum of compound 2.3 in DMSO-d6. 
 
 
Figure 2.3 
1
H NMR spectrum of compound 2.5 in CDCl3. 
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2.2.2 Syntheses and characterization of the thiopyridylphthalocyanines 
 
The Pc 2.6 was synthesized via cyclotetramerization of 4-thiopyridylphthalonitrile 
2.3 in dimethylaminoethanol (DMAE) at 140 ºC, in the presence of anhydrous zinc(II) 
chloride (ZnCl2) (Scheme 2.2). The reaction mixture was maintained under reflux 
overnight and then it was added methanol. The resulting precipitated was washed several 
times with methanol and water in order to remove the excess of metallic ZnCl2 salt. After 
drying under vacuum, product 2.6 was obtained in 82% yield. 
 
 
Scheme 2.2 
 
The octa-substituted Pc 2.7 was obtained by self-tetramerization of 4,5-
dithiopyridylphthalonitrile (2.5) using a synthetic procedure similar to the one outlined 
above for 2.6 (Scheme 2.2); this Pc was isolated in 85% yield after purification. 
The central zinc metal was chosen to favour noncovalent interactions with the 
pyridyl assemblies, but also to tune the features of the final materials. The photophysical 
properties of metallated Pcs are influenced by the metal nature. Closed shell diamagnetic 
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ions, like Zn
2+
, Ga
3+
 and Si
4+
, give to Pc complexes excellent properties such as high triplet 
yields and long lifetimes.
46
 In particular, ZnPcs have been extensively studied because of 
d
10
 configuration of the central Zn
2+
, which contributes for simple optical spectra. ZnPcs 
have an intense absorption at the red-visible region and high singlet and triplet yields, 
making them valuable photosensitizers for PDT and for supramolecular applications.
47,48
  
The 
1
H NMR spectrum of 2.6 illustrate all proton resonances as multiplets for the 
α- and β-aromatic proton atoms of the Pc macrocycle between  8.88–9.45 and 8.26–8.48 
ppm, respectively, corresponding to the 8 α-protons α-Ha,b and 4 β-protons β-Hc. 
Furthermore, the proton resonances of the mercaptopyridyl moiety are more shielded than 
the macrocycle aromatic α-protons and consequently the ortho-Hd and meta-He protons 
appear at  7.74–8.00 and 8.52–8.79 ppm, respectively (Figure 2.4). 
 
Figure 2.4 
1
H NMR spectrum of compound 2.6 in DMSO-d6 + TFA. 
 
The 
1
H NMR spectrum of tetra-substituted Pc derivative 2.6 shows a complex 
pattern due to the presence of the different positional isomers resulting from possible 
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combinations of the mercaptopyridyl moiety on the β-positions of the four isoindole units 
of the macrocycle. 
In 
1
H NMR spectrum of Pc 2.7 bearing mercaptopyridyl groups in both β-positions, 
the resonances due to the 16 ortho-H
b
 and 16 meta-H
c
 proton of the pyridyl moiety were 
observed at  8.02 and 8.70 ppm, respectively. Moreover, it was also observed a singlet 
corresponding to the 8 α-Ha of the Pc ring at  10.15 ppm (Figure 2.5); these protons suffer 
a deshielding comparatively with the analogous ones of the Pc 2.6 (8.88 – 9.45 ppm). The 
MALDI-TOF-MS spectra confirmed the structures of 2.6 and 2.7 showing the presence of 
the protonated molecular ion peaks [M+H]
+
at m/z 1013 and 1448, respectively. 
 
 
Figure 2.5 
1
H NMR spectrum of compound 2.7 in DMSO-d6 + TFA. 
 
The octa-substituted Pc 2.8 also considered in the preparation of graphene 
nanohybrids was synthesized from the commercial available 
hexadecafluorophthalocyaninato zinc(II) (ZnPcF16) and mercaptopyridine (Scheme 2.3). 
In Pc 2.8 both α-positions of the Pc macrocycle bear fluorine atoms instead of hydrogen 
atoms as in 2.7. It will be important to compare how the main spectroscopic features of 
71 
these two octa-substituted Pcs are affected by the presence or absence of the 
electronegative fluorine atoms. 
The nucleophilic substitutions of all 8 β-fluorine atoms by mercaptopyridine (10 
equivalents) took place overnight at room temperature in basic conditions. The reaction 
was ended by precipitation in water and the resulting green solid, after being filtered and 
washed several times with water and acetone, was identified as Pc 2.8 (89% yield). 
 
 
Scheme 2.3 
 
Figure 2.6 
1
H NMR spectrum of compound 2.8 in DMSO-d6 + TFA. 
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The 
1
H NMR spectrum of 2.8 shows the resonances of the ortho-H
a
 and meta-H
b
 
protons of the peripheral pyridyl groups as two broad singlets, respectively at  7.28 and 
8.19 ppm (Figure 2.6). Interesting, it is the influence of the fluorine atoms of the Pc 2.8 
where is observed a shift of the pyridyl proton resonances comparatively with the 
analogous resonances of 2.7. In case of 2.8, occurs a high field shift for both pyridyl 
protons ortho-H
a
 and meta-H
b
 when compared with the equivalent Pc 2.7 ( 8.02 and 8.70 
ppm) due to the shield effect of the electronegative fluorine atoms on the Pc 2.8. The 
19
F 
NMR spectrum of 2.8 shows clearly the presence of the fluorine atom resonances as a 
duplet at  -126.91 ppm (Figure 2.7). Likewise, the MALDI-TOF-MS spectrum confirmed 
the structure of 2.8 showing the presence of the protonated molecular ion peak [M+H]
+
 at 
m/z 1595. 
 
Figure 2.7 
19
F NMR spectrum of compound 2.8 in DMSO-d6 + TFA. 
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2.3 Photophysical studies* 
2.3.1 Optical characterization of thiopyridylphthalocyanines 
 
The initial measurements regarding the ground and excited state features of 2.6-2.8 
were performed in DMF. The occurrence of aggregation was detected at concentrations, 
higher than 10
-5
 M from the broadening and asymmetry observed in the Q-band  region 
(data not shown). This fact can be rationalized by the presence of pyridyl groups as an 
inception to form intermolecular complexes by coordination with the metal present in the 
inner core of the macrocycle. Evidence for monomeric 2.6-2.8 with Q-band maxima at 
684, 703, and 722 nm, respectively, were gathered at concentrations below 10
-5
 M (Figure 
2.8). Interestingly, as the number of substituents at the β-position increases the Soret- and 
the Q-bands shift bathochromically. Figure 2.8 shows also the fluorescence spectra of 2.6-
2.8 monomers upon excitation at 630 nm in DMF. These spectra reveal maxima at 689, 
710 and 730 nm, respectively, and the quantum yields found for 2.6 (0.23), 2.7 (0.18) and 
2.8 (0.12) – Table 2.1), are slightly lower than the quantum yield of ZnPc used as 
reference (0.3).
49 
 
a)
 
b)
 
Figure 2.8 a) Absorption and b) fluorescence spectra of 2.6-2.8 in DMF, upon excitation at 
630 nm, at concentration of 10
-6
 M. 
 
                                                 
*These compounds were tested by Leonie Wibmer, Alexandra Roth and Georgios Katsukis Hausmann 
who kindly provided their results for a comprehensive analysis of the photophysical values of these 
supramolecular assemblies. 
- 2.6 
- 2.7 
- 2.8 
- 2.6 
- 2.7 
- 2.8 
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As a complement, time-correlated single photon counting (TCSPC) measurements 
were performed following 403 nm excitation (Figure 2.9). The resulting fluorescence time 
profiles for the thiopyridylphthalocyanines are best fit monoexponentially. The resulting 
lifetimes are respectively 2.5 ns for 2.6, 2.1 ns for 2.7 and 1.9 ns for 2.8. 
 
 
Figure 2.9 Emission time profiles of 2.6-2.8 in DMF, upon excitation at 403 nm. 
 
Table 2.1 The molar extinction coefficient (ε), Q-band maxima (λmax), fluorescence 
quantum yields (ɸF), and time correlated single photon counting (τ) in DMF. 
Compounds ε (M-1cm-1) λmax / nm ɸF τ1 (ns) 
2.6 2.50 × 10
4
 684 0.23 2.5 
2.7 0.85 × 10
4
 703 0.18 2.1 
2.8 2.03 × 10
4
 722 0.12 1.9 
 
2.3.2 Femtosecond transient absorption spectroscopy of 
thiopyridylphthalocyanines 
 
The transient absorption spectra of 2.6-2.8 and ZnPc were recorded following 387 
nm femtosecond excitation. The differential absorption characteristics of their singlet 
excited state obtained right after the excitation is discernable in Figure 2.10 for Pc 2.7. The 
minima which evolve at 632 and 705 nm and also the maxima at 500, 840 and 1200 nm are 
ascribed to the ground state bleaching in the range of the Q-band transitions. The singlet 
excited state is, however, metastable and during its decay a notable red-shift moves the 
maximum from 500 nm to 524 nm. This underlying trend reflects the superimposition of 
two different transients driven by intersystem crossing. One hand is due to the decay from 
the singlet excited state and the other to the concurrently developing triplet excited state 
- 2.6 
- 2.7 
- 2.8 
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with maxima at 524, 564 and 605 nm. The analyses of the absorption time profiles at 500 
nm, etc. shed light onto the kinetics. In particular, a short lifetime of 10 ± 0.8 ps, a long 
lifetime of 2.7 ± 0.3 ns, and an intermediate lifetime with minor amplitude of 250 ± 60 ps 
can be correlated with internal conversion, intersystem crossing, and the presence of 
aggregates, respectively. 
a)
 
b)
 
Figure 2.10 a) Differential absorption spectra (visible and near infrared) obtained upon 
femtosecond pump probe experiments (387 nm) of 2.7 in DMF with time delays between 
0.1 and 6750.1 ps at room temperature – for time delays see figure legend. b) Time 
absorption profiles of the spectra shown at 500, 665, 705 and 850 nm. 
 
The lifetime of the triplet excited state exceeds the time resolution of our 
experimental setup. The behaviour of 2.6, 2.8 and also ZnPc is quantitatively similar to the 
one described for 2.7 (Figure 2.11), only showing slightly different lifetimes. 
a)
 
b)
 
Figure 2.11 Differential absorption spectra (visible and near infrared) obtained upon 
femtosecond pump probe experiments (387 nm) of a) 2.6 and b) 2.8 in DMF with addition 
of pyridine to ensure monomeric Pcs with time delays between 0 and 6500.0 ps at room 
temperature – for time delays see figure legend. 
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2.3.3 Electrochemistry characterization of thiopyridylphthalocyanines 
 
The electrochemical properties of 2.6-2.8 were studied by electrochemistry 
techniques using distilled DMF as solvent. In terms of reductions, the reduction potentials 
are -1.22 V for the first two Pc followed by a second reduction at -1.56 V for 2.6, -1.04 V 
for 2.7, and -0.86 V and -1.25 V for 2.8. In terms of oxidation, only for 2.6 an oxidation 
potential was noted at +0.51 V. For 2.7 and 2.8 within our experimental range, namely up 
to 1.3 V, no oxidation potential was found. An extrapolation from absorption data gives an 
oxidation potential of +0.7 V and +0.9 V for 2.7 and 2.8, respectively. In this respect, the 
choice of different solvents including DMSO, THF (or in these solvents but with addition 
of 4-(dimethylamino)-pyridine for guaranteeing monomeric Pcs), DCM and an 
acetonitrile/toluene (3/1 v/v) mixture did not change the results. In contrast, ZnPc revealed 
a reduction at -1.43 V and oxidation at +0.24 V in DMF. 
As a complement, spectroelectrochemical assays were performed in DMF. In the 
case of 2.7, applying a voltage of -0.4 V vs Ag-wire leads to changes in the absorption 
spectra, which are ascribed to the formation of the one electron reduced phthalocyanine. In 
particular, next to the bleaching of the Soret- and Q-bands, new maxima in the visible 
region at 467, 594 and 740 nm as well as in the near infrared region at 876, 913, 952 and 
1000 nm arise in the differential absorption spectra (Figure 2.12a). For 2.6 and 2.8, similar 
results are noted at, however, slightly different potentials (Figures 2.12b and 2.13). 
 
a) b) 
  
Figure 2.12 Differential absorption spectrum (visible and near infrared) in DMF obtained 
upon spectroelectrochemical one electron reduction with a voltage of a) -0.4 V vs Ag-wire 
for 2.7 and b) -0.6 V vs Ag-wire for 2.6. 
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Figure 2.13 Differential absorption spectra (visible and near infrared) obtained upon 
spectroelectrochemical one electron (black spectrum) and two electron (red spectrum) 
reductions of 2.8 in DMF with voltages of -0.2 and -0.6 V vs Ag-wire, respectively. 
 
For example, the signature of one electron reduced phthalocyanine 2.6 evolves at an 
applied potential of -0.6 V vs Ag-wire. For 2.8, an applied potential of only -0.2 V vs Ag-
wire is sufficient to form the one electron reduced phthalocyanine, while at -0.6 V its two 
electrons reduced form is generated. In other words, the electron accepting properties scale 
with increasing number of substituents at the β-position of the phthalocyanine. 
Interestingly, no appreciable changes in the absorption spectra were seen upon applying 
positive voltages in any of the used solvents. For ZnPc, in contrast, a 
spectroelectrochemical oxidation was possible in dichloromethane at an applied potential 
of 0.5 V. Here, features at 411, 525, 835 and 916 nm are due to the characteristic and well 
known signature of the one electron oxidized phthalocyanine. 
 
2.3.4 Supramolecular preparation of nanographene/Pc nanohybrids G2.6-
G2.8 
 
After the establishment of the key features of Pc 2.6-2.8, the respective 
nanographene/Pc nanohybrids G2.6-G2.8 were prepared; for comparison the nanohybrid 
GZnPc (using the standard ZnPc) following a previously reported procedure.
50
 In 
particular, 1-2 mg of natural graphite was added to a 10
-5
 M DMF solution of 
thiopyridylphthalocyanines, which were ultrasonicated for 45 min and subsequently 
centrifuged at 20 G for 20 min. The supernatants were then extracted and again subjected 
to ultrasonication with newly added natural graphite. 
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2.3.5 Optical characterization of nanographene/Pc nanohybrids G2.6-G2.8 
 
During the preparation of the nanographene/Pc nanohybrids G2.6-G2.8, the 
absorption spectra were recorded after each enrichment cycle and were compared to those 
of the corresponding Pc 2.6-2.8 references. Overall, an increase in absorbance is 
discernable with each enrichment cycle when using G2.6-G2.8 as well as GZnPc with 
equal contributions from absorption and scattering processes of exfoliated graphite (Figure 
2.15 for graphene assembly with Pc 2.7). Notably, the exact amount of exfoliated graphite 
cannot be calculated due to superimposing absorption features of exfoliated graphite and 
G2.6-G2.8. No additional changes are detected in the absorption spectra of GZnPc. In 
contrast, new absorption features evolve for G2.6-G2.8 namely a red shift with respect to 
the original Q-band which intensifies after each enrichment cycle. The maxima of the new 
Q-bands appear at 718, 737 and 760 nm for G2.6, G2.7 and G2.8, respectively (Figure 
2.14). 
 
 
Figure 2.14 Absorption spectra of G2.6-G2.8 in DMF. 
 
Notably, in the end the original Q-bands have completely disappeared. Instead, 
merely the new 35 nm red-shifted Q-bands are visible. In the case of G2.7, only four 
enrichment cycles are necessary (Figure 2.15) to obtain the fully shifted Q-band for G2.6 
and G2.8, at least 5-6 enrichment cycles are needed. 
 
 
 
- G2.6 
- G2.7 
- G2.8 
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a) 
 
b)
 
Figure 2.15 a) Absorption spectrum of 2.7. b) Absorption spectra of G2.7 after 1
st
, 2
nd
, 3
rd
 
and 4
th
 enrichment. 
 
The fluorescence spectra obtained after each enrichment cycle were also recorded, 
as it is exemplified in Figure 2.16 for G2.7. The results show that after four enrichment 
cycles the Pc centred fluorescence is nearly quantitatively quenched for G2.7 (98.6%) and 
G2.6 (99.4%); a quenching of 74.8% was observed for G2.8. These trends are in line with 
the absorption changes seen for G2.6-G2.8 and indicate that in the end the Pcs are 
immobilized in graphene and no free Pcs is present in solution. The results obtained with 
GZnPc show a different situation: only a weak quenching was detected. 
 
a)
 
b)
 
Figure 2.16 a) Fluorescence spectrum of G2.7 before enrichment. b) Fluorescence spectra 
of G2.7 after 1
st
, 2
rd
, 3
rd
 and 4
th
 enrichment. 
 
 
 
 
- 1st enrichment 
- 2nd enrichment 
- 3rd enrichment 
- 4th enrichment 
 
- 1st enrichment 
- 2nd enrichment 
- 3rd enrichment 
- 4th enrichment 
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2.3.6 Raman spectroscopy and transmission electron microscopy of 
nanographene/Pc nanohybrids 
 
Further insights into the nature of G2.7 came from Raman spectroscopy following 
laser excitation at 532 nm after drop casting the dispersion onto a Si/SiO2 wafer. Raman 
spectroscopy is an important mean to characterize graphitic materials and identify single, 
bi- and few-layer graphene or turbostratic graphite. Typically, the D-band is discernable at 
around 1350 cm
-1
, while the G- and 2D-bands are centred around 1580 and between 2650 
and 2700 cm
-1
, respectively. Figure 2.17 shows a selected Raman spectrum of G2.7. The 
I(2D)/I(G) intensity ratio of 6.3 and a single lorentzian fit of the 2D-band with a full width 
at half maximum (FWHM) of 34.6 cm
-1
 indicate monolayer graphene. In order to get a 
statistical overview over the sample, a Raman map with around 600 different spectra was 
evaluated (Figure 2.17). 
 
a)
 
b)
 
Figure 2.17 a) Selected Raman spectrum of G2.7. b) Histogram with relative counts vs 
I(2D) / I(G) ration and the corresponding log-normal distribution with a maximum at 0.97. 
The sample was drop casted from a DMF dispersion onto silicon oxide wafers and excited 
at 532 nm. 
 
The resulting I(2D)/I(G) intensity ratios are best fit by a log-normal distribution 
function, which maximizes at a ratio of 0.97. From reference experiments we attribute any 
ratio of 0.7 or less to bulk graphite or few- to multilayer graphene. That means, in the 
current case, 25% of the collected spectra reveal bulk graphite / few- to multilayer 
graphene character, while 75% of the collected spectra correspond to turbostratic exfoliated 
graphite and monolayer graphene. For a further differentiation between the latter the 
FWHM of the 2D-band is decisive. Furthermore, a shape analysis of the 2D-band of the 
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spectra with a 2D/G intensity ratio above 1 was performed. In this case, the spectra could 
be fitted with a single lorentzian function, but differ in FWHM. On the one hand, 5% of the 
spectra display a FWHM between 25 and 45 cm
-1
 representing real monolayer graphene 
and 95% turbostratic graphite with a FWHM between 45 and 70 cm
-1
, on the other hand. 
The high amount of turbostratic graphite is probably due to our preparation method of 
simply drop casting the dispersion onto the wafer. Hereby, the once exfoliated flakes tend 
to re-agglomerate upon the slow evaporation of the solvent DMF.
51
 
This is also confirmed by transmission electron microscope images as it is 
exemplified for G2.7 in Figure 2.18. In particular, small thin flakes as well as larger 
individual few-layer graphene flakes with lateral sizes up to 2 µm appear folded and 
intertwined to minimize surface energy. Furthermore, in atomic force microscopy (AFM) 
homogenous flakes can be found onto which smaller flakes as well as graphitic materials 
agglomerate. Specifically, height profiles of graphene flakes reveal sizes up to 1 µm that 
are around 1 nm in height, which still corresponds to a monolayer flake due to adsorbed 
water or stabilizer molecules.
52,53
 Further agglomerated flakes are again 1 nm in height, 
whereas height profiles of graphitic materials reach 10 nm and beyond (Figure 2.18). 
 
a)
 
b)
 
c)
 
Figure 2.18 a) Transmission electron microscopy (TEM) images of G2.7 on a lacey carbon 
grid – scale bar is 100 nm. b) Tapping mode AFM image of G2.7 on a SiO2 surface – scale 
bar is 500 nm. c) Height profiles at positions 1, 2, 3 and 4. 
 
2.3.7 Femtosecond transient absorption spectroscopy of nanographene/Pc 
nanohybrids G2.6-G2.8 
 
Finally, to characterize and to quantify the nature of the electronic interactions 
between graphene and the Pcs in terms of energy and / or electron transfer, it was 
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performed transient absorption experiments with G2.6-G8 and GZnPc by means of 
exciting them at 387 nm. In order to obtain better results in the spectroscopic range 
between 700 and 800 nm, all measurements were carried out with optimized white light 
setting in this range of the spectrum and, additionally, the near-infrared (nIR) region is 
equally optimized in the range between 1000 to 1600 nm. In the case of GZnPc, the 
differential absorption spectrum lacks features in addition to those seen for the references, 
that is, graphene, on one hand, and ZnPc, on the other hand (data not shown). With regard 
to the earlier, a graphene related bleaching is discernable in the range from 900 to 1600 
nm. With regard to the latter, the intensity of the phthalocyanines ground state bleaching, 
which is seen in the form of minima at 623 and 679 nm prompts to the presence of ZnPc 
that is free in solution and not immobilized onto graphene. Furthermore, the accordingly 
formed singlet-singlet absorption gives rise to maxima at 506, 592 and 856 nm, 
respectively, and, as such, identical to what is seen for the reference ZnPc. 
In stark contrast, in the case of G2.7, within the first picoseconds following 
excitation broad minima evolve (Figures 2.19 and 2.20). It comprises graphene related 
bleaching in the visible and near infrared regions and Pc related ground state bleaching 
between 650 and 740 nm. Importantly, the Pc related ground state bleaching is 35 nm red-
shifted in G2.7 to 740 nm relative to the spectra recorded for 2.7. In fact, the minima for 
G2.7 are in excellent agreement with the shifted Q-band absorption seen in the absorption 
spectra. Both, that is, graphene and phthalocyanine related bleaching, decay rapidly – vide 
infra. For example, considering the bleaching of graphene at 1035 nm a lifetime of <1 ps 
evolves. Following the fast decays of these excited state features new features develop in 
the visible region at 462, 578 and, especially, at 763 nm. In line with the 
spectroelectrochemical investigations carried out with 2.7 in DMF (Figure 2.12a) the latter 
features suggest the formation of the one electron reduced form of the Pc following excited 
state electron transfer. The near infrared region is equally important. Here, new features 
were noted during the transient decay with a broad maximum ranging from 950 to 1300 
nm. Implicit are new valence band holes in graphene – accepted from photoexcited 2.7. 
Implicit is the formation of radical ion pair states, that is, reduced 2.7 and oxidized 
graphene. Analyses at the characteristic wavelengths give rise to three lifetimes, that were 
best fit by a multi-exponential fitting function affording for G2.7 lifetimes of <1 and 330 ± 
50 ps for charge separation and charge recombination, respectively. In addition, 1 ns 
component, which relates to Q-band ground state bleaching, is derived. 
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a) b) 
  
Figure 2.19 Differential absorption of a) visible and b) near infrared spectra obtained upon 
femtosecond pump probe experiments (387 nm) of G2.7 in DMF with time delays between 
0 and 13.8 ps at room temperature – for time delays see figure legend. 
 
 
Figure 2.20 Time absorption profiles of the spectra shown at 480, 735, 760 and 1230 nm. 
 
Overall, similar results with, however, slightly different spectral features and 
lifetimes came from complementary studies with G2.6 and G2.8 as shown in Figures 2.24 
and 2.25, respectively. Please note that the new absorption features include signals red 
shifted to the Q-bands. In the case of G2.6, the maximum is found at 742 nm, while for 
G2.8 it is expected to be around 780 nm. The latter is, however, masked by fundamental of 
the laser excitation at 775 nm. Interesting is the trend in terms of charge separation and 
charge recombination. The charge separation for G2.6-G2.8 always occurs in less than 1 
ps, but differs in terms of charge recombination: for G2.7 the lifetime of the charge 
separated state is more than two times longer than for G2.6 and G2.8. 
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a) b) 
  
Figure 2.21 Differential absorption of a) visible and b) near infrared spectra obtained upon 
femtosecond pump probe experiments (387 nm) of G2.6 in DMF with time delays between 
0 and 13.8 ps at room temperature – for time delays see figure legend. 
 
a) b) 
  
Figure 2.22 Differential absorption of a) visible and b) near infrared spectra obtained upon 
femtosecond pump probe experiments (387 nm) of G2.8 in DMF with time delays between 
0 and 13.8 ps room temperature – for time delays see figure legend. 
 
2.4 Conclusions 
 
Newly synthesized thiopyridylphthalocyanines 2.6-2.8 reveal low reduction 
potentials compared with the ZnPc reference. As such, they have evolved as interesting 
and promising building blocks to exfoliate graphite via their immobilization onto the basal 
plane of graphene. As a matter of fact, immobilization is enabled through electronic 
coupling as seen in newly developing absorption features and an almost complete 
85 
quenching of the Pc fluorescence in the case of the electron donor-acceptor nanohybrids 
G2.6-G2.8. The aforementioned was complemented by femtosecond pump probe 
spectroscopy, which corroborated that the electronic coupling between G2.6-G2.8, on one 
hand, and graphene, on the other hand, is indeed accompanied by charge transfer 
characteristics, yielding the one electron reduced phthalocyanine. In stark contrast, 
reference experiments with ZnPc completely lack any of the aforementioned new features. 
Therefore, in this case no immobilization occurs onto and/or electronic coupling with 
graphene compared to the graphene hybrids G2.6-G2.8. Raman, TEM and AFM analysis 
revealed that after drop casting the dispersion onto a Si/SiO2 wafer, the exfoliated flakes 
tend to minimize surface energy by folding or reaggregating, thus forming turbostratic 
graphene. 
 
2.5 Experimental section 
2.5.1 General information  
 
The organic solvents were dried according to standard methods by distillation over 
drying agents and stored under nitrogen or argon gas. Other solvents were used as 
commercial pure analytical. Deuterated solvents such as CDCl3 and DMSO-d6 were used 
for 
1
H, 
19
F and 
13
C NMR spectra. The solvents used in this work were purchased from 
Fluka, Merck, TCI Europe and Acros.  
The commercial reagents used from Sigma-Aldrich, Acros, TCI Europe and Merck 
have a purity ≥ 97 % protected of the air in dry conditions. 
Preparative TLC was performed using aluminium plates coated with SiO2 (Merck 
60, F-254). TLC plates were viewed under UV light (λ = 254 nm). Flash column 
chromatography was performed using SiO2 (0.040-0.063 mm). Gel column 
chromatography was done using Bio-Beads (BIO-RAD, 200-400 mesh). 
NMR spectra were recorded on Brucker AC 300/500 instruments. Chemical shifts 
are reported as δ-values in ppm relative to tetramethylsilane (TMS). 
Mass spectra were obtained using a Q-TOF (Q-TOF 2, Micromass, Manchester, 
UK) and a linear ion trap (LXQ, ThermoFinnigan, San Jose, CA, USA) mass spectrometer. 
ESI-HR mass spectra were acquired in Apex-Qe. 
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Steady-state absorption spectra were recorded with a Perkin-Elmer Lambda 35 and 
a Perkin-Elmer Lambda 2. Steady-state emission spectra were recorded with a Fluoromax-
3-spectrometer from HORIBA Jobin Yvon. All samples were measured in a fused quartz 
glass cuvette with a diameter of 10 mm. 
Femtosecond transient absorption spectra were obtained with a Ti:sapphire laser 
system CPA-2101 (Clark-MXR Inc.) in combination with a Helios TAPPS detection unit 
from Ultrafast Inc. The initial laser excitation wavelength is 775 nm with a pulse width of 
150 fs. The used excitation wavelength was 387 nm, which was generated with a SHG 
crystal. For the generation of the white light a sapphire crystal of adequate thickness was 
used. The chirp-effect between 420 and 770 nm is approximately 350 fs. The detection was 
carried out with two CCD cameras, each for a specific measuring range. The spectral 
window is therefore 415 to 770 nm and 770 to 1600 nm. The delay line allows spectral 
acquisition up to time delays of 8000 ps. All samples were measured in a fused quartz glass 
cuvette with a thickness of 2 mm. Data was acquired with the software HELIOS 
Visible/nIR (Newport / Ultrafast Systems). 
For electrochemistry, a Teflon coated Pt wire was used as working electrode, a Pt 
wire as counter electrode, and an Ag wire as quasi reference electrode. For better 
comparison the potentials were then converted to a ferrocene/ferrocenium redox couple. 
For spectroelectrochemistry, a Pt net was used as working electrode, a Pt sheet as counter 
electrode, and an Ag wire as quasi reference electrode. The potentials were applied with a 
METROHM PGSTAT 101 and the absorption spectra taken with a UV/nIR Cary5000 
spectrometer. 
Raman measurements were carried out with Renishaw in Via Reflex Confocal 
Raman Microscope using laser excitations of 532 nm. The sample was prepared by drop 
casting a dispersion on a Si substrate with a 300 nm oxide layer. 
Sample preparation was performed by drop casting and drying the hybrids on lacey 
carbon coated copper grids. Bright-field TEM images were recorded with an 80 kV EM 
900 from Carl Zeiss AG. 
AFM images were obtained with a Nanoscope IIIa Multimode, Veeco in tapping 
mode. The sample was prepared by dip coating of onto a Si wafer. 
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2.5.2 Synthesis of thiopyridylphthalonitriles 
 
4-(thiopyridyl)phthalonitrile (2.3): 
A mixture of 4-nitrophthalonitrile 2.1 (1.00 g, 5.78 mmol, 1 eq.) and 4-
mercaptopyridine 2.2 (1.61 g, 14.4 mmol, 2.5 eq.) were stirred in 5 mL of DMF in the 
presence of using K2CO3 (2.14 g, 15.48 mmol, 2.7 eq.) for 5 h at 60 ºC. After this period of 
time it was added water and the obtained precipitate after being crystalized in 
MeOH/CH2Cl2 (1/1), afforded product 2.3 in 70% yield. 
1
H NMR (300 MHz, DMSO-d6): 
δ 7.35 (dd, J = 4.5, 1.6 Hz, 2H, Hd), 7.91 (dd, J = 8.4, 1.9 Hz, 1H, Ha), 8.15 (d, J = 8.4 Hz, 
1H, H
c
), 8.28 (s, 1H, H
b
), 8.53 (dd, J = 4.5, 1.6 Hz, 2H, H
e
). 
13
C NMR (75 MHz, DMSO-
d6): δ 113.9, 115.4, 115.8, 116.1, 124.0, 134.9, 136.1, 136.2, 139.9, 143.8, 150.5. ESI-MS: 
m/z 237 [M+H]
+
. 
 
4,5-(dithiopyridyl)phthalonitrile (2.5): 
A mixture of 4-mercaptopyridine 2.2 (0.50 g, 4.50 mmol, 1 eq.) and 3,4-
dichlorophthalonitrile 2.4 (1.71 g, 8.70 mmol, 1.9 eq.) in 10 ml of DMF was stirred at 
room temperature, in the presence of K2CO3 (2.01 g, 14.5 mmol, 3.2 eq.). After 2 h it was 
added water, and the solid obtained was filtered and washed with several additions of 
water and methanol. Product 2.5 was isolated in 50% yield after crystallization of the crude 
precipitate in a mixture of MeOH/CH2Cl2. 
1
H NMR (300 MHz, CDCl3): δ 7.25 (dd, J = 
4.6, 1.6 Hz, 4H, H
b
), 7.57 (s, 2H, H
a
), 8.67 (dd, J = 4.6, 1.6 Hz, 4H, H
c
). 
13
C NMR (75 
MHz, CDCl3): δ 114.2, 114.8, 125.4, 135.0, 141.7, 142.6, 151.2. ESI-MS: m/z 347 
[M+H]
+
. 
 
2.5.3 Synthesis of thiopyridylphthalocyanines 
 
2,9(10),16(17),23(24)-tetrakis(4-pyridylsulphanyl)phthalocyaninato zinc(II) (2.6): 
The mono-substituted phthalonitrile 2.3 (400 mg, 1.69 mmol, 1 eq.) in 1.5 mL of 
DMAE was maintained overnight at reflux (140 ºC) in the presence of anhydrous ZnCl2 
(230 mg, 1.69 mmol, 1 eq.). Then, it was added methanol and the obtained crude was 
washed several times with methanol and water to remove the excess of ZnCl2. Finally, the 
solid was dried under vacuum atmosphere during 2 h at 60 ºC, affording product 2.6 in 
82% yield. 
1
H NMR (300 MHz, DMSO-d6 + TFA): δ 7.74 – 8.00 (br m, 8H, Ar-o-H
d
), 8.26 
88 
– 8.48 (br m, 4H, β-Hc), 8.52 – 8.79 (br m, 8H, Ar-m-He), 8.88 – 9.45 (br m, 8H, α-Ha,b). 
UV–Vis (DMSO), λmax (log ε): 347 (4.98), 617 (4.55), 684 (5.37) nm. MALDI-TOF-MS: 
m/z 1013 [M+H]
+
. 
 
2,3,9,10,16,17,23,24-Octakis(4-pyridylsulphanyl)phthalocyaninato zinc(II) (2.7): 
The synthesis of the octa-substituted Pc 2.7 was performed as it was described 
above but using the 4,5-dithiopyridylphthalonitrile (2.5). The Pc 2.7 was isolated in 85% 
yield.
1
H NMR (300 MHz, DMSO-d6 + TFA): δ 8.02 (d, J = 6.1 Hz, 16H, Ar-o-H
b
), 8.70 
(d, J = 6.1 Hz, 16H, Ar-m-H
c), 10.15 (s, 8H, Pc α-Ha). UV–Vis (DMSO), λmax (log ε): 371 
(4.59), 632 (4.47), 663 (4.68), 702 (5.03) nm. MALDI-TOF-MS: m/z 1448 [M+H]
+
. 
 
1,4,8,11,15,18,22,25-Octafluoro-2,3,9,10,16,17,23,24-Octakis(4-
pyridylsulphanyl)phthalocyaninato zinc(II) (2.8): 
The reaction between commercial ZnPcF16 (200 mg, 0.23 mmol, 1 eq.) and 4-
mercaptopyridine 2.2 (256.8 mg, 2.3 mmol, 10 eq.) was carried out in 50 mL of DMF and 
in the presence of 5 mL of diethylamine (DEA). The reaction mixture was maintained 
under stirring, at room temperature, overnight under nitrogen atmosphere. Then, it was 
added water and the green solid obtained by precipitation was filtered and washed with 
water and acetone. The Pc 2.8 was isolated in 89%, after drying the green solid during 2 h 
under vacuum atmosphere at 60 ºC. 
1
H NMR (300 MHz, DMSO-d6 + TFA): δ 7.28 (br s, 
16H, Ar-o-H
a
), 8.19 (br s, 16H, Ar-m-H
b
). 
19
F NMR (282 MHz, DMSO-d6 + TFA): δ -
126.91 (d, J = 173.5 Hz, 8F, α-F). UV–Vis (DMSO), λmax (log ε): 384 (4.82), 690 (5.04), 
720 (5.09) nm. MALDI-TOF-MS: m/z 1595 [M+H]
+
. 
 
2.5.4 Preparation of hybrids Pc/graphene 
 
Natural graphite (1-2 mg) was added to a solution of thiopyridylphthalocyanines 
2.6-2.8 in DMF (10
-5
 M), followed ultrasonication for 45 min and centrifugation at 20 G 
for 20 min. The supernatants were then extracted and again subjected to ultrasonication 
with newly added natural graphite. 
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Chapter 3 
 Supramolecular interactions between pyridyl and pyridinium 
phthalocyanines with SWNTs 
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3.1  Overview 
 
Carbon nanotubes (CNTs) have been considered attractive candidates for diverse 
nanotechnological applications due to their extraordinary properties, such as molecular 
tanks/deliveries,
1
 “bio”-sensors,2,3 electronics,4 nanomagnetical particles,5 structural 
materials,
6
 and many others.
7-9
 However, CNTs are practically insoluble or hardly 
dispersed in any solvent, due to the formation of big bundles held strongly together. This 
lack of solubility and the difficult manipulation have imposed great limitations to their use. 
For this, several ways of dispersion and solubilization have been tried and can be basically 
divided in two main approaches: covalent
10-12
 and noncovalent
13-15
 functionalization. Both 
methodologies have advantages and disadvantages, however on noncovalent interactions 
CNTs aromatic structure and their electronic characteristics are preserved.
16,17
 This 
supramolecular way to render CNTs soluble in a wide range of solvents is based on their 
noncovalent hydrophobic and π-π stacking interactions with specific molecules. Indeed, 
this methodology has been widely used to prepare individual CNTs by wrapping on the 
tubular surface several organic molecules,
18
 biomolecules,
20,21
 polymers,
22,23
 surfactants
24
 
and more recently, ionic liquids.
25
 In this context, it is envisaged the use of phthalocyanine 
(Pc) derivatives with single-wall carbon nanotubes (SWNTs) due to their unique 
absorption features in a large range of the UV-Vis spectrum.
26,27 
Interactions between different photosensitizer macrocycle cores have interesting 
adsorption properties and play a significant role in supramolecular chemistry.
28
 It has been 
well documented that different conjugated aromatic units have preferences to associate on 
the SWNT surface by host-guest interactions promoting aromatic association.
29-33
 These 
macrocycles bearing flexible, rigid planar or non-planar frameworks
34
 are considered to 
enhance a specific face-to-face orientation around the SWNT scaffold.
35
 Depending on the 
molecule type it is possible to obtain electronic transitions between the aromatic 
macrocycle and SWNT establishing potential electronic donor-acceptor properties.
36
 The 
association of SWNT with electron-donors or acceptors produces active materials, which 
are able to generate electrical energy when irradiated.
37
 Indeed, the development of 
trustworthy and reproducible procedures to incorporate CNT into functional assemblies, 
like donor/acceptor hybrids to convert sunlight into electrical energy, has emerged as an 
interesting research area. In this way, Pcs as electron donors and SWNT as electron 
acceptors are promising building blocks in donor-acceptor devices for solar energy 
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conversion, which is nowadays an important research topic to produce innovative 
materials, composites, and electronic devices of greatly reduced size.
38
 
Attending to their properties, it was envisaged that zinc complexes of Pcs bearing 
mercaptopyridine groups
39
 could interact by coordinating the pyridine units with the metal 
of neighbour molecules. These non-covalent interactions can approach the zinc thiopyridyl 
Pcs around the SWNT providing a compact assembly. Moreover, the cationization of the 
pyridine units affording amphiphilic thiopyridinium Pc derivatives,
39
 can allow a possible 
dispersion of the SWNTs though π-π stacking interactions in water media. The connection 
of photosensitizer-type compounds e.g. Pcs, may also employ some effect on solubility 
features and the formation of such a Pc/SWNT conjugate may be used in solar cells, 
nanodevices, nanosensors, nanoheaters, among others.
40
 
Likewise, Nyokong have been developed interesting pyridyl Pcs due to their 
assembly properties with SWNTs.
41,42
 In this work, host-guest supramolecular interactions 
of neutral and cationic thiopyridyl Pc derivatives with SWNTs were characterized by 
different spectroscopic techniques, namely steady-state absorption and fluorescence 
spectroscopy (analysing respectively the absorption shift – ∆λ, optical difference – and the 
emission quenching), time correlated single photon counting (TCSPC), and femtosecond 
transient absorption spectroscopy. 
 
3.2  Synthesis of the pyridinium phthalocyanine derivatives 
 
The thiopyridyl Pcs 2.6-2.8 (Figure 3.1) were prepared according with the 
procedure described in Chapter 2. The posterior cationization of the pyridine with methyl 
iodide afforded the corresponding amphiphilic cationic Pcs 3.1-3.3. These positively 
charged derivatives were prepared in order to study the formation of thiopyridinium 
Pcs/SWNT supramolecular assemblies in water media. 
The cationization of the pyridyl units of the Pcs 2.6-2.8 were performed with an 
excess of methyl iodide at 40 ºC in dry DMF. After stirring overnight in a hermetic 
pressure flask, the reaction mixtures were cooled down in ice and then it was added diethyl 
ether. The precipitates were retaken in a mixture of methanol/acetone and re-precipitated 
again with diethyl ether, filtered and dry under reduced pressure at 60 ºC. The 
thiopyridinium Pcs 3.1-3.3 were obtained in almost quantitative yields. 
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Figure 3.1 Thiopyridyl 2.6-2.8 and thiopyridinium 3.1-3.3 phthalocyanines. 
 
The success of the cationization was confirmed by 
1
H NMR spectroscopy; the 
spectra of 3.1-3.3 show in the aliphatic region at ca  4 ppm a peak or peaks (for 3.1 due to 
the presence of regioisomers) corresponding to the resonance of the methyl protons 
(Figures 3.2-3.4). In fact this is the main difference when these spectra are compared with 
the ones of the corresponding thiopyridyl Pcs 2.6-2.8. 
 
Figure 3.2 
1
H NMR spectrum of compound 3.1 in DMSO-d6. 
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The resonances ortho- and meta-protons of the pyridinium moieties suffer a shift to 
lower fields due to the insertion of the methyl groups when compared with the 
corresponding neutral. Again, the resonances of the ortho- and meta-protons of the 
pyridinium moieties of 3.3 ( 8.25 and 8.77 ppm, Figure 3.4) appear at slightly low field 
than the ones of the homologous Pc 3.2 ( 8.10 and 8.72 ppm, Figure 3.3), due to presence 
of the electronegative fluorine atoms at the α-positions of the Pc 3.3. Additionally, the α-
proton resonances of 3.2 ( 10.15 ppm, Figure 3.3) appear at lower fields when compared 
with the ones of 3.1 ( 9.10–9.48 ppm, Figure 3.2) due to the presence of the two electron-
withdrawing thiopyridinium units instead of one in the 3.1. 
The 
19
F NMR spectrum of 3.3 confirmed also its high symmetry by showing the 
resonance of the α-fluorine atoms as a singlet at  127.25 (Figure 3.5).  
The spectra of structures of compounds 3.1-3.3 confirmed also their structures by 
showing peaks at m/z at 1027 ([M-3CH3]
+
), 1463 ([M-7CH3]
+
) and 1608 ([M-7CH3]
+
) 
corresponding respectively to their base peak. 
 
Figure 3.3 
1
H NMR spectrum of compound 3.2 in DMSO-d6. 
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Figure 3.4 
1
H NMR spectrum of compound 3.3 in DMSO-d6. 
 
Figure 3.5 
19
F NMR spectrum of compound 3.3 in DMSO-d6. 
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3.3  Photophysical properties of phthalocyanine/SWNT assemblies 
 
As it was already mentioned, the host-guest supramolecular interactions between 
SWNTs and Pcs 2.6-2.8 and 3.1-3.3 were evaluated by different spectroscopic techniques, 
namely steady-state absorption and fluorescence spectroscopy (analysing respectively the 
absorption shift – ∆λ, optical difference – and the emission quenching), TCSPC, and 
femtosecond transient absorption spectroscopy. However, in order to understand the type 
of interaction it is important to report previously the photophysical properties of the 
individual molecules.  
 
3.3.1 Absorption and emission properties of the pyridinium phthalocyanines 
 
The absorption and the emission properties of charged thiopyridinium Pcs 3.1-3.3 
were evaluated in deuterium oxide (D2O) with 0.1 wt% sodium dodecylbenzenesulfonate 
(SDBS), instead of DMF as it was reported for 2.6-2.8 in Chapter 2. These cationic Pcs 
3.1-3.3 show absorption features similar to the ones described for 2.6-2.8 (Table 2.1 in 
Chapter 2), with the Q-band maxima at 683, 701 and 717 nm respectively (Figure 3.6a), 
and molar extinction coefficients (ε) of the same order of magnitude (Table 3.1). The 
fluorescence spectra of monomeric 3.1-3.3 in D2O/SDBS (0.1 wt %) upon 620 nm 
excitation give rise to maxima at 689 nm for 3.1, 704 nm for 3.2, and 726 nm for 3.3 were 
gathered at concentrations below 10
-5
 M (Figure 3.6b). These Pcs show slightly lower 
fluorescence quantum yields, 0.031 for 3.1, 0.056 for 3.2, and 0.018 for 3.3 than ZnPc 
(0.30) used as reference
43
 (Table 3.1). 
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Figure 3.6 a) Absorption and b) emission, upon excitation wavelength at 620 nm, spectra 
of Pcs 3.1-3.3 in D2O/SDBS (0.1 wt %) at concentrations of 10
-6
 M. 
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Table 3.1 The molar extinction coefficient (ε), fluorescence quantum yields (ɸF), and time 
correlated single photon counting (τ) in D2O/SDBS (0.1 wt %). 
Compounds ε (M-1cm-1) λmax / nm ɸF τ1 (ns) τ2 (ns) 
3.1 1.84 × 10
4
 689 0.031 1.42 2.97 
3.2 2.58 × 10
4
 704 0.056 0.18 1.53 
3.3 1.83 × 10
4
 726 0.018 0.08 1.90 
 
 
Moreover, it was also studied the TCSPC using a λexc. at 403 nm to analyse the 
relaxation of molecules from an excited state to a lower energy state. Since various 
molecules in a sample will emit photons at different times, despite their simultaneous 
excitation, the observed decay must be a certain rate of emission photons (Figure 3.7). 
The resulting histograms are best fitted by biexponential functions yielding a short 
(τ1) and a long lifetime (τ2). The lifetimes values τ1 and τ2 along with the ratio of their 
relative amplitudes are 1.42 and 2.97 ns (0.075) for 3.1, 0.18 and 1.53 ns (5.19) for 3.2 as 
well as 0.08 and 1.90 ns (0.13) for 3.3 (Table 3.1), respectively. Taking the aforementioned 
into concert, it was related the shorter lifetimes to those the aggregates, while the longer 
lifetimes are assigned to the fluorescing behaviour of the monomers. 
 
 
 
Figure 3.7 Emission time profiles of 3.1-3.3 in D2O/SDBS (0.1 wt%) following 403 nm 
excitation wavelength and the corresponding emission maxima. 
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3.3.2 Absorption and emission properties of 
thiopyridylphthalocyanine/SWNT assemblies 
 
The host-guest supramolecular interactions between the neutral Pcs 2.6-2.8 and 
SWNTs were performed by titrating SWNT suspensions in DMF with the Pcs dissolved 
also in DMF. The homogeneous and stable greyish suspensions of SWNT were obtained 
by ultrasonication (2×20 min, 100 W, 37 GHz), followed by centrifugation (10 min of at 
5.000 RPM) in DMF.  
The interactions were confirmed through the absorption wavelength alterations 
between the single Pcs 2.6-2.8 and the corresponding conjugates 2.6-2.8/SWNT.  
In the first set of titration assays (small additions of Pc solution to SWNT 
dispersion), the interactions between both species were probed unequivocally in all cases, 
by detection of an absorption red shift of the respectively Q-band (Figures 3.11a-3.13a). 
The maximum absorption wavelength of the Q-band for Pc 2.6-2.8 is respectively 683, 702 
and 721 nm and their maximum absorption wavelength is modified after the interaction 
with the carbon allotrope. The optical difference between the corresponding single Pc 2.6-
2.8 and the Pc 2.6-2.8/SWNTs conjugates were: 2.6/SWNT (∆λ = 17 nm), Pc 7/SWNT (∆λ 
= 24 nm), and Pc 2.8/SWNT (∆λ = 19 nm). On the other hand, the fluorescence 
measurements using an excitation wavelength (λexc) at 620 nm show, that after the first 
additions of Pc 2.6-2.8 to the SWNTs, the intensity of the prominent Q-band is 
substantially reduced, evidencing supramolecular interactions band (Figures 3.11b-3.13b). 
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Figure 3.8 Titration of SWNT suspension with Pc 2.6 solution (10
-5
 M) in DMF. a) 
Absorption and b) emission spectra of the single Pc 2.6 and Pc 2.6/SWNT (∆λ = 17 nm). 
Excitation wavelength at 620 nm. The insets show the expansion between 600-800 nm. 
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Figure 3.9 Titration of SWNT suspension with Pc 2.7 solution (10
-5
 M) in DMF. a) 
Absorption and b) emission spectra of the single Pc 2.7 and Pc 2.7/SWNT (∆λ = 24 nm). 
Excitation wavelength at 620 nm. The insets show the expansion between 600-800 nm. 
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Figure 3.10 Titration of SWNT suspension with Pc 2.8 solution (10
-5
 M) in DMF. a) 
Absorption and b) emission spectra of the single Pc 2.8 and Pc 2.8/SWNT (∆λ = 19 nm). 
Excitation wavelength at 620 nm. The insets show the expansion between 600-800 nm.  
 
The supramolecular assemblies most probably combine different interactions such 
as π-π and metal coordination between the inner zinc and the pyridyl groups (Figure 
3.14).
44-47
 These structures, even in the solution phase, may be associated via coordination 
around SWNTs as represented, for example, for the Pc 2.6. 
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Most problably it is formed “nanocages”, because the multiple coordinated 
possibilities between the multiple pyridyl groups and the zinc metal ion of the neighbour 
molecules (Figure 3.15). 
 
 
Figure 3.11 Possible noncovalent interactions of thiopyridyl Pcs 2.6/SWNT assemblies. 
 
 
 
 
 
Figure 3.12 Randomly network performed with thiopyridyl Pcs 2.6 around SWNTs. 
 
 
It was confirmed the supramolecular functionalization of SWNTs by the neutral 
thiopyridyl Pcs 2.6-2.8 by absorption and emission spectroscopic experiments explicitly 
referenced on the last Figures 3.11-3.13. However, it is important others photophysical 
studies, like transient absorption experiments, to prove the respective electronic 
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interactions of Pcs 2.6-2.8/SWNTs, evidencing the donor-acceptor properties of these 
nanoconjugates. 
 
3.3.3 Absorption and emission properties of 
thiopyridiniumphthalocyanine/SWNT assemblies 
 
The supramolecular interactions between the single thiopyridinium Pcs 3.1-3.3 and 
the SWNTs suspensions were studied using a similar procedure to the one described for 
neutral Pc, but in this case the Pc were dissolved in D2O/SDBS (0.1 wt%). 
The single cationic Pcs 3.1-3.3 present the maximum Q-band absorption 
wavelength at respectively 689, 704 and 726 nm. The absorption shifts detected after the 
interaction of 3.1 and 3.2 with SWNTs were: Pc 3.1/SWNT (∆λ = 13 nm) and Pc 
3.2/SWNT (∆λ = 7 nm). Despite the small values of the optical difference ∆λ, the 
quenching of the emission intensity evidence host-guest interactions for both Pc 3.1/SWNT 
and Pc 3.2/SWNT nanoconjugates (Figures 3.16 and 3.17). A possible explanation of these 
lower shift values when compared with the shifts observed with the neutral Pc are probably 
due to repulsion between the positively charged Pc. Concerning the Pc 3.3, it was not 
possible to obtain a decent spectrum for Pc 3.3/SWNT maybe due to the aggregation of Pc 
3.3 in D2O/SDBS (0.1 wt%). Indeed, it will be necessary to perform more spectral 
measurements in different solvents to take unequivocal conclusions. 
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Figure 3.13 Titration of SWNTs suspension with Pc 3.1 solution (10
-5
 M) in D2O/SDBS 
(0.1 wt%). a) Absorption and b) emission spectra of the single Pc 3.1 and Pc 3.1/SWNT 
(∆λ = 13 nm) in D2O/SDBS (0.1 wt%). Excitation wavelength at 620 nm. The insets show 
the expansion between 600-800 nm. 
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Figure 3.14 a) Absorption spectra of SWNT suspended in D2O/SDBS (0.1 wt%) and 
titration of the SWNT with 3.1-3.3 (10
-5 
M) in D2O/SDBS (0.1 wt%). Excitation 
wavelength at 620 nm. The insets show the expansion between 600-800 nm. 
 
3.3.4 3D NIR fluorescence spectra of SWNT and Pc 3.1-3.3:SWNT 
 
Motivated by absorption and emission properties of the hybrid materials Pc 3.1-
3.3/SWNT, it was mapped the 3D NIR fluorescence to detect the possibility of 
supramolecular interactions between both components. As a standard, was prepared a 
similar absorbing SWNT suspension in D2O/SDBS (0.1 wt%). From Figures 3.18 and 
3.19-3.21, which compare SWNT/D2O/SDBS (0.1 wt%) and Pc 3.1-3.3:SWNT/D2O/SDBS 
(0.1 wt%), it is derived several trends with an excitation wavelength of 387 nm. 
 
 
Figure 3.15 Steady-state 3D NIR fluorescence spectra of SWNT/D2O/SDBS (0.1 wt%) – 
with increasing intensity from blue to green to yellow and to red. 
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Figure 3.16 Steady-state 3D NIR fluorescence spectra of 3.1:SWNT/D2O/SDBS (0.1 wt%) 
– with increasing intensity from blue to green to yellow and to red. 
 
 
Figure 3.17 Steady-state 3D NIR fluorescence spectra of 3.2:SWNT/D2O/SDBS (0.1 wt%) 
– with increasing intensity from blue to green to yellow and to red. 
 
 
Figure 3.18 Steady-state 3D NIR fluorescence spectra of 3.3:SWNT/D2O/SDBS (0.1 wt%) 
– with increasing intensity from blue to green to yellow and to red. 
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The differences observed in steady-state 3D NIR fluorescence spectra of 3.1-
3.3:SWNT/D2O/SDBS (0.1% wt) in comparison to NIR fluorescence spectra of 
SWNT/D2O/SDBS (0.1% wt) are probably due to the electron-donor/acceptor interactions 
between them, while sizeable contributions from solvent effects were not ruled out (Figure 
3.22). 
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Figure 3.19 Comparison of the NIR fluorescence spectra of pristine SWNT/D2O/SDBS 
(0.1 wt%) (black) and Pc 3.1-3.3:SWNT/D2O/SDBS (0.1 wt%) (red) upon lamp excitation 
at 575 nm. 
 
3.3.5 Femtosecond Transient absorption spectroscopy 
 
The differential absorption spectrum of 3.2, which was probed in 0.1 wt% SDBS in 
D2O, with minima at 631 and 701 nm arise as a consequence of 387 nm excitation (Figure 
3.23). These are ascribed to ground state bleaching. The latter, together with rather broad 
maxima around 472, 596 and 1096 nm are assigned to singlet excited state features. 
Analyses of the absorption time profiles at these maxima reveal similar lifetimes, namely 
15.5 ± 0.87 ps due to the presence of aggregates, 1.39 ± 0.06 ps for the transition from S2 
to S1, and 440.1 ± 44.4 ps for intersystem crossing. As such, the intersystem crossing to the 
corresponding triplet excited state is nearly ten times faster for 3.2 than for 2.7. In the latter 
case, maxima at 654 and 849 nm develop during the first picoseconds. Here, it is derived 
lifetimes of 2.72 ± 0.2 ps, 27.8 ± 1.5 ps, and 1.2 ± 0.08 ns at 849 nm. Again, similar trends 
are noted for 3.1 and 3.3 (Figures 3.24 and 3.25). 
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Figure 3.20 a) Differential absorption spectra (visible) obtained upon femtosecond pump 
probe experiments (387 nm) of 3.2 in D2O/SDBS (0.1 wt %) with time delays between 0.1 
and 6750.1 ps at room temperature. b) Time absorption profiles of the spectra shown at 
485, 710 and 840 nm. 
 
a)
 
b)
 
Figure 3.21 a) Differential absorption spectra (visible) obtained upon femtosecond pump 
probe experiments (387 nm) of 3.1 in D2O/SDBS (0.1 wt%) with time delays between 0.1 
and 6750.0 ps at room temperature. b) Time absorption profile of the spectra shown at 488, 
720 and 843 nm. 
 
a)
 
b)
 
Figure 3.22 a) Differential absorption spectra (visible) obtained upon femtosecond pump 
probe experiments (387 nm) of 3.3 in D2O/SDBS (0.1 wt%) with time delays between 0.1 
and 6750.3 ps at room temperature. b) Time absorption profile of the spectra shown at 449, 
693 and 846 nm. 
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Initially, upon photoexciting Pc 3.1-3.3:SWNT/SDBS (0.1 wt%) at 387 nm, the Pc 
singlet excited state fingerprints – vide supra – are notable (Figures 3.26-3.28). At first 
glance, the visible range is dominated by transient maxima and transient minima ranges. 
These findings are important, since they attest to the successful formation of the ZnPc 
singlet excited state. At the end of the Pc 3.1-3.3 and SWNT excited state decays, 
characteristic changes occur in the differential absorption for Pc 3.1-3.3:SWNT/SDBS (0.1 
wt%). In the visible is appreciable a bleaching of the Q-bands (Figures 3.26-3.28). In the 
near infrared, on the other hand, we see a set of maxima and a set of minima that prove 
electronic communication in these assemblies. 
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Figure 3.23 Transient absorption spectra of Pc 3.1/SWNT in D2O/SDBS (0.1 wt%) with 
time delays between 0.0 and 7500 ps at room temperature. Excitation at 387 nm, pulse 
width 150 fs, pump energy 200 nJ. 
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Figure 3.24 Transient absorption spectra of Pc 3.2/SWNT in D2O/SDBS (0.1 wt%) with 
time delays between 0.0 and 7500 ps at room temperature. Excitation at 387 nm, pulse 
width 150 fs, pump energy 200 nJ. 
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Figure 3.25 Transient absorption spectra of Pc 3.3/SWNT in D2O/SDBS (0.1 wt%) with 
time delays between 0.0 and 7500 ps at room temperature. Excitation at 387 nm, pulse 
width 150 fs, pump energy 200 nJ. 
 
3.4  Final considerations 
 
In conclusion, neutral Pcs 2.6-2.8 evidence π-π interactions with SWNTs (∆λ = 17–
24 nm) in DMF, were the SPy groups have ability to coordinate the metal of the 
macrocycle core of the neighboring Pcs, around the SWNTs surface. Cationic Pcs 3.1 and 
3.2 presents also noncovalent interactions but with smaller optical shift comparatively with 
the corresponding neutral Pcs 2.6 and 2.8. With regards to the electron donor/acceptor 
character of these assemblies more studies will be necessary, in order to take final 
conclusions. However, the first photophysical properties of Pc 3.1-3.3:SWNT 
nanoconjugates showed π–π stacking interactions by absorption and emission 
spectroscopy. We think that is essential more time-resolved studies to verify an electron 
transfer between the Pc to SWNT, upon photoexcitation, which will make this donor-
acceptor hybrids promising for future electronic applications. 
 
3.5  Experimental section 
3.5.1 General information 
 
The general information for this chapter is similar to the one described in Chapter 2 
experimental. Steady-state absorption spectra were recorded with a Perkin-Elmer Lambda 
112 
35. Steady-state emission spectra were recorded with a Fluoromax-3-spectrometer from 
HORIBA Jobin Yvon. All samples were measured in a fused quartz glass cuvette with a 
diameter of 10 mm. 
Femtosecond transient absorption spectra were obtained with a Ti:sapphire laser 
system CPA-2101 (Clark-MXR), Inc.) in combination with a Helios TAPPS detection unit 
from Ultrafast Inc. All samples were measured in a fused quartz glass cuvette with a 
thickness of 2 mm. Data was acquired with the software HELIOS Visible/nIR (Newport / 
Ultrafast Systems). 
 
3.5.2 Syntheses of thiopyridiniumphthalocyanines 3.1-3.3 
 
The methylation of Pcs 2.6-2.8 (150.0 mg) was performed in 10 mL of DMF using 
methyl iodide in excess (3.0 mL, 48.1 mmol). The reaction mixture was stirred for 24 h at 
40 ºC. Then, the mixture was cooled down and the desired product was precipitated with 
diethyl ether. The solid was filtered and washed several times with diethyl ether. After that, 
the products were retaken in a mixture of methanol/acetone, re-precipitated from acetone, 
filtered and dry under reduced pressure at 60 ºC. Compounds 3.1-3.3 were obtained almost 
in quantitative yields. 
 
2,9(10),16(17),23(24)-tetrakis(4-methylpyridiniumsulfanyl)phthalocyaninato zinc(II) (3.1): 
1
H NMR (300 MHz, DMSO-d6): δ 4.18 – 4.23 (m, 12H, H
f
), 7.87 – 7.96 (m, 8H, Ar-o-Hd), 
8.33 – 8.52 (m, 4H, β-Hc), 8.67 – 8.74 (m, 8H, Ar-m-He), 9.10 – 9.48 (m, 8H, α-Ha,b). UV–
Vis (DMSO), λmax (log ε): 352 (4.60), 616 (4.39), 685 (5.20) nm. MALDI-TOF-MS: m/z 
1027 [M-3CH3]
+
. 
 
2,3,9,10,16,17,23,24-Octakis(4-methylpyridiniumsulfanyl)phthalocyaninato zinc(II) (3.2): 
1
H NMR (300 MHz, DMSO-d6): δ 4.23 (s, 24H, H
d
), 8.10 (d, J = 7.1 Hz, 16H, Ar-o-H
b
), 
8.72 (d, J = 7.1 Hz, 16H, Ar-m-H
c
), 10.15 (s, 8H, Pc α-Ha). UV–Vis (DMSO), λmax (log ε): 
383 (4.55), 630 (4.38), 702 (5.03) nm. MALDI-TOF-MS: m⁄z 1463 [M-7CH3]
+
. 
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1,4,8,11,15,18,22,25-Octafluoro-2,3,9,10,16,17,23,24-Octakis(4-
methylpyridiniumsulfanyl)phthalocyaninato zinc(II) (3.3): 
1
H NMR (300 MHz, DMSO-d6): δ 4.22 (s, 24H, H
c
), 8.25 (d, J = 7.1 Hz, 16H, Ar-o-H
a
), 
8.77 (d, J = 7.1 Hz, 16H, Ar-m-H
b
). 
19
F NMR (DMSO-d6): δ -127.25 (s, 8F, Pc-α-F). UV–
Vis (DMSO), λmax (log ε): 407 (4.46), 647 (4.29), 722 (4.84) nm. MALDI-TOF-MS: m⁄z 
1608 [M-7CH3]
+
. 
 
3.5.3 Preparation of stable SWNT suspensions and the stock solutions of 
phthalocyanines 
 
SWNTs (0.5 mg) were dispersed in DMF (10 mL) by ultrasonication (around 15 
min), obtaining a dark gray suspension of SWNTs. Significantly, an excess of SWNTs was 
removed by centrifugation for 15 min at 9.6 kG. The resulting SWNT suspensions did not 
show appreciable SWNT-based fluorescence in the NIR, since most likely, debundling is 
incomplete. Nevertheless, their overall stability renders them an ideal starting point for 
further tests. The stock solutions of 2.6-2.8 and 3.1-3.3 were prepared in DMF and 
D2O/SDBS (0.1 wt%), respectively, at concentrations of 10
-5
 M. 
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Chapter 4 
Noncovalent assemblies based on thiopyridyl porphyrins and 
ruthenium phthalocyanines  
 
119 
4.1 Overview 
 
Porphyrins (Pors) and phthalocyanines (Pcs) have been studied in different 
electronic applications,
1-15
 namely in photoactive coordinated-systems due to their large 
range of UV-Vis absorption features and the ability to construct noncovalent assemblies, 
namely with carbon nanostructures, such as SWNTs and C60.
16-22
 In particular, Pors and 
Pcs with pyridyl units have been used to form supermolecules with ruthenium tetra-tert-
butyl phthalocyanines (RuPcs), by noncovalent linkage involving the between pyridyl units 
and the ruthenium metal ion of the Pc.
23-26
 In fact, RuPc derivatives are attractive, not only 
due to their application as photosensitising elements of photoelectrochemical cells but also 
due to their ability to coordinate neighbour molecules with pyridine units.
27,28,29,30
 On the 
other hand, the selection of RuPcs with tert-butyl substituents can ensure a better solubility 
and a less tendency to form aggregates in solution.
31-35
 
The crucial topic of synthetic photosynthesis is a line-up of light-induced energy- 
and electron-transfer reactions.
36
 In this way, aromatic compounds evidencing light-
harvesting and reactive processes should comprise light-absorbing chromophores, which 
arise as antenna molecules, excited-state electron donor and additionally electron 
acceptors.
37
 Donor-acceptor ensembles also play key roles in molecular photovoltaic
 
devices
38-40
, where the prompt conversion of the energy is stored in the photogenerated 
radical ion pair states into electrical power. Supramolecular interactions between different 
dye molecules have interesting adsorption properties since they can cover a higher region 
of the visible spectrum.
41-45
 
The potential in electronic supramolecular chemistry depends of the absorption and 
emission performance of the dyes that can be driven by self-assembly coordination 
processes. In this context, certain researchers have been constructed noncovalent multi-dye 
systems, such as the ones involving different pyridyl-dye derivatives and tert-butyl 
ruthenium phthalocyanines (RuPcs).
46,47
 Due to the association properties, it is possible to 
obtain electronic transitions between both aromatic compounds. It has been well 
documented that different supramolecular electron donor-acceptor building blocks, such as 
perylenebisimide
28
 or perylenediimide
27
 with pyridyl units has been considered through 
axial coordination to the ruthenium(II) metal centres of two or four RuPc units, depending 
on the available pyridyl groups. Recently, a series of supramolecular Por-Pc assemblies 
have been prepared by D’Souza group presenting the axial coordination of (ortho-, meta- 
120 
or para-) imidozylphenyl-substituted free-base Pors to RuPc dyes.
48
 On the other hand, 
pyridylporphyrins have been reported by Cook and co-workers to allow electron donor-
acceptor hybrids with pronounced design flexibility.
49
 
Zinc Pors are also known to successfully form self-assembled supramolecular 
dyads and triads via metal-ligand coordination with pyridyl-fullerene (C60) derivatives, 
crown-ether inclusion, ion pairing, hydrogen-bonding, or π-π stacking interactions.50 The 
supramolecular heterochromophore ensembles presented an energy transfer from the 
periphery to the central core of these multichromophore systems. The interesting properties 
brought to synthesise and study Por-Pc electron donor/acceptor assemblies as promising 
candidates for solar energy conversion, based on noncovalent linkage. Indeed, it is reported 
here the mono- and tetra-thiopyridylporphyrins, previously reported by our research 
group,
52
 coordinated with one or four RuPc unit(s) to perform the supramolecular 
assemblies 4.10-4.12 (Figure 4.10, pg. 133). It is noteworthy that the synthesis involves 
rigorous control conditions due to the possibility of incomplete axial derivatization of the 
RuPc by pyridyl groups of the Por derivatives.
51,52
 It is established a versatile platform to 
functionalize pyridyl porphyrins and present the synthesis of porphyrin dyes peripherally 
supramolecular-substituted with ruthenium chromophores. Herein, it is reported a notable 
redistribution of electron density of new heterochromophore structures, evidencing the 
electron-donating/-accepting communication between both dyes in the supramolecular 
hybrids. Photophysical investigation by time-resolved transient absorption, mainly 
fluorescence and femtosecond spectroscopy, evidenced efficient intermolecular energy 
transfer from the photoexcited central porphyrin to the peripheral phthalocyanines in the 
supramolecular multichromophore ensembles. The outcome forms the source to architect 
interesting materials in solar light converting systems. 
 
4.2 Synthesis of the ruthenium(II) tert-butylphthalocyanine 
 
The synthesis of the supramolecular assemblies 4.10-4.12 (Figure 4.10) requires the 
previous preparation of the RuPc 4.3. Generally, metallated Pcs can be synthesised by two 
different methods.
53
 One of them consists on the cyclotetramerization of a phthalonitrile 
derivative in the presence of the adequate metal salt, and the other involves the direct 
insertion of a metal into the macrocycle core of a pre-synthesised metal-free Pc. In this 
121 
study, the access to RuPc 4.3 was based on the cyclotetramerisation of the precursor 4-
(tert-butyl)phthalonitrile 4.1 affording the corresponding metal free H2Pc 4.2, followed by 
insertion of the ruthenium metal ion with triruthenium dodecacarbonyl, Ru3(CO)12 
(Scheme 4.1).
54
 It is noteworthy that the synthesis requires a rigorous control on the 
experimental conditions in order to obtain the metal with only one axial ligand; in this way, 
the second ligand, the thiopyridylporphyrins 4.7-4.9 (Schemes 4.3 and 4.4) can be 
successfully incorporated to develop the multichromophoric clusters. This is a well-known 
procedure used to prepare ruthenium complexes of Pcs bearing two different ligands.
51
 
The tetramerization of 4-tert-butylphthalonitrile 4.1 was performed in 1-pentanol at 
150 ºC in the presence of lithium (Scheme 4.1).
55
 
 
 
Scheme 4.1 
 
After 12 h under stirring, the reaction was finished by adding a mixture of 
methanol/water (1:1). The obtained precipitate was filtrated and washed several times with 
the same mixture of methanol/water to remove the lithium residues. Then, the solid after 
being purified in a silica gel chromatography column, using dichloromethane/hexane (3:1) 
as eluent, afforded the pure metal-free H2Pc 4.2 as a deep blue solid in 84% yield. 
The structure of 4.2 was confirmed by NMR spectroscopy and mass spectrometry. 
The 
1
H NMR spectrum of 4.2 (Figure 4.1) shows the resonances corresponding to the 
aromatic protons β-Hc and α-Ha,b, as two multiplets at δ 8.27-8.39 and 9.14-9.58 ppm, 
respectively. The resonances of the 36 tert-butyl protons (H
d
) appear as a singlet at δ 1.90 
ppm. The multiplet between δ -1.20 and -0.98 ppm corresponds to the resonance of the 
internal -NH protons. In the mass spectrum of 4.2, the presence of a peak at m/z 739, 
corresponding to the molecular ion is also in agreement with the expected structure. 
122 
 
Figure 4.1 
1
H NMR spectrum of compound 4.2 in CDCl3. 
 
The metallation of the tetra-tert-butyl phthalocyanine 4.2 was carried out using 
Ru3(CO)12 in refluxing phenol (190 ºC). After 16 h, the control by TLC showed the 
complete consumption of the starting material 4.2. After the usual work up and purification 
by column chromatography, the Pc 4.3 was obtained in 82% yield as a mixture of 
regioisomers (Scheme 4.1). 
The 
1
H NMR spectrum of 4.3 in deuterated chloroform shows the β-Hc and α-Ha,b 
aromatic protons of the isoindole units as broad multiplets at δ 8.01-8.14 and 9.14-9.40 
ppm, respectively. The resonances of the aliphatic tert-butyl protons H
d
 appear as a singlet 
at δ 1.71 ppm and the absence of the multiplet at high field due to the inner -NH protons of 
the macrocycle core confirmed the success of the ruthenium complexation (Figure 4.2). 
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Figure 4.2 
1
H NMR spectrum of compound 4.3 in CDCl3. 
 
The UV-Vis spectrum of 4.3 displays Soret- and Q-band absorptions at 296 and 652 
nm, respectively. Finally, the ESI-MS spectrum of 4.3 confirmed also the success of the 
metal insertion by showing the peak corresponding to the molecular ion at m/z 866.
27
 
In this way, the potential noncovalent access between RuPcs and pyridyl dyes 
provides a high interest to study new examples of supermolecules.
56,57
 In this sense, it is 
reported here the noncovalent functionalization of the free and complexed 
thiopyridylporphyrins, which promote association with RuPcs 4.3 owing the 
intermolecular affinity between the pyridyl substituents and the ruthenium-Pc metal ions. 
 
4.3 Syntheses of the thiopyridylporphyrins 
 
The 5,10,15,20-tetraquis(pentafluorphenyl)porphyrin 4.6 (TPPF20) (Scheme 4.2) 
required to prepare the thiopyridylporphyrins 4.7 (Scheme 4.3) and 4.8 (Scheme 4.4) was 
synthesised using a modified Rothemund condition.
58,59
 The simple one-step reaction 
124 
involved the equimolar condensation of pyrrole with pentafluorobenzaldehyde in a mixture 
of acetic acid/nitrobenzene under refluxing conditions. The expected porphyrin, was 
obtained after removing the mixture of acetic acid/nitrobenzene under reduced pressure 
and purification of the crude residue by silica gel chromatography.
60-63 
 
 
Scheme 4.2 
 
The 
1
H NMR spectrum of 4.6 in CDCl3 is in agreement with the structure. The 
proton resonances of the inner -NH appears at δ -3.19 ppm and the signal due to the β-
protons at δ 9.45 ppm. The 19F NMR spectrum of 4.6 shows the resonances due to the 
ortho-, para-, and meta-fluorine atoms, respectively at δ -184.92 to -184.70, -174.70, and -
160.04 ppm as a multiplet, triplet and doublet of doublets (Figure 4.3). 
 
 
Figure 4.3 
19
F NMR spectrum of compound 4.6 in CDCl3. 
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The nucleophilic substitution reactions of the four para-fluorine atoms on TPPF20 
(4.6) are already well documented.
64-68
 The reactivity of the para-fluorine atoms on the 
pentafluorophenyl moiety varies significantly with the specific nucleophile used and 
several studies about nucleophile reactivity can be found in literature.
69
 The synthesis of 
the mono- and tetra-thiopyridylporphyrins 4.7 and 4.8 (Schemes 4.3 and 4.4) required the 
selection of 4-mercaptopyridine 2.2 to be used as nucleophile. Although both reactions 
were accomplished in DMF and in the presence of diethylamine (DEA) the experimental 
conditions were different in order to favour the mono- or the tetra-substitution of the 
fluorine atoms. 
The synthesis of the mono-thiopyridylporphyrin 4.7 (Scheme 4.3) required the 
presence of an excess of TPPF20 comparatively to the 4-mercaptopyridine (1:0.7) and it 
was carried out at room temperature under nitrogen atmosphere. This is an important 
aspect in order to avoid the oxidation of the 4-mercaptopyridine. After 1 h, the solvent was 
removed under reduced pressure and the residue after purification and crystallization, 
afforded compound 4.7 in 22% of yield. 
 
 
Scheme 4.3 
 
The structure of 4.7 was confirmed by NMR and mass spectrometry. The 
1
H NMR 
spectrum shows the typical internal aromatic -NH protons as a singlet at δ -2.97 ppm and 
the resonances of the aromatic β-pyrrolic protons (β-H) appear between δ 8.87 and 8.89 
ppm (Figure 4.4). 
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Figure 4.4 
1
H NMR spectrum of compound 4.7 in CDCl3. 
 
The resonances of the four ortho- and meta-protons of the extra pyridyl unit appear 
as doublet of doublets at δ 7.29 and 8.58 ppm, respectively. The 19F NMR spectrum of 4.7 
is also in agreement with the mono-substitution (Figure 4.5). The two multiplets and the 
doublet of doublets at δ -184.87 to -184.67, -174.75 to -174.51 and -160.02 ppm 
correspond to the 6 ortho-F, 3 para-F and 6 meta-F resonances of the unsubstituted rings. 
The doublet of doublets at δ -158.15 and -154.30 ppm correspond to the 2 ortho-F and 2 
meta-F atoms of the substituted fluorophenyl unit. The MALDI-MS spectrum of 4.7 shows 
a peak at m/z 1066 corresponding to the protonated molecular ion [M+H]
+
. 
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Figure 4.5 
19
F NMR spectrum of compound 4.7 in CDCl3. 
 
The synthesis of the tetra-thiopyridylporphyrin 4.8 required more drastic conditions 
when compared with the previous synthesis (Scheme 4.4). The nucleophilic substitution 
was performed in the presence of an excess of 4-mercaptopyridine 2.2 and in DMF at 
reflux  
The Zn(II) complex 4.9 was prepared by metallation of 4.8 using an excess of 
Zn(AcO)2 in a mixture of CHCl3/MeOH (9/1) (Scheme 4.4). After refluxing for 3 h it was 
added a mixture of CHCl3/MeOH (98:2)/hexane; the resulting precipitate afforded 
compound 4.9 in 96% yield, after a careful elimination of the excess of zinc(II) salt with 
water. 
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Scheme 4.4 
 
The NMR, UV-Vis and mass spectrometry confirm the structures of 4.8 and 4.9. 
The 
1
H NMR spectrum of 4.8 (Figure 4.6) indicates clearly the presence of two distinct 
regions: a singlet at higher field (δ -3.12 ppm) due to the resonances of the inner -NH 
protons of Por core and signals at lower field due to the aromatic β-pyrrolic (singlet at δ 
9.61 ppm) and pyridyl protons. 
 
 
Figure 4.6 
1
H NMR spectrum of compound 4.8 in DMSO-d6. 
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The resonances of the ortho- and meta-protons of the pyridyl moieties appear as 
doublets at δ 7.73 and 8.63 ppm, respectively. The 19F NMR spectrum of 4.8 confirmed 
also the complete nucleophilic substitution of the four para-fluorine atoms by the 4-
mercaptopyridine units by the disappearance of the corresponding resonance signals in the 
spectrum. The resonances of the ortho- and meta-fluorine atoms appear as two doublet 
doublets (J = 11.9 and 26.3 Hz) at δ -161.11 and -156.14 ppm, respectively (Figure 4.7). 
The MALDI-TOF-MS spectrum of 4.8 confirmed the molecular ion peak at m/z 1339 
[M+H]
+
. 
 
 
Figure 4.7 
19
F NMR spectrum of compound 4.8 in DMSO-d6. 
 
The structure of compound 4.9 was also confirmed by the same spectroscopic data 
(
1
H and 
19
F
 
NMR and mass spectrometry). The 
1
H NMR spectrum (Figure 4.8) shows the 
expected disappearance of the resonance of inner -NH protons due to inclusion of the zinc 
metal ion. The signals of the ortho- and meta-protons of the pyridyl groups and of the 
aromatic β-pyrrolic protons suffer a slight high field shift (δ 7.23, 8.07 and 8.95 ppm) 
when compared with the signals of the free-base analogues. The presence of a peak 
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corresponding to the protonated molecular ion [M+H]
+
 at m/z 1401 in the MALDI-MS 
spectrum of 4.9 is also in agreement with the structure. 
 
Figure 4.8 
1
H NMR spectrum of compound 4.9 in CDCl3. 
 
In the 
19
F NMR spectrum of 4.9 (Figure 4.9) the resonances of the fluorine atoms 
appear as two doublet doublets at δ -154.93 and -151.46 ppm. 
 
Figure 4.9 
19
F NMR spectrum of compound 4.9 in CDCl3. 
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4.4 Supramolecular arrays based on thiopyridylporphyrins and ruthenium 
phthalocyanines 
 
Torres et al. showed that the appropriate peripheral substitution of the aromatic 
perylene core with strongly ruthenium-coordinating pyridyl ligands afforded highly-
ordered supramolecular arrays with electron donor-acceptor features.
28
 Analogously, the 
novel supramolecular assemblies 4.10-4.12 were developed through axial coordination of 
the thiopyridylporphyrins 4.7-4.9, bearing one or four pyridyl substituents to the 
ruthenium(II) metal centre of one or four RuPcs 4.3 (Figure 4.10). It is noticeable, that the 
coupling of the RuPcs to the thiopyridylporphyrin improves the solubility of the assembly 
in organic solvents without altering significantly the electron-donor features
27
 of the Por 
backbone; this fact was confirmed by transient photophysical experiments (see discussion 
below in subtopic 4.4). 
 
Figure 4.10 Supramolecular arrays of 4.10-4.12. 
 
The supramolecular arrays of 4.10-4.12 (Figure 4.10) were obtained by just adding 
porphyrin 4.7-4.9 to the adequate number of RuPc 4.3 equivalents in dichloromethane. 
The mixtures were maintained under stirring at room temperature overnight. After this 
period, the TLC control confirmed the formation of the new Por-RuPc clusters 4.10-4.12 
and the solvent was then evaporated. The crude mixtures, after being purified by molecular 
exclusion Bio-Beads gel chromatography using CHCl3 as eluent, afforded the Por-RuPc 
clusters 4.10-4.12 in 71, 91 and 90% yields, respectively. The new assemblies were 
characterised by 
1
H, 
19
F NMR, UV-Vis spectroscopy and mass spectrometry. 
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The 
1
H NMR spectrum of 4.10 (Figure 4.11) shows the resonances of -NH protons 
of the porphyrin macrocycle as a singlet at high field (δ -3.02 ppm), and of the RuPc tert-
butyl protons as a singlet at δ 1.79 ppm. Moreover, the ortho- and meta-proton resonances 
of the pyridine unit appear as doublets at δ 8.62 and 8.80 ppm (J = 4.6 Hz). The signals of 
the β- and α-proton resonances of the RuPc are distributed at δ 8.18 and 9.30-9.47 ppm, 
respectively. Finally, the signals at δ 6.99-7.13 and 8.90 ppm are probably due to the β-
pyrrolic protons of the porphyrin unit. The 
19
F NMR spectrum of 4.10 presents the 
resonances of the fluorine atoms in the unsubstituted rings as three multiplets between δ -
184.89 and -184.68, δ -174.74 and -174.51 and δ -160.09 and -159.91 ppm; these signals 
correspond respectively to the 6 ortho-F, 3 para-F and 6 meta-F atoms (Figure 4.12). The 
resonances of the fluorine atoms in the substituted ring emerge as doublet of doublets at δ -
157.62 (2 ortho-F) and -153.97 ppm (2 meta-F). The ESI-MS spectrum of 4.10 (Figure 
4.13) is also in agreement with the proposed assembly, by showing a peak corresponding 
to the molecular ion at m/z 1931 [M]
+·. 
 
 
Figure 4.11 
1
H NMR spectrum of compound 4.10 in CDCl3. 
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Figure 4.12 
19
F NMR spectrum of compound 4.10 in CDCl3. 
 
 
Figure 4.13 ESI-MS/MS spectrum of compound 4.10. 
 
As a complement it was also analyzed the results obtained in the ESI-MS/MS 
spectrum of the [M]
+· ion of 4.10 and the results are summarized in Table 4.1. The MS/MS 
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spectrum shows a product ion at m/z 1066, corresponding to the loss of the RuPc residue (-
865 Da, loss of ≈RuPcres), and another one at m/z 866 due to the loss of the 
thiopyridylporphyrin unit (-1065 Da, loss of ≈PorSPyres). This pattern of fragmentation 
confirms the presence of the RuPc moiety linked supramolecularly to the Por 4.7. 
 
 
Table 4.1 Results of ESI-MS experiments performed for 4.10. 
Produced ions from 
Neutral 
loss (Da) 
m/z 
[M]
+·  1931 
[M-RuPcres]
+
 -865 1066 
[M-PorSPyres]
+
 -1065 866 
 
 
The 
1
H NMR spectrum of 4.11 indicates unequivocally all the resonance signals 
(Figure 4.14). Definitely, the proton resonances of the Por core are located as a multiplet at 
high field (δ -3.39 to -3.35 ppm). On the high field of the spectrum are also situated the 
tert-butyl proton resonances which appear as a singlet at δ 1.60 ppm. On the other side of 
the spectrum, it is detected the pyridyl ortho-H and Por β-H proton resonances respectively 
as a doublet (δ 5.27 ppm) and singlet (δ 8.36 ppm). On the middle of these signals are 
positioned the β-H proton resonances of the RuPc at δ 8.06 ppm, integrating for 16 
protons. Finally, in the cluster 4.11 it was detected as multiplet the overlapping signals α-H 
protons of the RuPc and pyridyl meta-H protons of Por among δ 9.25-9.39 ppm, 
integrating for 40 protons. However, the 
19
F NMR spectrum of 4.11 showed the ortho- and 
meta-fluorine atoms as two multiplets respectively between δ -134.18 and -133.96 and 
between δ -130.45 and -130.29 ppm (Figure 4.15). 
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Figure 4.14 
1
H NMR spectrum of compound 4.11 in CDCl3. 
 
Figure 4.15 
19
F NMR spectrum of compound 4.11 in CDCl3. 
 
The structure of 4.11 was also confirmed by electrospray ionisation tandem mass 
spectrometry ESI-MS/MS (Figure 4.16), which is a very fast and sensitive technique that 
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provided clearly the molecular ion peak of 4.11 at m/z 4803 [M]
+· (Figure 4.16 and Table 
4.2) and consequently the gradual fragmentation of each RuPc 4.3. 
The obtained results are summarized in Table 4.2, demonstrating losses of one to n-
RuPc residues (-865 Da, loss of ≈RuPcres) with maximum sequential losses of 4 RuPcres 
units for [M-RuPcres]
+
 (m/z 3938), [M-2RuPcres]
+
 (m/z 3070), [M-3RuPcres]
+
 (m/z 2598) 
and [M-4RuPcres]
+
 (m/z 1339), respectively. This pattern of fragmentation confirms the 
presence of 4 RuPc moiety linked to the free-base Por 4.8. These fragmentations are rather 
interesting, since the maximum number of lost RuPcres is equal to the coordination number 
of pyridyl units of the porphyrin. This information confirms the structural identification of 
the Por-RuPc complex which it is easy to observe the gradual elimination of the Pc units 
linked noncovalently to the thiopyridylporphyrin. 
 
 
Figure 4.16 ESI-MS/MS spectrum of compound 4.11. 
 
Table 4.2 Results of ESI-MS experiments performed for 4.11. 
Produced ions from 
Neutral 
loss (Da) 
m/z 
[M]
+·  4803 
[M-1RuPcres]
+
 -865 3938 
[M-2RuPcres]
+
 -1733 3070 
[M-3RuPcres]
+
 -2205 2598 
[M-4RuPcres]
+
 -3464 1339 
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The hybrid 4.11 and zinc acetate were stirred in a mixture of CH2Cl2/MeOH (9:1, 5 
mL) for 3 h refluxing under nitrogen atmosphere. After that, the product was purified by 
molecular exclusion to obtain the corresponding zinc complex 4.12 in 90% of yield, 
isolated as a deep blue solid. The 
1
H NMR spectrum of 4.12 shows a more complex and 
broad pattern than the spectrum of the corresponding free-base 4.11 (Figure 4.17). As 
expected no signal was detected at high field region due to the absence of the internal -NH 
protons. On the other hand, 
19
F NMR spectrum of 4.12 shows two distinct multiplets at δ -
157.95 to -157.15 and at δ -155.07 to -153.31 ppm referent to the integration of the 16 
fluorine atoms (Figure 4.18). 
 
 
Figure 4.17 
1
H NMR spectrum of compound 4.12 in CDCl3. 
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Figure 4.18 
19
F NMR spectrum of compound 4.12 in CDCl3. 
 
4.5 Photophysical properties* 
 
Considering the remarkable photochemical and photophysical properties of Pors 
and Pcs to act as electron carriers and the simple access to obtain the new supramolecular 
conjugates 4.10-4.12 (Figure 4.10), in this section it will be discussed the photophysical 
characterization of the supramolecular hybrids. In fact, the procedure that proved to be an 
efficient methodology to prepare the desired supramolecular ensembles 4.10-4.12 via 
noncovalent interaction of Pors 4.7 or 4.8
52
 with the adequate number of RuPc 4.3 units 
allowed us to study the type of photoinduced energy and electronic communication 
involving the dyes present. 
The absorption spectra of 4.10-4.12 are summarised in Figure 4.19 and their profile 
were compared with the profile of the individual components. The absorption spectra of 
                                                 
*These compounds were tested by Anita Hausmann and Christina Schubert, who kindly provided their 
results for a comprehensive analysis of the photophysical values of these supramolecular arrays. 
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4.7 and 4.8 show a dominating Soret-band absorption that maximizes at ca 415 nm and a 
series of weaker Q-band absorptions in the region between 500 and 650 nm, which are in 
agreement with the spectrum of 5,10,15,20-tetraphenylporphyrin (H2P) reference
70
 (Table 
4.3). Similarly, the absorption spectrum of zinc tetra-thiopyridylporphyrin 4.9 is a good 
resemblance of the absorption spectrum of zinc(II) complex of 5,10,15,20-
tetraphenylporphyrin (ZnP)
70
 comprising a dominant Soret-band absorption that 
maximizes at 423 nm and weak Q-band absorptions in the region of 500 – 600 nm (Table 
4.3). On the other hand, the optical absorption spectrum of RuPc 4.3 shows a weak Soret-
band, in the region of 300 – 400 nm and a strong Q-band maximum at 650 nm, which 
matches quite well with the absorption features seen for metallated phthalocyanines. 
 
 
Figure 4.19 Room temperature absorption spectra of 4.10-4.12 in toluene. 
 
Table 4.3 Soret-band wavelengths, maxima of fluorescence wavelength (λmax. emission), 
fluorescence quantum yields (φF) and life times of 4.7-4.12. 
Compound 
Soret-band 
(nm) 
Q-bands 
(nm) 
Emission
a)
 
(λmax. nm) 
φF
b)
 τ 
4.7 412 505, 536, 581, 634 --- --- --- 
4.8 415 507, 537, 581, 633 705 0.06 --- 
4.9 423 552, 586 655 0.03 2.1 ns 
4.10 418 587, 650 663 0.01 --- 
4.11 422 587, 650 655 0.003 < 100 ps 
4.12 430 586, 650 658 0.0002 112 ± 10 ps 
a)
excited at 420 nm; 
b)
using H2P and ZnP as reference. 
 
The UV-vis spectra of 4.10 and 4.11, show the characteristic absorption features of 
the corresponding individual constituents 4.7 and 4.8 and of RuPc 4.3 (Figure 4.19 and 
Table 4.3). In particular, the spectra show the Soret-bands at 418 and 422 nm for 4.10 and 
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4.11, respectively, as well as the characteristic Q-band of the metallated Pc or Pcs at 650 
nm. By the same token, 4.12 features the absorption characteristics of 4.9, with a Soret-
band that maximizes at 430 nm and of the RuPc with a strong Q-band at 650 nm that 
remained unchanged. Finally, considering the Soret- and Q-bands intensity of hybrids 4.10 
and 4.11, it was expected that absorption intensity of Q-band of 4.11 would be amplified 
by the contribution of the four RuPc units comparatively to the dyad 4.10 (Figure 4.19). 
Interesting it was observed a less intense Q-band absorption for the pentamer. 
In Table 4.3 are also summarized the fluorescence maxima, fluorescence quantum 
yields, and fluorescence lifetimes obtained from the steady state and time resolved 
fluorescence studies. Porphyrins 4.8 and 4.9 and the references H2P and ZnP were all 
photoexcited at 420 nm, while RuPc 4.3 was photoexcited at 610 nm. In Figure 4.20, the 
fluorescence spectra of 4.8 and H2P
71
 are shown featuring maxima at 640 and 705 nm and 
quantum yields of 0.06 and 0.1, respectively. In contrast, 4.9 and ZnP
71
 reveal maxima at 
600 and 655 nm and quantum yields of 0.03 and 0.04, respectively. The energy of the 
triplet excited states of H2P and ZnP are known from the literature as 1.43 and 1.53 eV, 
respectively.
71
 For 4.8 and 4.9 we expect the same energetic levels of their triplet excited 
states. Finally, for RuPc a maximum at 670 nm and a quantum yield of 0.01 evolves. 
Furthermore, the phosphorescence spectrum of RuPc features a maximum at 968 nm. For 
the latter, the energy of the triplet excited state is estimated in 1.33 ± 0.01 eV. 
 
a)
 
b)
 
Figure 4.20 Room temperature fluorescence spectra of a) 4.8 in dichloromethane and 4.11 
in toluene and b) 4.9 in dichloromethane and 4.12 in toluene with identical absorption at 
the 420 nm excitation wavelength. 
 
In case of 4.12, the Por 4.9 centred fluorescence is notably quenched when 
photoexcited at 420 nm with a value of around 0.007 (Figure 4.20). Similarly, the Por 4.9 
– 4.8 
– 4.11 
– 4.9 
– 4.12 
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fluorescence lifetime is in 4.12 much shorter (112 ps ± 10 ps) relative to that seen in the 
absence of RuPc (2.1 ns). These are considered as first evidences for electronic 
communication either in the form of energy or electron transfer between the light 
harvesting 4.9 and RuPc. Despite the exclusive excitation of 4.9, RuPc centred 
fluorescence emerges at 657 nm with a quantum yield of 0.0002. Implicit in such a finding 
is a thermodynamically driven transduction of singlet excited state energy from the higher 
lying singlet exited state of 4.9 (2.05 eV) to the lower lying singlet excited state of RuPc 
(1.85 eV). Important is the confirmation of the energy transfer hypothesis by means of 
measuring an excitation spectrum for 4.9 at the newly evolving RuPc fluorescence. It 
resembles the ground state absorption, that is, giving rise to the absorption features of 4.9 
(430, 500 – 600 nm), on one hand, and of RuPc (300 – 400, 650 nm), on the other hand. 
All of the aforementioned effects are even more pronounced when photoexciting 
4.11 and 4.8 at 420 nm and comparing their fluorescence features it is observed a 
fluorescence quenching (Figure 4.20). In fact, the fluorescence quantum yield of 4.11 is 
much lower (0.003) than that of 4.8 (0.06) and H2P (0.1). Also in the case of 4.11, RuPc 
fluorescence evolved at 658 nm, which, again, came at the expense of the 4.8 fluorescence. 
A complementary performed excitation spectrum of the RuPc fluorescence corroborates 
with the 4.8 and RuPc sensitised fluorescence with maxima at 422, 500 – 600 and 300 – 
400 / 650 nm, respectively. More importantly, it also confirms the energy transfer between 
the 4.8 singlet exited state (1.95 eV) and the RuPc singlet excited state (1.85 eV). Like 
what has been seen before for 4.12, the 4.8 fluorescence lifetime is in 4.11 very short with 
a value below the time resolution of 100 ps. Interesting is the fact that in 4.10 the 
fluorescence quenching is weaker than in 4.11 with a quantum yield of nearly 0.01. 
Notably, besides the 4.9 (2.05 eV), 4.8 / 4.7 (1.95 eV) and RuPc (1.85 eV) fluorescence no 
additional features are seen. 
In additional experiments, all of the RuPc containing systems 4.10-4.12 were 
excited at 610 nm. Here, the exclusive RuPc excitation results only in the fluorescence of 
the latter without giving rise to any appreciable 4.9 or 4.8 / 4.7 fluorescence and without 
any notable RuPc fluorescence quenching. Moreover, the corresponding maxima match in 
these 610 nm excitation experiments those seen for 4.10 (663 nm), 4.11 (655 nm), and 4.12 
(658 nm) in 420 nm excitation experiments. 
In order to shed more light onto the mutual interactions in the excited state of 4.10-
4.12 and of their references, the femtosecond transient absorptions were probed. Here, 
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either excitation of 4.9 / 4.8 at 420 nm or excitation of RuPc at 656 nm stood at the 
forefront of the investigations. 
The excitation of 4.9 at 420 nm gives rise to the direct formation of the singlet 
excited state with maxima at 531, 575 and 623 nm and minima at 552, 595 and 652 nm; a 
similar excitation of 4.8 affords maxima at 494, 535, 571 and 622 nm and minima at 515, 
550, 592 and 648 nm (Figure 4.21). 
 
a)
 
b)
 
Figure 4.21 Differential absorption spectra (visible and near-infrared) obtained upon 
femtosecond pump probe experiments (420 nm) of a) 4.8 and b) 4.9 in dichloromethane 
with several time delays between 0.1 and 6749.9 ps at room temperature. 
 
Via intersystem crossing (ISC) corresponding to the triplet manifolds evidence 
latter decay with lifetimes about 2.1 ± 0.5 and 9.8 ± 0.5 ns for 4.9 and 4.8, respectively, 
featuring maxima at 840 nm (4.9) as well as 780 nm (4.8). The triplet lifetimes are 80 µs 
for 4.9 and 1 µs for 4.8. Immediately after exciting RuPc at 656 nm its singlet excited state 
features are formed in the form of a bleaching at around 590 and 650 nm (Figure 4.22). 
The latter features a lifetime of 7.5 ± 2.5 ps. Owing to the presence of ruthenium the 
intersystem crossing to the corresponding triplet excited state is fast and efficient yielding 
a 1 µs lived transient maximum at 515 nm. 
In case of 4.12, which was also excited at 420 nm, the spectral features of the 4.9 
singlet excited state – vide supra – are seen. Most notably, are the minimum at 560 nm and 
the maxima at 465, 605 and 695 nm (Figure 4.23). 
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a)
 
b)
 
Figure 4.22 a) Differential absorption spectra (visible and near-infrared) obtained upon 
femtosecond pump probe experiments (656 nm) of RuPc in toluene with several time 
delays between 0.1 and 6749.9 ps at room temperature. b) Time absorption profiles of the 
spectra shown in the upper part at 515 (red spectrum), 915 (black spectrum) and 590 nm 
(grey spectrum) monitoring the excited state decay. 
 
a)
 
b)
 
Figure 4.23 a) Differential absorption spectra (visible and near-infrared) obtained upon 
femtosecond pump probe experiments (420 nm) of 4.12 in toluene with several time delays 
between 0.1 and 6749.9 ps at room temperature. b) Time absorption profiles of the spectra 
shown in the upper part at 510 (red spectrum), 650 (black spectrum) and 610 nm (grey 
spectrum) monitoring the excited state energy transfer. 
 
The presence of the RuPc evokes a significant shortening of the 4.9 singlet excited 
state lifetimes, namely 130 ± 20 ps. Concomitant with the latter decay it was noted the 
formation of a new transient state. The new transient features a characteristic words 
minima at 590 and 650 nm, which resembles that seen for RuPc. In other, in case of 4.12 
an intramolecular energy transfer transduces singlet excited state energy from the initially 
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excited 4.9 to RuPc. As a matter of fact, the current finding compares well with the 
conclusions from the steady-state and time-resolved fluorescence experiments. On the 
nanosecond time scale the decay of the triplet excited state features of RuPc leads to a 
lifetime of 8.3 ± 1 µs. 
Turning again to 4.11, right after the 420 nm excitation of the 4.8 singlet ground 
states, its singlet excited state is formed (Figure 4.24). Evidence for the latter stems from 
monitoring ground state bleaching at 510 nm and transient maxima at 460, 615 and 690 
nm. In analogy to the observation made with 4.12 – vide supra – an intramolecular energy 
transfer sets in shortly after the formation of the 4.8 singlet excited state. In fact, the RuPc 
singlet excited minima at 590 and 650 nm grown in with 21 ± 7 ps, which matches the 
decay of the 4.8 singlet excited state. On the nanosecond time scale, the decay of the triplet 
excited state features of RuPc are discernible, which give rise to lifetimes of 4.0 ± 0.5 µs. 
A quantitatively similar picture evolves for 4.10 with an intramolecular energy transfer that 
takes 150 ± 50 ps (Figure 4.25). 
 
a)
 
b)
 
Figure 4.24 a) Differential absorption spectra (visible and near-infrared) obtained upon 
femtosecond pump probe experiments (420 nm) of 4.11 in toluene with several time delays 
between 0.1 and 6749.9 ps at room temperature. b) Time absorption profiles of the spectra 
shown in the upper part at 510 (red spectrum) and 650 nm (black spectrum) monitoring the 
excited state energy transfer. 
 
 
 
 
 
145 
a)
 
b)
 
Figure 4.25 a) Differential absorption spectra (visible and near-infrared) obtained upon 
femtosecond pump probe experiments (420 nm) of 4.10 in toluene with several time delays 
between 0.1 and 6749.9 ps at room temperature. b) Time absorption profiles of the spectra 
shown in the upper part at 510 (red spectrum) and 650 nm (black spectrum) monitoring the 
excited state energy transfer. 
 
In complementary experiments, when 4.10-4.12 are excited at 656 nm only the 
features of RuPc are observed. No appreciable 4.7, 4.8, and 4.9 based features are seen at 
any time during the time evolution due to the dominating absorptions of RuPc. 
The thiopyridylporphyrins 4.10-4.12 and the ruthenium phthalocyanine proved to 
be versatile building blocks of novel supramolecular Por-Pc hybrid systems by axial 
ruthenium coordination. The thiopyridyl groups placed at the bay region of the porphyrins 
coordinate the RuPc dye, showing a notable redistribution of electron density of new 
heterochromophore structures evidencing the electron-donating/-accepting communication 
between both dyes in the supramolecular hybrids. These structural hybrids were projected 
to promote electronic coupling between the electron donor-acceptors and were 
physicochemical investigated by the ground and excited state reactivities. 
 
4.6 Final considerations 
 
In summary, we have unequivocally demonstrated herein the preparation of three 
novel heterochromophore structures 4.10-4.12 based on noncovalent linkage, to study 
photoinduced energy- and/or electron-transfer processes. Pyridyl substituted Pors were 
coordinated with RuPc to promote electronic communication between these electron donor 
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/ acceptor moieties. It is noteworthy, that an energy transfer from the thiopyridylporphyrins 
to the RuPcs was found. However, in case of the hybrid 4.10 occurs an unidirectional 
energy transfer, and for hybrids 4.11 and 4.12 energy transfer sets are noted. This was 
demonstrated by RuPc centred fluorescence features, evolved upon photoexcitation of the 
Por, which show lower fluorescence quantum yields and shorter fluorescence lifetimes 
than the corresponding references. Excitation spectra as well as transient absorption 
measurements help to confirm that hypothesis, while the latter reveals a significant 
shortening of the porphyrin´s singlet excited state lifetimes. In this circumstance, we 
corroborate the electronic communication of the supramolecular building blocks by energy 
transfer. Photophysical investigation by means of time-resolved transient absorption, 
namely fluorescence and femtosecond spectroscopy, revealed in the supramolecular 
multichromophore ensembles efficient intermolecular energy transfer from the 
photoexcited central thiopyridylporphyrin to the peripheral RuPcs. These results prove to 
be important for the future design of new Por-Pc electron donor / acceptor hybrids to be 
used as building blocks in solar light converting systems. 
 
4.7 Experimental Section 
4.7.1 General information 
 
1
H and 
19
F NMR spectra were recorded in a Bruker Avance-300 spectrometer at 
300.13 and 282.38 MHz, respectively. Tetramethylsilane was used as internal reference. 
Steady-state absorption spectra were recorded with a Perkin-Elmer Lambda 35. Steady-
state emission spectra were recorded in a Fluoromax-3-spectrometer from HORIBA Jobin 
Yvon. All samples were measured in a fused quartz glass cuvette with a 10 mm of light 
path. Analytical TLC was carried out on precoated silica gel sheets (Merck, 60, 0.2 mm). 
Column chromatography was carried out over silica gel (Merck, 63–200 mesh). Molecular 
exclusion column chromatography was carried out over Bio-beads
TM
 S-X1 Beads (200-400 
Mesh, 100 g), Bio-Rad Laboratories, Inc. MALDI-MS mass spectra were acquired using a 
MALDI-TOF/TOF Applied Biosystems 4800 Proteomics Analyzer (Applied Biosystems, 
Framingham, MA, USA) instrument equipped with a nitrogen laser emitting at 337 nm. 
Prior to MALDI-MS analysis, 4 µL of matrix, dithranol (10 mg mL
-1
 in methanol / 0.1% 
TFA) were mixed with 2 µL of the dye solution in CH2Cl2/MeOH (10 µg.mL
-1
), and 1 µL 
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of this mixture was deposited on the MALDI plate and let to dry. MALDI-MS spectra were 
acquired in the positive ion reflector mode using delayed extraction in the mass range 
between 600 and 4500 Da with ca. 1500 laser shots. For the following acquisition of 
tandem mass spectra collision energy of 2 keV was used to induce fragmentation, and air 
was used as collision gas. 
Femtosecond transient absorption spectra were obtained with a Ti:sapphire laser 
system CPA-2101 (Clark-MXR), Inc.) in combination with a Helios TAPPS detection unit 
from Ultrafast Inc. The initial laser excitation wavelength is 775 nm with a pulse width of 
150 fs. The used excitation wavelength was 387 nm, which was generated with a SHG 
crystal. For the generation of the white light a sapphire crystal of adequate thickness was 
used. The chirp-effect between 420 and 770 nm is approximately 350 fs. The detection was 
carried out with two CCD cameras, each for a specific measuring range. The spectral 
window is therefore 415 to 770 nm and 770 to 1200 nm. The delay line allows spectral 
acquisition up to time delays of 6750 ps. All samples were measured in a fused quartz 
glass cuvette with a thickness of 2 mm. Data was acquired with the software HELIOS 
Visible/nIR (Newport / Ultrafast Systems). 
 
4.7.2 Synthesis and characterization of the free tert-butylphthalocyanine 
 
2(3),9(10),16(17),23(24)-tetrakis-tert-butylphthalocyanine (4.2): 
A mixture of phthalonitrile 4-(tert-butyl)phthalonitrile 4.1 (2.74 mmol, 1 eq.) and 
lithium (53.0 mg, 7.64 mmol, 3 eq.) was carried out overnight at 140 ºC in 5 mL of 1-
pentanol as solvent.
55
 The crude of reaction was precipitated from a mixture of MeOH/H2O 
(1/1), filtrated and washed several times with the same mixture. The obtained blue solid 
was redissolved in CH2Cl2 and purified over silica gel chromatography column using 
CH2Cl2/C6H14 (3:1) as eluent. The main fraction was dry under reduce pressure and the 
pure product 4.2 was obtained in 84% yield. 
1
H NMR (300 MHz, CDCl3): δ -1.20 – -0.98 
(m, 2H, NH), 1.90 (s, 36H, 
t
Bu-H
d
), 8.27–8.39 (m, 4H, β-Hc), 9.14–9.58 (m, 8H, α-Ha,b). 
MALDI-TOF-MS: m/z 739 [M+H]
+
. 
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4.7.3 Synthesis and characterization of the ruthenium tert-
butylphthalocyanine 4.3 
 
[Carbonyl-2(3),9(10),16(17),23(24)-tetrakis-tert-butylphthalocyaninato] ruthenium(II) 
(4.3): 
A mixture of H2Pc 4.2 (100 mg, 0.13 mmol), Ru3(CO)12 (173 mg, 0.27 mmol) and 
phenol (6 g) was heated at reflux temperature (190 ºC) under argon during 16 h. The 
solution was cooled to room temperature, and then dissolved in 50 mL of ethanol. After 
addition of 200 mL of water, the resulting blue precipitate was filtered, washed with a 
mixture of water/methanol (4/1), and dry under reduce pressure. The crude was redissolved 
and purified by column chromatography on silica gel using toluene as eluent.
27,28
 The 
product was dry and the blue solid 4.3 was determined in 82% of yield. H
1
 NMR (300 
MHz, CDCl3): δ 1.71 (s, 36H, 
t
Bu-H
d
), 8.01-8.14 (m, 4H, RuPc β-Hc), 9.14-9.40 (m, 8H, 
RuPc α-Ha,b). UV-Vis (CHCl3), λmax. nm (): 296 (5.01), 330 (4.56), 590 (4.42), 627 (4.81), 
650 nm (5.18). ESI-MS: m/z 866 [M]
 +·. 
 
4.7.4 Synthesis of the meso-pentafluorophenyl porphyrin, TPPF20 4.6 
 
5,10,15,20-tetrakis(2,3,4,5,6-pentafluorophenyl)porphyrin, TPPF20 (4.6): 
A mixture of pyrrole (5 mL, 72.0 mmol) and pentafluorobenzaldehyde (8 mL, 65.0 
mmol) was stirring in a mixture of acetic acid (400 mL) and nitrobenzene (300 mL) 
refluxing at 120 ºC. The reaction was followed by TCL and after 1 h was concluded. After 
that, the mixture of solvents was distillate under reduce pressure. The obtained residue was 
dissolved in petroleum ether and purified by silica gel chromatography column using a 
mixture of petroleum ether/CH2Cl2 (3:1) as eluent. The first fraction was identified by 
TPPF20. The 
1
H and 
19
F NMR spectra confirmed the corresponding TPPF20 (4.6). 
1
H 
NMR (300 MHz, CDCl3): δ -3.19 (s, 2H, NH), 9.45 (s, 8H, β-H). 
19
F NMR (282 MHz, 
CDCl3): δ -184.92 – -184.70 (m, 8F, Ar-o-F), -174.70 (t, J = 20.9 Hz, 4F, Ar-p-F), -160.04 
(dd, J = 22.8, 7.7 Hz, 8F, Ar-m-F). 
 
 
 
 
149 
4.7.5 Synthesis and characterization of thiopyridylporphyrins 4.7-4.9 
 
5-[2,3,5,6-tetrafluoro-4-(pyridylsulphanyl)phenyl]-10,15,20-
tris(pentafluorophenyl)porphyrin (4.7): 
The reaction of 5,10,15,20-tetrakis(pentafluorophenyl)porphyrin (TPPF20, 222.1 
mg, 0.228 mmol) and 4-mercaptopyridine (17.1 mg, 0.154 mmol, 0.7 eq.) using 1 mL of 
DEA was accomplished in 3 mL of DMF during 1 h at room temperature. After reaction, 
DMF was evaporated under reduced pressure and the residue was subjected to flash 
chromatography, using CH2Cl2 and CH2Cl2/MeOH (98/2) as eluents. The product was 
crystallised from CH2Cl2/MeOH (98:2)/hexane as purple solid in 22% yield. 
1
H NMR (300 
MHz, CDCl3): δ -2.97 (s, 2H, NH), 7.29 (dd, J = 4.6, 1.5 Hz, 2H, SPy-o-H), 8.58 (dd, J = 
4.6, 1.5 Hz, 2H, SPy-m-H), 8.87–8.89 (m, 8H, β-H). 19F NMR (282 MHz, CDCl3): δ -
184.87 – -184.67 (m, 6F, Ar-o-F), -174.75 – -174.51 (m, 3F, Ar-p-F), -160.02 (dd, J = 
23.1, 7.8 Hz, 6F, Ar-m-F), -158.15 (dd, J = 24.8, 12.5 Hz, 2F, SPyAr-F), -154.30 (dd, J = 
24.8, 12.5 Hz, 2F, SPyAr-F). MALDI-TOF-MS: m/z 1066 [M+H]
+
. 
 
5,10,15,20-Tetrakis[2,3,5,6-tetrafluoro-4-(pyridylsulphanyl)-phenyl]porphyrin (4.8): 
4-Mercaptopyridine (47.0 mg, 4 eq.) and DEA (1 mL) were added to a solution of 
TPPF20 (100.0 mg, 0.1 mmol) in dry DMF (5 mL). This mixture was kept under stirring 
for 1 h, under a nitrogen atmosphere, at room temperature. After reaction, the DMF was 
evaporated under reduced pressure and the residue was subjected to flash chromatography, 
using dichloromethane and CH2Cl2/MeOH (98/2) as eluents. The fraction containing Por 
4.8 (120 mg, 90%) was concentrated and crystallised from a mixture of CH2Cl2/MeOH 
(98:2)/hexane. 
1
H NMR (300 MHz, DMSO-d6): δ -3.12 (s, 2H, NH), 7.73 (d, J = 5.9 Hz, 
8H, SPy-o-H), 8.63 (d, J = 5.9 Hz, 8H, SPy-m-H), 9.61 (s, 8H, β-H). 19F NMR (282 MHz, 
DMSO-d6): δ -161.11 (dd, J = 11.9 and 26.3 Hz, 8F, Ar-o-F), -156.14 (dd, J = 11.9 and 
26.3 Hz, 8F, Ar-m-F). UV-Vis (CH2Cl2), λmax. nm (): 415 (5.48), 507 (4.34), 581 (3.87), 
633 (3.59). MALDI-TOF-MS: m/z 1339 [M+H]
+
. 
 
5,10,15,20-Tetrakis[2,3,5,6-tetrafluoro-4-(pyridylsulphanyl)-phenyl]porphyrinato zinc(II) 
(4.9): 
A mixture of Por 4.8 (31.6 mg, 0.024 mmol) and zinc acetate (23.7 mg, 0.13 mmol, 
5 equiv.) were carried out in 5 mL of CHCl3/MeOH (9:1) at reflux. The reaction was 
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followed by TCL and completed after stirring during 3 h under nitrogen atmosphere. By 
precipitation from a mixture of CHCl3/MeOH (98:2)/hexane, it was obtained a purple solid 
and washed several times with water in order to remove the excess of zinc acetate. 
Compound 4.9 was obtained in 96% yield. 
1
H NMR (300 MHz, CDCl3): δ 7.23 (d, J = 5.7 
Hz, 8H, SPy-o-H), 8.07 (d, J = 5.7 Hz, 8H, SPy-m-H), 8.95 (s, 8H, β-H). 19F NMR (282 
MHz, CDCl3): δ -154.93 (dd, J = 24.5, 11.8 Hz, 8F, Ar-o-F), -151.46 (dd, J = 24.5, 11.8 
Hz, 8F, Ar-m-F). UV-Vis (CH2Cl2), λmax. nm (): 423 (5.63), 552 (4.31), 586 (3.40). 
MALDI-TOF-MS: m/z 1401 [M+H]
+
. 
 
4.7.6 Synthesis of the supramolecular arrays 4.10-4.12 
 
Compound 4.10: 
A mixture of Por 4.7 (14.8 mg, 0.014 mmol) and RuPc (13.2 mg, 0.015 mmol, 1.1 
equiv.) was stirred in 5 mL of CH2Cl2 overnight at room temperature. After concentration 
under reduce pressure, the products was purified by molecular exclusion chromatography 
column (Bio-Beads S-X1) using CH2Cl2 as eluent. The main fraction was dry and the solid 
product 4.10 afforded in 71% yield. 
1
H NMR (300 MHz, CDCl3): δ -3.02 (s, 2H, NH), 1.79 
(s, 36H, 
t
Bu-H), 6.99 – 7.13 (m, 4H, Por β-H), 8.18 (d, J = 8.1 Hz, 4H, RuPc β-H), 8.62 (d, 
J = 4.6 Hz, 2H, SPy-o-H), 8.80 (d, J = 4.6 Hz, 2H, SPy-m-H), 8.90 (s, 4H, Por β-H), 9.30 – 
9.47 (m, 8H, RuPc α-H). 19F NMR (282 MHz, CDCl3): δ -184.89 – -184.68 (m, 6 F, Ar-o-
F), -174.74 – -174.51 (m, 3 F, Ar-p-F), -160.09 – -159.91 (m, 6 F, Ar-m-F), -157.62 (dd, J 
= 24.3, 11.9 Hz, 2F, SPyAr-F), -153.97 (dd, J = 24.3, 11.9 Hz, 2F, SPyAr-F). ESI-MS: m/z 
1931 [M]
+·. 
 
Compound 4.11: 
A mixture of 4.8 (15.0 mg, 0.011 mmol) and RuPc (51.3 mg, 0.056 mmol, 5 
equiv.) was stirred in 5 mL of CH2Cl2 overnight at room temperature. After reaction, the 
products were purified by molecular exclusion chromatography column (Bio-Beads S-X1) 
using CH2Cl2 as eluent. The main fraction was dry and the obtained blue solid 4.11 
afforded in 91% yield. 
1
H NMR (300 MHz, CDCl3): δ -3.39 – -3.35 (m, 2H, NH), 1.60 (s, 
144H, 
t
Bu-H), 5.27 (d, J = 6.6 Hz, 8H, SPy-o-H), 8.06 (d, J = 8.0 Hz, 16H, RuPc β-H), 
8.36 (s, 8H, Por β-H), 9.25 – 9.39 (m, 40H, RuPc α-H and SPy-m-H). 19F NMR (282 MHz, 
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CDCl3): δ -134.18 – -133.96 (m, 8F, Ar-o-F), -130.45 – -130.29 (m, 8F, Ar-m-F). ESI-MS: 
m/z 4803 [M]
+·. 
 
Compound 4.12: 
A mixture of 4.11 (15.0 mg, 0.003 mmol) and zinc acetate (0.57 mg, 0.003 mmol, 1 
equiv.) was stirred in 5 mL of CH2Cl2/MeOH (9:1) during 3 h at reflux. After that, the 
products of reaction werer purified by molecular exclusion to obtain the corresponding 
zinc complex 4.12 in 90% yield, isolated as a deep blue solid. 
1
H NMR (300 MHz, 
CDCl3): δ 1.59 (s, 144H, 
t
Bu-H), 5.22 (d, J = 18.9 Hz, 8H, SPy-o-H), 7.96 (br s, 24H, 
RuPc β-H and Por β-H), 8.40 (d, J= 18.9 Hz, 8H, Ar-m-H), 9.04 – 9.38 (m, 40H, Por β-H 
and RuPc α-H). 19F NMR (282 MHz, CDCl3): δ -157.95 – -157.15 (m, 8F, Ar-o-F), -
155.07 – -153.39 (m, 8F, Ar-m-F). UV-Vis (C6H5CH3), λmax. nm (): 430 (5.93), 552 
(5.06), 587 (5.48), 650 (6.14). 
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Chapter 5 
Inverted pyridinium phthalocyanines as PDI agents against 
pathogenic bacteria 
 
159 
5.1 Overview 
 
Phthalocyanines (Pcs),
1,2
 and the corresponding naphthalocyanine analogues,
3,4
 are 
well-known aromatic compounds, which have being intensively studied for different 
applications due to their excellent physicochemical properties (absorb light in the red and 
near-infrared regions of the electromagnetic spectrum, 600-800 nm).
5-7
 In particular, Pc 
derivatives have been exploited as photosensitizers (PSs) for photodynamic therapy (PDT), 
evidencing a high potential in cancer treatment
8-17
 and in the photodynamic inactivation 
(PDI) of microorganisms in infectious diseases
18-23
 and/or in contaminated 
environments
5,24,25
 All these applications are based on cell death induced by reactive 
oxygen species (ROS), mainly singlet oxygen (
1
O2), generated by the combined action of 
visible light, molecular oxygen and a PS.
26-28 
Since the chemical structure is a key factor in 
the physicochemical properties of the PSs, different approaches have been used to 
introduce particular functionalities on the phthalocyanine structures
29
 in order to obtain 
certain physicochemical features, namely desired levels of hydrophobicity or 
hydrophilicity. The molecular structure of unsubstituted phthalocyanines can be modified 
by the incorporation of substituents in the peripheral positions of the macrocycle to 
improve their amphiphilicity,
10,30
 or by metallation of the Pc core with different metal ions 
in the macrocycle.
31
  Pcs modifications are an important factor for an efficient generation 
of ROS. In fact, the introduction of diamagnetic metal ions (Zn, Si, Al, Ga or In) into the 
cavity of the Pc core can results in an enhancement of triplet state parameters (triplet 
quantum yields and lifetimes) and 
1
O2 quantum yields.
32-34
 The addition of axial ligands in 
coordinative positions of such metal centres can also improve the efficiency of these 
compounds as PSs.
35-42
 These modifications can unequivocally modulate the photophysical 
and photochemical characteristics of Pc derivatives and affect their interaction with cells, 
providing different photobiological effects.
5,6,43
 
The emergent antibiotic resistance of pathogenic bacteria has prompted several 
research groups, namely our, to explore the principle of PDT as an alternative antibacterial 
therapy. In this way, it is recognised that some metallated Pcs upon photoexcitation with 
light, photoinactivate efficiently different pathogenic microorganisms and could be an 
excellent approach to inactivate bacteria.
18,44,45
 The two photodynamic mechanisms that 
can justify the cell death through the interaction of light-excited PS with the cellular 
substrate are known as type I (initial formation of radicals by direct reaction of the excited 
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PS with cellular substrates, followed by reaction with molecular oxygen) and type II 
(interaction of the excited PS with molecular oxygen originates singlet oxygen).
46,47
 The 
ability of Pcs to interact with bacteria and their capability to generate ROS has been related 
with the cell death mediated by the concerted action of cellular oxidative stress.
48
 
It is well established that in general, for an efficient photoinactivation of Gram-
negative bacteria, it is required the use of photoactive cationic PSs.
18,49,50,51
 The positive 
charged PS derivatives can interact electrostatically with the negative charged parts of the 
outer wall (lipoproteins, lipopolysaccharides), which simplifies the binding and relative 
entrance, mainly in the Gram-negative bacteria.
52
 The presence of cationic moieties 
promotes a strait electrostatic interaction with negatively charged sites at the outer 
membrane surface of the Gram-negative bacteria, increasing the efficiency of the 
photodynamic activity. On the other hand, inactivation of Gram-positive bacteria is 
ensured by neutral, anionic and cationic PSs which promptly cross the relatively porous 
cell wall.
52,53
 However, the set of damages involved in the bacterial PDI is not fully 
clarified yet. 
As already highlighted, Gram-negative bacteria are resistant to the photodynamic 
action of mostly neutral and anionic PSs;
54
 so the presence of positively charged functional 
groups in the Pc dyes allows an extensive photoinduced killing of these pathogenic 
microorganisms.
18 
 In that way,
 
considering that PDI of microorganisms can be a promising 
methodology for the treatment of infectious diseases
18-23
 or contaminated media, and 
following our undoubtedly interest in this subject, we describe here the relationship 
between the chemical structure of innovative inverted pyridinium Pc derivatives and their 
efficiency as PSs in the inactivation of microbial strains. For that, a bioluminescent 
Escherichia coli (E. coli) strain was used as a model of Gram-negative pathogenic bacteria. 
Knowing that 4-hydroxypyridine exists under many conditions preferably as 
pyridine, that results from a tautomerization of the enolic phenol form, previous results 
showed that the tetra-substitution of TPPF20 results in a 4-pyridinone derivate.
55
 So, in this 
chapter, it is described the synthesis and characterization of pyridinone and pyridinium Pc 
derivatives 5.6-5.9 (Schemes 5.2 and 5.3). It is also reported the photophysical, 
photochemical and photobiological properties of these inverted pyridinium Pcs 5.8 and 5.9 
and compared then with the thiopyridiniumphthalocyanine ones, previously reported by 
our research group.
18
 The later ones already had exhibited a number of interesting features 
for a prospective phototherapeutic application and a notable phototoxicity against bacteria. 
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5.2 Syntheses of pyridinone phthalonitrile and phthalocyanine derivatives 
 
Considering the remarkable photochemical and photophysical properties of Pc 
derivatives and the excellent features of pyridinium groups to act as PDI drugs, it was 
envisaged a simple access to obtain the new amphiphilic pyridinium Pc conjugates 5.8 and 
5.9 (Scheme 5.3). The synthetic strategy required the previous preparation of the new 
pyridinone phthalonitrile derivatives 5.4 and 5.5 (Scheme 5.1) and the corresponding 
pyridinone Pc dyes 5.6 and 5.7 (Scheme 5.2). 
The phthalonitriles 5.4 and 5.5 were obtained from commercially available 
reagents, 4-hydroxypyridine (5.1) and the adequate 4-fluorophthalonitrile (5.2) and 4,5-
difluorophthalonitrile (5.3) (Scheme 5.1). Both reactions were performed at 80 ºC in dry 
DMF (3 mL) under nitrogen atmosphere. After 5 h, the total consumption of the starting 
fluorophthalonitriles was confirmed by analytical TLC. The products were then directly 
purified by column chromatography (silica gel) using a mixture of CHCl3/MeOH as eluent. 
After precipitation with CHCl3, the desired products were filtered and washed with CHCl3. 
Recrystallization from MeOH/CHCl3 gave products 5.4 and 5.5, as light yellow solids, 
with yields above 92%. Both products were characterized by 
1
H, COSY 2D 
1
H-
1
H, 
13
C 
NMR, and mass spectroscopy (MS) using electrospray (ESI) in positive mode.  
 
 
Scheme 5.1 
 
In particular, the 
1
H NMR spectrum of the phthalonitrile 5.4 (Figure 5.1), show the 
resonances of all protons at  6.31, 8.14–8.17, 8.33 and 8.50 ppm. The doublet and 
multiplet at  6.31 and 8.14–8.17 ppm were attributed respectively to the protons He and 
H
c,d
 (confirmed by the COSY 2D 
1
H-
1
H spectrum, Figure 5.2). The resonance of H
d
 at 
lower fields comparatively to H
e
 can be justified by the electron-withdrawing character of 
162 
the carbonyl group and the nitrogen atom. The 2 protons of the phthalonitrile moiety H
a
 
and H
b
 appear as two doublets respectively at  8.33 and 8.50 ppm. The structure 5.4 was 
also confirmed by ESI-MS spectrum that showed the presence of the molecular ion peak 
[M+H]
+ 
at m/z 222. 
 
Figure 5.1 
1
H NMR spectrum of compound 5.4 in DMSO-d6. 
 
Figure 5.2 COSY 2D 
1
H-
1
H NMR spectrum of compound 5.4 in DMSO-d6. 
 
The 
1
H NMR spectrum of the pyridinone phthalonitrile derivative 5.5 (Figure 5.3) 
show the resonances of the 10 protons at  6.21, 7.64 and 8.70 ppm. The two doublets at  
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6.21 and 7.64 ppm were attributed to the 8 pyridinone protons H
c
 and H
b
 (see also the 
COSY 2D 
1
H-
1
H spectrum, in Figure 5.4). The two phthalonitrile protons H
a
 appear at 
lower fields as a singlet at 8.70 ppm. The structure of 5.5 was also confirmed by ESI-MS 
spectrum that showed the presence of protonated molecular ion peak [M+H]
+
 at m/z 315. 
 
Figure 5.3 
1
H NMR spectrum of compound 5.5 in DMSO-d6. 
 
Figure 5.4 COSY 2D 
1
H-
1
H NMR spectrum of compound 5.5 in DMSO-d6. 
 
The pyridinone phthalocyanines 5.6 and 5.7 were obtained by tetramerization of the 
adequate pyridinone phthalonitrile derivatives 5.4 and 5.5, respectively, in the presence of 
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anhydrous zinc chloride (Scheme 5.2). Both reactions were performed in 1-pentanol at 
reflux under N2 atmosphere. After 16 h (overnight), the reaction mixtures were allowed to 
cool down and then chloroform was added. The obtained crude solids were purified by 
molecular exclusion column chromatography (Bio-beadsTM S-X1) using pure DMF as 
eluent. After the elimination of the solvent, the desired products were washed several times 
with chloroform and dried under vacuum. Compounds 5.6 and 5.7 were isolated as dark 
green solids with yields above 58%. 
 
 
Scheme 5.2 
 
The 
1
H NMR spectrum of 5.6 (Figure 5.5) showed all proton resonances as 
multiplets due to the obtained mixture of regioisomer compounds and the corresponding 
attribution was also confirmed by COSY 
1
H-
1
H NMR. The signals between  6.58–6.66 
and 8.54-8.58 ppm correspond to the resonances 16 pyridinone protons H
e 
and H
d
, 
respectively. The 8 α-protons Ha,b are distributed at lower fields as a multiplet at  8.96–
9.05 ppm, and the resonance of the 4 β-protons Hc are the ones between  8.21 and 8.24 
ppm. The structure of 5.6 was also confirmed by the ESI-HRMS, which shows the 
protonated molecular ion peak [M+H]
+
 at m/z 949. 
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Figure 5.5 
1
H NMR spectrum of compound 5.6 (with some impurities) in DMSO-d6. 
 
Considering the characterization of the Pc 5.7, the 
1
H NMR spectrum (Figure 5.6) 
show the resonances of the 32 pyridinone-protons H
c
 and H
b
 as two doublets (each 
integrating for 16 protons) at  6.36 and 8.13 ppm. Interesting is a higher field shift of the 
pyridinone proton resonances H
c
 and H
b
 comparatively with the analogous ones of the 
tetra-substituted Pc 5.6 ( 6.58–6.66 and 8.54–8.58 ppm, Figure 5.5), confirming the 
undoubtable resonance influence of the eight pyridinone groups on the Pc β-positions. 
Moreover, it was observed a singlet at  9.63 ppm that was attributed to the 8 α-protons Ha 
of the Pc ring, evidencing a single symmetric compound when compared with the analogue 
signal of the tetra-substituted 5.6. The structure of 5.7 was also confirmed by ESI-HRMS, 
showing in the spectrum the protonated molecular ion peak [M+H]
+
 at m/z 1321. 
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Figure 5.6 
1
H NMR spectrum of compound 5.7 in DMSO-d6. 
 
5.3 Synthesis of inverted pyridinium phthalocyanines 
 
The inverted pyridinium Pcs 5.8 and 5.9 were obtained by cationization of the 
corresponding pyridinone phthalocyanines 5.6 and 5.7 using the experimental conditions 
shown in (Scheme 5.3). The reactions were performed by adding to a suspension of the 
pyridinone phthalocyanines 5.6 and 5.7 in dry DMF a large excess of dimethyl sulphate. 
Then, the reaction mixtures were kept under stirring overnight at 80 ºC in a sealed pressure 
flask. After this period the mixtures were cooled down and precipitated in 
acetone/dichloromethane. The residues were filtered, taken up in MeOH/H2O (2:1) and 
reprecipitated by addition of dichloromethane. The desired products were filtered, washed 
with dichloromethane and dried under vacuum. The products 5.8 and 5.9 (Scheme 5.3) 
were obtained as dark green solids with yields above 85%. 
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Scheme 5.3 
 
The 
1
H NMR spectrum of 5.8 (Figure 5.7), using also COSY 
1
H-
1
H NMR, present 
all proton resonances as multiplets at  4.29–4.54, 6.69–6.75, 7.99–8.15, 8.62–8.70, and 
9.62–9.73 ppm corresponding to the aliphatic protons Hf, pyridinium protons He, β-
aromatic proton atoms β-Hc, pyridinium protons Hd, α-aromatic proton Ha,b, respectively. 
 
Figure 5.7 
1
H NMR spectrum of compound 5.8 (with some impurities) in DMSO-d6. 
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As expected, a shift of the pyridinium protons H
e
 and H
d
 to lower fields was 
observed when compared with the analogous proton resonances of the corresponding 
noncationic tetra-substituted Pc 5.6 ( 6.17–6.36 and 8.54-8.58 ppm). In case of the α-
aromatic proton resonances H
a,b
 of Pc 5.8 also occur a lower field shift. In this way, the 
presence of the methoxy group changes considerably the electronic distribution of the 
phthalocyanine 5.8. The structure of 5.8 was also confirmed by MALDI-MS, showing in 
the spectrum the molecular ion peak m/z 963 [M-CH3]
+·
. 
The 
1
H NMR spectrum of 5.9 (Figure 5.8) presents two singlets at  4.31 and 10.12 
ppm corresponding to the resonances of the 24 aliphatic protons H
d
 and of the 8 α-aromatic 
protons H
a
, respectively. Moreover, the resonance of methoxypyridinium protons H
c
 and 
H
b
 appears as two doublets at  7.93 and 9.43 ppm, respectively. The presence of the 
methoxy groups and the aromatic structure of the derivative 5.9 induces entirely the 
methoxypyridium proton resonances to lower fields when compared with the proton 
resonances of the analogous signals of the corresponding noncationic Pc 5.7 (δ 6.36 and 
8.13 ppm). The structure of 5.9 was confirmed by MALDI-MS, showing in their spectrum 
the molecular ion peak at m/z 1335 [M-7CH3]
+·
. 
 
Figure 5.8 
1
H NMR spectrum of compound 5.9 in DMSO-d6. 
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5.4 Optical properties 
 
Phthalocyanine dyes are well-known optical absorbers, with high chemical stability 
and tailorability, and possess unequivocally strong absorption bands in the UV-Vis 
region.
56
 The characteristic absorption features of metallic phthalocyanines are seen for 
Pcs 5.6-5.9 in the form of a rather weak absorption Soret-band in the region of 300 – 425 
nm and a strong Q-band maximum at 680 – 684 nm (Figure 5.9). Figure 5.9 also shows the 
fluorescence spectra of Pc derivatives 5.6-5.9 upon excitation at 400 nm in DMF. All the 
fluorescence spectra show a maximum at 688 nm and the main photophysical features – Q-
band wavelengths, molar extinction coefficients (ɛ), fluorescence emission wavelength 
(λemission), Stokes shift and fluorescence quantum yields (ΦF) – are gathered in Table 5.1. 
The values of the quantum yields, which vary between 0.05-0.14, are slight lower than the 
one of ZnPc (0.3) used as reference. 
 
a) 
300 350 400 450 500 550 600 650 700 750 800
0,000
0,025
0,050
0,075
0,100
0,125
0,150
0,175
0,200
0,225
A
b
s
o
rb
a
n
c
e
Wavelength (nm)
 5.6
 5.7
 5.8
 5.9
 
b) 
625 650 675 700 725 750 775 800 825
0,00
1,50x10
7
3,00x10
7
4,50x10
7
6,00x10
7
7,50x10
7
9,00x10
7
In
te
n
s
it
y
 /
 a
.u
.
Wavelength (nm)
 5.6
 5.7
 5.8
 5.9
 
Figure 5.9 a) absorption and b) emission spectra of Pc derivatives 5.6-5.9 (C = 1 × 10
-6
 M) 
in DMF. 
 
 
Table 5.1 Photophysical properties of phthalocyanine derivatives 5.6-5.9. 
Compound Q-band λmax (nm) log ɛ λemission (nm)
a)
 Stokes shift (nm) ΦF
b)
 
5.6 681 4.90 688 7 0,10 
5.7 684 5.31 688 4 0,18 
5.8 680 5.36 688 8 0,24 
5.9 683 4.56 688 5 0,09 
a)
excited at 400 nm; 
b)
using ZnPc in DMF as reference (ΦF = 0.30)
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5.5 Inverted pyridinium phthalocyanine derivatives as PDI agents* 
 
Solubility 
 
UV-Vis absorption spectra acquire in phosphate buffered saline (PBS) and DMSO 
are displayed in Figure 5.10. Both cationic tetra-Pc 5.8 and octa-Pc 5.9 showed typical 
absorption spectra in DMSO, with two well-defined Q-bands at 605 and 677 nm. However, 
a visible change is observed in the UV-Vis spectra when PBS was used as solvent. In case 
of PS 5.8, the two Q-bands became a broad brand with absorbance maximum at 610 nm 
and an intense Soret-band, signal of high aggregation in PBS. The PS 5.9 shows slight blue 
shift of both bands but still sharp, evidence of good solubility in PBS. 
 
 
Figure 5.10 Normalized UV–Vis absorption spectra of phthalocyanines 5.8 and 5.9 in 
DMSO and PBS (×10-6 M). 
 
Solubility studies relying on Beer-Lambert law, determined in DMSO and PBS 
(Figure 5.11), did not show aggregation behaviour for concentrations bellow 20 and 5 M, 
respectively. However, 5.8 exhibited visible signs of aggregation after being at the same 
conditions as in the pre-incubation period used in PDI assays (15 min stirring in PBS and 
covered with aluminium foil), Figure 5.12. 
 
                                                 
*
These compounds were tested by Andreína Sousa and Clara Gomes, who kindly provided their results for 
a comprehensive analysis of the photophysical and photodynamic activity values of the Pc derivatives. 
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Figure 5.11 Linear regression graphics of Pcs 5.8 and 5.9 plotted the Q-band absorbance 
vs the concentrations in PBS and DMSO. 
 
 
 
Figure 5.12 12-well plate prepared for PDI studies with 20 M of 5.8, two left wells, and 
5.9, two right wells, after 15 min of pre-incubation in the dark, under gentle shaking 
conditions. 
 
Ability to generate 
1
O2 
 
The photodegradation of 1,3-diphenylisobenzofuran (DPBF) allowed qualitative 
evaluation of the ability of these cationic pyridinone (5.8 and 5.9) and 
thiopyridiniumphthalocyanines (3.1 and 3.2) to generate singlet oxygen (1O2). According 
to the results (Figure 5.13), both pyridinium Pcs 5.8 and 5.9 and 
thiopyridiniumphthalocyanine 3.1 proved to be efficient 1O2 generators (92, 37 and 76% of 
DPBF decay, respectively) in DMF/H2O (9:1). In turn, Pc 3.2, under the same 
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experimental conditions, only presented 9% of DPBF decay, being the less efficient one at 
least in this mixture of solvents. 
 
 
Figure 5.13 Time-dependent decomposition of DPBF (50 M) photosensitized by Pc 5.8, 
5.9, 3.1 and 3.2, in DMF/H2O (9:1) upon irradiation with a LED array system (640 nm ± 
20 nm) at a fluence rate of 6.0 mW.cm
−2
 with or without PS (0.5 M). 
 
5.5.1 Photodynamic inactivation of bioluminescent Escherichia coli 
 
The inactivation kinetics of E. coli during the irradiation assays with artificial white 
and red lights, in the presence of PSs 5.8, 5.9, 3.1 and 3.2 are represented in Figure 5.14. 
Two different controls, light and dark control (L.C. and D.C., respectively) were 
performed, in order to ensure that the obtained PDI results were exclusively due to the PS 
effect. Both controls showed that the viability of bioluminescent E. coli are not affected 
neither by irradiation itself (L.C.), nor by any of the PSs tested in the dark (D.C.) using the 
same concentration studied. Looking to white light condition (Figure 5.14a) it is clear that 
PS 5.9, 3.1 and 3.2 produced significantly higher inactivation rate (2.8, 2.3 and 2.5 log of 
inactivation, respectively; ANOVA, p < 0.05) than PS 5.8 (0.8 log of inactivation; 
ANOVA, p > 0.05), after 20 min of irradiation with white light. Concerning to red light 
(Figure 5.14b), three distinct profiles were observed. Once again, PS 5.8 showed lower 
inactivation results (0.9 log of reduction; ANOVA, p < 0.05) followed by PS 3.2 (2.3 log 
of reduction) (ANOVA, p < 0.05). With respect of PSs 5.9 and 3.1, their photoinactivation 
profile is very similar during the initial 15 min of irradiation (3.2 log of reduction). 
However, during the last 5 min of irradiation PS 3.1 inactivation stagnate, while PS 5.9 
photoinactivation increases to 4.3 log of reduction. Comparing the PDI efficiency of both 
light conditions, red one presents significantly better photoinactivation results for PS 5.9 
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and 3.1 (ANOVA, p < 0.05), while for PS 3.2 the wavelength of the irradiation light seems 
to have no effect in terms of bacterial photoinactivation. 
 
a) 
 
b) 
 
Figure 5.14 Survival of bioluminescent E. coli during PDI experiments with 20 M of PSs 
5.8, 5.9, 3.1 and 3.2, after irradiation with a) white light (400–800 nm) and b) red light 
(620-750 nm) at a fluence rate of 150 mW.cm
−2
, during 20 min. Values correspond to the 
average of 3 independent experiments in duplicate. Error bars represent standard deviation. 
 
Photosensitizer uptake by the bioluminescent E. coli cells 
 
The amount of PSs adsorbed by the bioluminescent E. coli in presence of the 
cationic PSs (20 M), after 15 min of incubation in dark conditions, are summarized in 
Figure 5.15. PS 5.8 showed significantly higher adsorption values (5.98 × 107 molecules 
(PS) CFU.mL-1, ANOVA, p <0.05) when compared to PS 5.9 (3.95 × 106 PS molecules 
CFU.mL-1). However, these values are most probably related to the aggregation tendency 
of 5.8 on the cells than related to uptake. 
 
 
Figure 5.15 Uptake of cationic pyridinone Pc 5.8 and 5.9 (20 M) by the bioluminescent 
E. coli cells after 15 min of incubation in dark at room temperature. Values correspond to 
the average of 3 independent experiments. Error bars represent standard deviation. 
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Photodynamic activities of pyridinium phthalocyanines 
 
Based on the interaction of the Gram-negative membranes with the cationic 
charges, new tetra- and octa-pyridinium Pcs were synthesized, being evaluated their 
photophysical, photochemical and photoinactivation efficiency. The use of cationic Pcs as 
antimicrobial agents has already been described in the literature using 
trimethylammonium
57,58
 or even pyridinium groups.
18
 The photodynamic inactivation 
(PDI) studies showed two clearly behaviours between the tetra- (5.8) and octa-cationic 
(5.9) PSs. PS 5.9 showed to be more efficient PS against bioluminescent E. coli (3.6 and 
4.4 log of reduction under white and red light, respectively) comparing the PS 5.8 (1.3 and 
1.0 log of reduction under white and red light, respectively). Charge number is an essential 
role in driving the PS toward sites that are critical for the stability of cell organization 
and/or the cell functions.
59,60
 According to previous studies where this matter has been 
emphasized, high number of positive charges hypothesized to be the reason of PS 
efficiency decreasing.
61,62
 However, other factors like PS binding, substitution type or even 
photophysical features can be related to PS efficiency against bacterial cells.
63
 Having this 
in mind, parallel studies such as singlet oxygen (
1
O2) production, aggregation and PS 
adsorption studies were conducted. The evaluation of these studies allowed us to 
understand the photosensitization behaviour of these tetra- and octa-cationic PSs. It has 
been already discussed by several researchers that 
1
O2 is the major ROS produced by this 
kind of macrocycles during PDI, being the intermediate for cell damage and subsequently 
death. In the present case, PS 5.8 shows significantly higher 
1
O2 production (92%) when 
compared to PS 5.9 (36%), however their PDI efficiency cannot be correlated just with the 
production of 
1
O2. The behaviour of PS 5.8 in PBS may be the reason of these results. In 
fact, PS 5.8 showed aggregation behaviour in the buffer solution used in the PDI assays, 
even when 5% of additional DMSO was added. This performance can also be the reason 
why PS 5.8 presented these particular values in terms of PS uptake/internalization (5.98 × 
10
7
 vs 3.95 × 10
6 
for PS 5.9). The addition of positive charges, besides the interaction with 
the negative bacteria membrane, should confer hydrophilicity to the molecule, making 
them amphiphilic. However, the way that hydroxypyridine is bound to the Pc core should, 
in some way, influence their behaviour. Indeed, the substitution by the nitrogen instead of 
the thiol in case of 3.1 and 3.2, make the first ones, most probably less flexible. In addition, 
the position of the positive charge may also contribute to the aggregation behaviour in 
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water, once it is more protected from the surrounding environment. This can make the 
molecule less water-soluble. 
Phthalocyanines are suitable PS due to their high absorbance in the red region of 
visible light. The significant difference between both lights (2 more log of reduction 
under red light) can also be explained by the overlap of the red light (620-750 nm) and the 
second Q-band of PS 5.9. As a matter of fact, the light wavelength necessary to induce 
microorganism photoinactivation depends on the electronic absorption spectrum of the PS 
and the emission spectrum of the light source.64 In case of PS 5.8, the aggregation 
performance overlapped the effect of light in terms of bacterial photoinactivation. 
Based on the studies conducted in parallel with PS 5.9, 3.1 and 3.2, the differences 
observed in the inactivation profiles can be mainly justified by aggregation phenomenon 
presented by 5.8 in PBS. In this context, the number and position of the positive charged 
groups play a key role in the physicochemical and biological behaviours. The 1O2 
production by 5.8 is higher than by 5.9 and 3.1, its aggregation behaviour overlaps this 
verdict. In fact, the method used to evaluate the 1O2 production (qualitatively) uses only a 
small percentage of water (10%). Moreover, PSs 5.9, 3.1 and 3.2 have equal 
photoinactivation performance, under white light, although 5.8 present higher 1O2 
production justified eventually by the overlapping absorbance spectra between PSs tested 
and white and red light used in biological assays (Figure 5.15).  
 
 
Figure 5.16 Normalized UV–Vis spectra of 5.8, 5.9, 3.1 and 3.2, in PBS, with white and 
red light source emission. 
 
Indeed, PSs 3.1 and 3.2 have higher absorbance in the wavelengths where white light 
also absorbs compared with 5.9. The better performance of 5.9 under red light may be due 
to the conjunction of several features, such as: better solubility, higher 1O2 production, 
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higher overlap with the absorbance spectrum of the red light, comparing to the 
thiopyridinium PSs previously studied. 
 
5.6 Final considerations and outlook 
 
In summary, it was reported here an efficient synthetic strategy that can be used to 
access phthalocyanines bearing pyridinium units. The approach requires the synthesis of 
adequate pyridinone phthalonitriles to obtain inverted tetra- or octa-substituted pyridinone 
Pcs that after cationization afford the corresponding pyridinium Pc derivatives. 
The new pyridinone and pyridinium Pc derivatives 5.6-5.9 were structurally 
characterized by NMR spectroscopy and mass spectrometry, in which the observed data 
were therefore relevant for the identification of such pyridinone and/or pyridinium Pc 
derivatives. Moreover, derivative 5.9 proved to be an efficient photosensitizer against 
bioluminescent E. coli. Interestingly, PS 3.1 and 3.2 have higher absorbance in the 
wavelengths where white light system emits compared with Pc 5.9; and the better 
performance of 5.9 under red light system can be due to its higher production of 1O2 and/or 
higher overlap with the absorbance spectrum of the red light, comparing to 
thiopyridiniumphthalocyanines. 
 
5.7 Experimental section 
 
General information 
 
All reagents were purchased from Sigma-Aldrich and used analytical TLC was 
carried out on precoated silica gel sheets (Merck, 60, 0.2 mm). Molecular extrusion 
column chromatography was carried out over Bio-beadsTM S-X1 Beads (200-400 Mesh, 
100 g), Bio-Rad Laboratories, Inc. 
1
H and 
13
C NMR spectra were recorded on a Bruker Avance-300 spectrometer at 
300.13 and 75.47 MHz, respectively, or on a Bruker Avance-500 spectrometer at 125.77 
MHz for 
1
H and 
13
C. Tetramethylsilane was used as internal reference. The chemical shifts 
are expressed in δ (ppm) and the coupling constants (J) in Hz. Absorption and fluorescence 
spectra were recorded in DMF using a Shimadzu UV-2501-PC and FluoroMax3 (excitation 
177 
wavelengths of 400 nm, emission range 625–825 nm, slit 2 nm), respectively. The 
fluorescence emission spectra of Pc derivatives 5.6-5.9 (C = 1 × 10
-6
 M) were measured in 
DMF in 1 cm × 1 cm quartz optical cells under normal air conditions on a computer 
controlled Horiba Jobin Yvon FluoroMax-3 spectrofluorimeter. The widths of both 
excitation and emission slits were set at 2.0 nm. The fluorescence quantum yields (ФF) of 
5.6-5.9 were calculated in DMF by comparison of the area below the corrected emission 
spectra (between 600 nm to 800 nm) using ZnPc as standard (λexcitation at 400 nm, Фf = 
0.17 in DMF).
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 For that, the following equation was used: 
 
    
         
           
                        
                
           
   ,  
 
where AUC is the integrated area under the fluorescence curves for each sample and 
standard, and Abs is the absorbance of the samples and the standard at the excitation 
wavelength (λexcitation at 400 nm). The acquisition of the electrospray high resolution mass 
spectra (ESI-HRMS) was obtained in an Apex-Qe. 
 
Synthesis and characterization of pyridinone phthalonitriles 5.4 and 5.5 
 
4-(4-oxopyridin-1(4H)-yl)phthalonitrile (5.4): 
In a 25 mL round-bottom flask, 4-fluorophthalonitrile (512.5 mg, 3.5 mmol) and 4-
hydroxypyridine (352.9 mg, 3.7 mmol, 1.1 equiv.) were dissolved in 3 mL of dry DMF, 
and then it was added some drops of triethylamine and keep under N2 atmosphere. The 
reaction mixture was maintained under stirring for 5 h at 80 ºC, when the TLC control 
confirmed the consumption of the starting phthalonitrile. Then the reaction mixture was 
purified by silica gel column chromatography using a mixture of CHCl3/MeOH (95/5) as 
eluent. The phthalonitrile 5.4 (712.3 mg, 3.2 mmol) was obtained in 92% yield, after 
recrystallization from CHCl3/MeOH. 
1
H NMR (500 MHz, DMSO-d6): δ 6.31 (d, J = 7.9 
Hz, 2H, H
e
), 8.14 – 8.17 (m, 3H, Hc,d), 8.33 (d, J = 8.6 Hz, 1H, Ha), 8.50 (d, J = 2.4 Hz, 
1H, H
b
). 
13
C NMR (75 MHz, DMSO-d6): δ 112.8, 115.3, 115.5, 116.2, 118.3, 127.1, 127.6, 
135.6, 139.0, 145.5, 177.7. ESI-MS: m/z 222 [M+H]
+
. 
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4,5-bis(4-oxopyridin-1(4H)-yl)phthalonitrile (5.5): 
In a 25 mL round-bottom flask, 4,5-difluorophthalonitrile (300.1 mg, 1.8 mmol) 
and 4-hydroxypyridine (356.5 mg, 3.7 mmol, 2.1 equiv.) were dissolved  in 3 mL of DMF, 
and then it was added some drops of triethylamine. The reaction mixture was maintained 
under stirring during 5 h at 80 ºC, when the TLC control confirmed the consumption of the 
starting phthalonitrile. Then, the reaction mixture was purified by silica gel column 
chromatograph using a mixture of CHCl3/MeOH (90/10) as eluent. After evaporation of 
the solvent, the residue was crystallized from the same mixture and phthalonitrile 5.5 
(569.3 mg, 1.8 mmol) afforded in 99% yield. 
1
H NMR (500 MHz, DMSO-d6): δ 6.21 (d, J 
= 7.9 Hz, 4H, H
c
), 7.64 (d, J = 7.9 Hz, 4H, H
b
), 8.70 (s, 2H, H
a
).
 13
C NMR (75 MHz, 
DMSO-d6): δ 114.6, 115.4, 118.3, 133.7, 140.0, 141.2, 177.2. ESI-MS: m/z 315 [M+H]
+
. 
 
5.7.1 Synthesis and characterization of pyridinone phthalocyanines 5.6 and 
5.7 
 
2,9(10),16(17),23(24)-tetrakis(4-oxopyridin-1(4H)-yl)phthalocyaninato zinc(II) (5.6): 
In a 25 mL round-bottom flask, a solution containing phthalonitrile 5.4 (207.5 mg, 
0.9 mmol) and anhydrous zinc chloride (138.9 mg, 1.0 mmol) in 2 mL of 1-pentanol was 
heated at 140 ºC under nitrogen atmosphere. After 16 h, the reaction was considered 
complete since no starting phthalonitrile 5.4 could be detected by analytic TLC. Then, it 
was added chloroform and the precipitate washed several times with the same solvent. The 
obtained solid was subsequently washed with water in order to remove the excess of zinc 
chloride. After being dried under vacuum, the crude product was purified by Bio-beadsTM 
S-X1 column molecular exclusion chromatography using DMF as eluent. The desired 
product was precipitated from chloroform, filtrated and washed with the same solvent. The 
Pc 5.6 (129.5 mg, 0.14 mmol) was isolated in 58% yield. 
1
H NMR (300 MHz, DMSO-d6): 
δ 8.21 – 8.24 (m, 4H, β-Hc), 6.58 – 6.66 (m, 8H, He), 8.54 – 8.58 (m, 8H, Hd), 8.96 – 9.05 
(m, 8H, α-Ha,b). 13C NMR (126 MHz, DMSO-d6): δ 41.3, 118.1, 118.6, 123.7, 139.8, 
140.3, 143.4, 177.8. ESI-HRMS: m/z 949.17293 [M+H]
+
. UV–Vis (DMF), λmax (log ε): 
613 (4.14), 681 (4.90). 
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2,3,9,10,16,17,23,24-Octakis(4-oxopyridin-1(4H)-yl)phthalocyaninato zinc(II) (5.7): 
In a 25 mL round-bottom flask, a solution containing phthalonitrile 5.5 (310.4 mg, 
1.0 mmol) and anhydrous zinc chloride (128.4 mg, 0.9 mmol, 0.9 equiv.) in 2 mL of 1-
pentanol was heated at 140 ºC under nitrogen atmosphere. After 16 h, the TLC control 
confirmed the reaction was complete. The reaction mixture was then precipitated with 
chloroform, and the solid obtained was washed several times with the same solvent and 
with water in order to remove the excess of zinc chloride. After being dried under vacuum, 
the crude product was purified by Bio-beadsTM S-X1 column molecular exclusion 
chromatography using DMF as eluent. The desired product was obtained from 
precipitation with chloroform, filtration and after washing with the same solvent. Pc 5.7 
(262.2 mg, 0.2 mmol) was obtained in 80% yield.
 1
H NMR (300 MHz, DMSO-d6): δ 6.36 
(d, J = 7.2 Hz, 16H, H
c
), 8.13 (d, J = 5.0 Hz, 16H, H
b), 9.63 (s, 8H, α-Ha). 13C NMR (75 
MHz, DMSO-d6): δ 118.0, 121.9, 138.3, 139.6, 141.0, 152.3, 176.9. ESI-HRMS: m/z 
1323.25865 [M+3H]
+
. UV–Vis (DMF), λmax (log ε): 616 (4.52), 684 (5.31). 
 
5.7.2 Synthesis and characterization of pyridinium phthalocyanines 5.8 and 
5.9 
 
2,9(10),16(17),23(24)-tetrakis(4-methoxypyridinium)phthalocyaninato zinc(II) (5.8): 
The pyridinone Pc 5.6 (103.3 mg, 0.11 mmol) after being dissolved in 20 mL of dry 
DMF was added to a large excess of dimethyl sulphate (4 mL, 37.5 mmol, 341 equiv.). The 
reaction mixture was kept under stirring overnight at 80 ºC in a sealed tube. After this 
period of time, the mixture was allowed to cool down and then it was precipitated with a 
mixture of acetone/CH2Cl2 (1:1). The obtained residue was filtrated and after being taken 
up in MeOH/H2O (2:1) was re-precipitated by addition of dichloromethane. The desired 
product was filtrated, washed with dichloromethane and dried under vacuum. The dark 
green solid identified as Pc 5.8 (110.7 mg, 0.09 mmol) was isolated in 85% yield. 
1
H NMR 
(300 MHz, DMSO-d6): δ 4.29 – 4.54 (m, 12H, H
f
), 6.69 – 6.75 (m, 4H, β-He), 7.99 – 8.15 
(m, 8H, H
c
), 8.62 – 8.70 (m, 8H, Hd), 9.62 – 9.73 (m, 8H, α-Ha,b). 13C NMR (126 MHz, 
DMSO-d6): δ 41.4, 48.6, 52.9, 58.9, 114.0, 117.9, 146.8, 172.1. UV–Vis (DMF), λmax (log 
ε): 614 (4.66), 680 (5.36); UV–Vis (DMSO), λmax (log ε): 615 (4.70), 682 (5.40); UV–Vis 
(PBS), λmax (log ε): 624 (4.49). MALDI-TOF-MS: m/z 963 [M-CH3]
+·
. 
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2,3,9,10,16,17,23,24-Octakis(4-methoxypyridinium)phthalocyaninato zinc(II) (5.9): 
The pyridinone Pc 5.7 (106.9 mg, 0.08 mmol) after being dissolved in 20 mL of dry 
DMF was added to a large excess of dimethyl sulphate (4 mL, 37.5 mmol, 469 equiv.). The 
reaction mixture was kept under stirring overnight at 80 ºC in a sealed tube. After this 
period, the mixture was cooled down and then it was precipitated using a mixture of 
acetone/dichloromethane (1/1). The residue obtained was filtrated and after being taken up 
in MeOH/H2O (2:1) was re-precipitated by addition of dichloromethane. The desired 
product was filtrated, washed with dichloromethane and dried under vacuum. The dark 
green solid identified as Pc 5.9 (130.6 mg, 0.07 mmol) was obtained in 88% yield. 
1
H 
NMR (300 MHz, DMSO-d6): δ 4.31 (s, 24H, H
d
), 7.93 (d, J = 7.1 Hz, 16H, H
c
), 9.43 (d, J 
= 7.1 Hz, 16H, H
b
), 10.12 (s, 8H, α-Ha). 13C NMR (126 MHz, DMSO-d6): δ 41.4., 48.6, 
52.9, 59.1, 114.3, 137.6, 139.5, 147.6, 153.0, 172.8. UV–Vis (DMF), λmax (log ε): 634 
(4.56), 683 (5.15); UV–Vis (DMSO), λmax (log ε): 616 (4.55), 683 (5.35); UV–Vis (PBS), 
λmax (log ε): 637 (4.10), 675 (5.13). MALDI-TOF-MS: m/z 1335 [M-7CH3]
+·
. 
 
Photosensitizer stock solution 
 
Stock solutions of the photosensitizers used in the photophysical and biological 
studies were prepared in dimethyl sulfoxide (DMSO) at a concentration of 500 M, and 
diluted in DMF/H2O (9:1), PBS or sodium dodecyl sulphate (SDS). 
 
Light source 
 
All the photoinactivation assays were performed under white and red light from a 
compatible optic fibre probe (400–800 nm and 620–750 nm, respectively) attached to a 
illumination system (LumaCare®, USA, model LC122, with halogen⁄quartz 250 W lamp) 
with a fluence rate of 150 mW.cm
−2
. 
 
Singlet oxygen generation 
 
An aliquot of 3 mL of a solution of the Pc (0.5 M) and 1,3-diphenylisobenzofuran 
(DPBF, 50 M) in DMF/H2O (9:1) was transferred to a glass cuvette and irradiated with a 
red LED array, in order to prevent the photodegradation of DPBF, at a fluence rate of 6.0 
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mW.cm
−2
, at room temperature and under gentle magnetic stirring. The LED array is 
composed of a matrix of 5 Å~ 5 LED that makes a total of 25 light sources with an 
emission peak at 640 nm and a bandwidth at half maximum of ± 20 nm. The absorption of 
DPBF at 415 nm was measured at defined time intervals during 15 min. The percentage of 
the DPBF absorption decay, proportional to the production of 
1
O2, was assessed by the 
difference between the initial absorbance and the absorbance of DPBF after a given period 
of irradiation.
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Solubility studies 
 
The solubility of new cationic phthalocyanines 5.8 and 5.9 in DMSO and PBS was 
assessed by UV–Visible spectroscopy. Concentrations, between 1 and 20 M, obtained by 
the addition of aliquots of each Pc stock solution (500 M), were analysed. The intensity 
of the Q-band versus Pc concentration was plotted in a graphic for linear regression to 
determine if these concentrations follow the Beer–Lambert law. 
 
Bacterial strains, growth conditions and preparation of stock-suspensions 
 
The used bioluminescent E. coli was collected from a sample previously 
transformed and storage at -80 ºC in 10% glycerol. Before the photoinactivation assay, a 
fresh culture of E. coli was growth in Tripic Soy Agar (TSA) with the antibiotics 
ampicillin (100 mg.mL
-1
) and chloramphenicol (25 mg.mL
-1
) and grown for 24 h at 37 ºC. 
One isolated colony was aseptically inoculated on Tripic Soy Broth (TSB) (30 mL) with 
both the antibiotics and grown overnight at 26 ºC under stirring (120 rpm). An aliquot (240 
L) of this culture was subcultured in TSB (30 mL) with antibiotics and grown during 20 h 
at 26 ºC. 
 
PDI experimental setup 
 
Bacterial suspensions prepared from overnight cultures (≈109 CFU.mL−1) were ten-
fold diluted in PBS to a final concentration of ≈108 CFU.mL−1. For the experiments, 450 
µL of bacterial suspension was aseptically transferred to sterilized 12-well plates and the 
PS was added from the stock solution to achieve final concentrations of 20 M. PBS was 
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added to the suspension in order to obtain a final volume of 4.5 mL. After the addition of 
the PS, wells were protected from accidental light exposure with an aluminium foil and 
pre-incubated for 15 min in the dark, under 100 rpm stirring at room temperature, to 
promote PS binding to E. coli cells. After this period, the irradiation was conducted under 
white and red light during 30 min. Light and dark controls were included in the 
experiments. The light control was irradiated without Pc. The dark control contained (20 
M) of Ps, but was protected from light with aluminium foil. Three independent assays 
were conducted for each condition. 
 
Bioluminescence monitoring 
 
In all experiments, aliquots (500 L) of treated and control samples were collected 
at time 0, 5, 10, 15, 20, 25 and 30 min of irradiation for bioluminescence measurement in a 
luminometer (TD-20⁄20 Luminometer; Turner Designs, Inc.). 
 
Photosensitizer uptake 
 
Three replicate bioluminescent E. coli (10
8
 cells mL
-1
) suspensions were prepared 
in PBS and incubated in the dark at room temperature in the presence of 20 μM of each PS. 
After 15 min of incubation, unbound PS was removed out of the suspension by 
centrifugation for 5 min, at 13000 G (Hettich Mikro 120). Pellets were further washed with 
PBS + 5% DMSO, digested in 1 mL of a solution containing 2% SDS (Merck) and 0.1 M 
of NaOH and incubated at room temperature for 24 h or until a clear solution. The 
fluorescence of the extracts was measured on a FluoroMax3 spectrofluorimeter with a slit 
of 2 nm. The excitation wavelengths for all compounds were 400 nm. The range for 
emission was 625 to 825 nm. The measured fluorescence intensity allowed the 
determination of the corresponding PS concentration by interpolation with a calibration 
plot built with known concentrations of each PS, using the digestion solution as solvent. 
Parallel aliquots of cell suspensions incubated in the presence of the PS were read and log 
luminescence (RLU) was assessed. The adsorption value (PS CFU.mL
−1
) was calculated 
according to the literature.
67
 Three independent assays were performed for each 
combination of bacterial strain PS. 
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Statistical analysis 
 
Statistical analysis was performed in SPSS 15.0 for Windows (SPSS Inc., USA). 
The significance of the PDI effect of each PS and of the irradiation time on bacterial cells 
viability was assessed by an unvaried analysis of variance (ANOVA) model with the 
Bonferroni post hoc test. Normal distributions were assessed by the Kolmogorov–Smirnov 
test and homogeneity of variances was assessed by the Levene test. A value of p < 0.05 
was considered significant. 
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Chapter 6 
Synthesis, photophysical and photodynamic activities of 
amphiphilic phthalocyanine-cyclodextrin conjugates 
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6.1 Overview 
 
Phthalocyanines (Pcs) and cyclodextrins (CDs) have been intensively studied due to 
their applications in many scientific areas, namely in medicinal and supramolecular 
chemistry.
1-5 
Pcs are well-known aromatic macrocycles with excellent photophysical 
properties to be used as photosensitizers (PSs) in photodynamic therapy (PDT) for the 
treatment of cancer.
6,7 
This therapy combines visible light, molecular oxygen and a PS that 
after irradiation with light are able to generate reactive oxygen species (ROS), like singlet 
oxygen (
1
O2), which can induce cell death pathways resulting in tumour tissues 
destruction.
8
 Pcs, besides their high efficiency in generating of 
1
O2, have the advantage to 
absorb light in the red and near-infrared regions (600-800 nm) of the electromagnetic 
spectrum.
7
 The conjugation of Pcs with biochemical motifs is of utmost importance in the 
development of promising PSs, since it improves their solubility in water and are able to 
act as Pcs carriers, delivering them into cancer cells. CDs offer unique features towards 
this goal allowing the design and synthesis of compounds perfectly defined with specific 
structural characteristics. The most common natural CDs are the α-, β- and γ-CDs, 
constituted respectively by six (α-CD), seven (β-CD) and eight (γ-CD) glucopyranose 
units, bound via α-1,4-glycosidic linkages. Moreover, these non-toxic molecules can 
encapsulate several hydrophobic PSs within their truncated cone-shaped hydrophobic 
cavity, conferring amphiphilicity, biocompatibility and availability at the surface of cancer 
cell membranes.
9,10
 In spite of the high potential of CDs as PS carriers, conjugates 
involving Pcs and CDs covalently linked are rare and only few works report their 
application as new PDT agents.
2,3,11-13
 Moreover, as far as we know, there are no reports 
comparing the PDT efficacy of Pcs conjugated with α-, β- and γ-CDs. 
Herein, it is reported the preparation, characterization and in vitro evaluation of 
photodynamic efficacy of the new phthalocyanine-cyclodextrin (Pc-CD) conjugates 6.1-6.3 
(Figure 6.1). The effect of different CDs (α-, β- and γ-CDs) in Pc solubility, 1O2 
production, photostability, ability to interact with human serum albumin (HSA) and 
phototoxicity against human bladder cancer cells were studied. 
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6.2 Synthesis and characterization of phthalocyanine-cyclodextrin (Pc-CD) 
conjugates 
 
Considering the remarkable photo-chemical and -physical properties of Pcs and the 
excellent features of CDs to act as the Pc carrier, it is envisaged a simple access to obtain 
new amphiphilic Pc-CD conjugates via post-modification of the commercial available 
hexadecafluorophthalocyaninatozinc(II) (PcF16). The reaction involved the nucleophilic 
substitution of two β-fluorine atoms, one each adjacent isoindole unit, by cyclo-
maltohexaose (α-CD), cyclo-maltoheptaose (β-CD) and cyclo-maltooctaose (γ-CD) – 
Figure 6.1. A nucleophilic substitution in the same isoindole unit of the Pc is improbable 
due to the structural hindrance. It is noteworthy that the hydrophilic properties of the CDs
14
 
allow the solubilization of this Pc in water and proves to be an exceptional methodology to 
prepare the water-soluble conjugates 6.1-6.3.
15
 
 
 
Figure 6.1 Representation of the Pc-CD conjugates 6.1-6.3. 
 
The reactions between PcF16 and the adequate equimolar quantity of CDs (α-, β- 
and γ-CD) were performed in 10 mL of dimethyl sulfoxide (DMSO) in the presence of 
excess potassium carbonate (8 equiv.) at 50 ºC. These reactions were finished after stirring 
for 16 h and the reactions mixtures were precipitated in chloroform. The corresponding Pc-
CD conjugates were purified by silica gel and reverse phase column chromatography, 
using a gradient of tetrahydrofuran/water as eluent; and finally by molecular exclusion 
column chromatography using DMF as solvent. The purified Pc-CDs were reprecipitated 
in chloroform. The structures of conjugates 6.1-6.3 were confirmed by UV–Vis 
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spectroscopy, 
19
F NMR spectroscopy (Figures 6.2-6.4) and MALDI-TOF mass 
spectrometry (Figures 6.5-6.7). The degree of homogeneity of the sample was assayed by 
high-performance liquid chromatography (HPLC) analysis (Figures 6.9-6.11). 
The low resolution observed in the 
1
H and 
19
F NMR spectra and the overlap of 
signals did not allow the adequate assignment of the protons and fluorine atoms, 
respectively. However, the 
19
F NMR spectra of Pc-CDs 6.1-6.3 in DMSO-d6 show the 
presence of two multiplets around  -167.16 to -164.15 and -179.92 to -175.51 ppm, 
corresponding to the six and eight β- and α-fluorine atoms of the Pc moiety (Figures 6.2-
6.4), respectively. 
 
 
Figure 6.2 
19
F NMR spectrum of compound 6.1, Pc-α-CD in DMSO-d6. 
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Figure 6.3 
19
F NMR spectrum of compound 6.2, Pc-β-CD in DMSO-d6. 
 
Figure 6.4 
19
F NMR spectrum of compound 6.3, Pc-γ-CD in DMSO-d6. 
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6.2.1 MALDI-TOF mass spectrometry of Pc-CD conjugates 
 
Amongst the techniques used for the characterization of the Pc-CDs 6.1-6.3, the 
most appropriate one was MALDI-TOF-MS, which is very useful for sequencing and 
structurally analyzing saccharide and oligosaccharide derivatives,
16,17
 namely CDs
18
 and 
glycophthalocyanines.
19
 Moreover, the study by MS/MS can also be an excellent and 
valuable tool to assess structural characterization. The MALDI-TOF-MS spectra of the Pc-
CDs showed the molecular ion peak [M+Na]
+
 at m/z 1821, 1981 and 2143 for Pc-α-CD, 
Pc-β-CD and Pc-γ-CD, respectively. These [M+Na]+ ions confirmed the nucleophilic 
substitution of two β-fluorine atoms of Pc by the corresponding α-, β- and γ-CDs, 
accompanied by elimination of two molecules of hydrofluoric acid.
20
 The formation of 
[M+Na]
+
 ions are typical of glycoderivatives
21,22
 and it was previously observed in other 
glycophthalocyanines.
19
 MALDI-TOF-MS/MS spectra were acquired to confirm the 
structural assignment of each [M+Na]
+
 ion of Pc-α-CD, Pc-β-CD and Pc-γ-CD, and the 
spectra are displayed respectively in Figures 6.5-6.7. The MS/MS spectra of Pcs 6.1-6.3 
showed a characteristic fragmentation owing to the preferential cleavage, whose the 
sequential loss number depends on the CD type coupled to the β-position of Pcs 
macrocycle. 
 
 
Figure 6.5 MALDI-TOF-MS/MS of the ion [M+Na]
+
 at m/z 1821.2 of 6.1 (Pc-α-CD). 
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Figure 6.6 MALDI-TOF-MS/MS of the ion [M+Na]
+
 at m/z 1981.2 of 6.2 (Pc-β-CD). 
 
 
Figure 6.7 MALDI-TOF-MS/MS of the ion [M+Na]
+
 at m/z 2143.3 of 6.3 (Pc-γ-CD). 
 
The results obtained in the MALDI-TOF-MS/MS spectra of Pc-CDs 6.1-6.3 are 
summarized in Table 6.1. All MS/MS spectra demonstrated losses of one to n-hexose 
residues (-162 Da, loss of C5H10O5  Hexres) with maximum sequential losses of 4, 5 and 6 
hexose units for [Pc-α-CD+Na-4Hexres]
+
 (m/z 1173), [Pc-β-CD+Na-5Hexres]
+
 (m/z 1171) 
and [Pc-γ-CD+Na-6Hexres]
+
 (m/z 1171), respectively. This pattern of fragmentation 
confirms the presence of the CD moiety linked to the Pc. These fragmentations are rather 
interesting, since the maximum number of lost hexoses is equal to the number of hexose 
residues present in the CD (6, 7 and 8 Hexres for α-, β- and γ-CDs, respectively) minus 2. 
This information confirms a scission of the structure for the Pc-CD derivatives since the 
two sugar units linked to the Pc core are more difficult to be eliminated. Other 
fragmentation pathways owing to the cleavage between the Pc and CD units lead to the 
formation of the product ions correspondent to the CD moiety at m/z 961, 1121 and 1284 
for Pc-α-CD, Pc-β-CD and Pc-γ-CD, respectively, but with minus two water molecules 
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([CD-2H2O+Na]
+
) which confirms the size of the CD linked to Pc (Figure 6.8). The 
formation of these product ions rather the total CD is due to the favored cleavage in the 
sugar units between the C6 and the O that occurs in both sides. This leads to a product ion, 
with a mass equal to the mass of the sugar minus 18 (sugar-H2O). Since this type of 
cleavages occur twice in these Pc-CDs, the product ion obtained in the MS/MS spectra was 
identified as [CD-2H2O+Na]
+
. In addition, the formation of sodium adducts of 
oligosaccharides [Hexresn+Na]
+
 (n = 2-4, 5 or 6 for Pc-α-CD, Pc-β-CD and Pc-γ-CD, 
respectively) also confirms the structural identification of these Pc derivatives. This 
fragmentation pattern occur at every acetal connection of the opened CD concerning to n 
(n = 1-6) monomeric units respectively.
23
 
 
 
Figure 6.8 Representation of the cleavage between Pc and CD for Pc-CDs 6.1-6.3. 
 
Table 6.1 Results of MS/MS experiments performed for Pc-α-CD, Pc-β-CD and Pc-γ-CD 
(6.1-6.3) ionized by MALDI-TOF-MS. 
Produced ions from 
Neutral 
loss (Da) 
6.1, Pc-α-CD 
m/z (%RA
Q-TOF
) 
6.2, Pc-β-CD 
m/z (%RA
Q-TOF
) 
6.3, Pc-ɣ-CD 
m/z (%RA
Q-TOF
) 
[PcCD+Na]
+
  1821 1981 2143 
[PcCD+Na-1Hexres]
+
 -162 1659 (55) 1819 (55) 1981 (65) 
[PcCD+Na-2Hexres]
+
 -324 1497 (40) 1657 (60) 1821 (100) 
[PcCD+Na-3Hexres]
+
 -486 1335 (20) 1495 (35) 1657 (48) 
[PcCD+Na-4Hexres]
+
 -648 1173 (10) 1333 (20) 1495 (30) 
[PcCD+Na-5Hexres]
+
 -810 ----- 1171 (7) 1333 (20) 
[PcCD+Na-6Hexres]
+
 -972 ----- ----- 1171 (12) 
[CD+Na-2H2O]
+
 -860 961 (5) 1121 (5) 1284 (22) 
[Hexres6+Na]
+
 -1148 ----- ----- 995 (22) 
[Hexres5+Na]
+
 ----- /-1148/-1310 ----- 833 (20) 833 (78) 
[Hexres4+Na]
+
 -1150/-1310/-1472 671 (45) 671 (55) 671 (100) 
[Hexres3+Na]
+
 -1312/-1472/-1634 509 (100) 509 (100) 509 (80) 
[Hexres2+Na]
+
 -1474/-1634/-1796 347 (30) 347 (38) 347 (25) 
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In summary, MALDI-TOF-MS/MS proved to be an excellent tool to distinguish the 
Pc-CD dyads 6.1-6.3, requiring very low quantities of sample without the need of sample 
manipulation. The MS/MS spectra of these samples allow differentiation of gradual loss of 
sugar units and confirm the structure of all three derivatives. 
 
6.2.2 HPLC analysis of Pc-CD conjugates* 
 
The degree of homogeneity of the Pc-CD conjugates was analysed by HPLC using 
the following experimental conditions: solvent A – water (33%), solvent B – methanol 
(20%), and Solvent C – tetrahydrofuran (47%); chromatograph column – waters spherisorb 
C8, 54.6 × 250 mm; flow of 0.5 mL/min; and chart speed of 1.25 mm/min. 
The Pc-β-CD 6.2 conjugate (Figure 6.9b) was found to elute as a reasonably sharp 
band at 20 min (uncorrected retention time) in a recently conditioned column (1/1 
methanol, THF). Retention times drop down to about 18 min after a series of six injections. 
a) 
 
b) 
 
c) 
 
Figure 6.9 HPLC chromatogram of a) Pc-α-CD 6.1, b) Pc-β-CD 6.2 and c) Pc-γ-CD 6.3 
after elution at 15, 18 and 17 min, respectively. 
                                                 
*
These compounds were analyzed by Prof. Fernando Domingues and Dr. Mónica Válega, which kindly 
provided their results for a comprehensive analysis of the homogeneity of these Pc-CD conjugates. 
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At higher concentrations a small peak elutes at 30 min, which accounts for less than 
4.5% of the area. Visible spectra were obtained for these peaks, using the built in facilities 
of the detector.  
Under similar conditions the Pc-α-CD 6.1 (Figure 6.9a) conjugate elutes at 15 min 
as a sharp band, with a small peak at 23 min, accounting for less than 2.5% of the area. 
Best conditions for the elution of the Pc-γ-CD 6.3 (Figure 6.9c) conjugate were as 
follows: water/methanol/THF (40/20/40) for 10 min, increasing to 0/20/80 during 5 min, 
with a 1.5 mL/min flow. The compound elutes at 17 min as a broad band. 
 
6.3 Photochemical and photophysical properties of Pc-CD conjugates* 
 
Absorption and emission spectra of Pc-CDs 6.1-6.3 were recorded on a UV-2501 
PC Shimadzu and FluoroMax3 spectrophotometers, respectively, and the spectroscopic 
properties of the novel Pc-CDs in DMSO are summarized in Table 6.2. 
 
6.3.1 Absorption and emission features 
 
In DMSO and in phosphate buﬀered saline (PBS) buffer, the compounds exhibited 
very similar absorption spectra with strong Q absorption bands at the red visible region 
(694-699 nm, Figures 6.10A and 6.11).  
It is noteworthy that the stock solutions of the conjugates were prepared at a 
concentration of 20 mM in DMSO and stored in the dark at room temperature (rt). The 
working solutions were freshly prepared prior to use by diluting the stock solutions in 
DMSO (Figure 6.12), phosphate buﬀered saline (PBS) (10 mM NaH2PO4, 70 mM 
Na2HPO4 and 145 mM NaCl at pH 7.6, Figure 6.13) with the concentration of DMSO 
being always below 1% (v/v), or DMF/H2O (9:1 v/v, Figure 6.14). 
 
                                                 
*
These compounds were tested by Patrícia Pereira, who kindly provided their results for a comprehensive 
analysis of the photophysical and photodynamic activity values of the Pc-CD conjugates. 
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Figure 6.10 Normalized electronic a) absorption and b) emission (λexc. = 610 nm) spectra 
of Pc-α-CD, Pc-β-CD and Pc-γ-CD in DMSO. 
 
 
Figure 6.11 Normalized electronic a) absorption and b) emission (λexc. = 610 nm) spectra 
of Pc-α-CD, Pc-β-CD and Pc-γ-CD in PBS. 
 
Table 6.2 Photophysical data of Pc-CDs 6.1-6.3 in DMSO. 
Compound 
Q-band 
λmax (nm) 
log ɛ λemission (nm)
a)
 
Stokes 
Shift (nm) 
ΦF
b)
 
Pc-α-CD (6.1) 694 3.67 698 4 0.28 ± 0.02 
Pc-β-CD (6.2) 696 3.03 700 4 0.10 ± 0.02 
Pc-γ-CD (6.3) 699 3.91 705 6 0.18 ± 0.02 
a)
OD = 0.03-0.05; excited at 610 nm; 
b)
using ZnPc in DMSO as reference (ΦF = 0.20)
24
.
 
 
The Pc-CDs in DMSO followed the Lambert-Beer’s law (Figure 6.12), suggesting 
that solubility of these conjugates was not compromised for concentrations ranging from 0 
to 50 µM. Upon excitation at 610 nm, all conjugates showed in DMSO the same emission 
behaviour, with a emission band in the red spectral region at 698-705 nm (Figure 6.10B) 
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and fluorescence quantum yields (ΦF) of 0.10-0.28 (Table 6.2), relative to the unsubstituted 
phthalocyaninato zinc(II) (Pc, ΦF = 0.20 in DMSO).
24
 The fluorescence quantum yields of 
the Pc-CDs decrease in the order Pc-α-CD > Pc-γ-CD > Pc-β-CD. 
 
 
Figure 6.12 UV-Vis spectra of A) Pc-α-CD 6.1, B) Pc-β-CD 6.2 and C) Pc-γ-CD 6.3 in 
DMSO at different concentrations 0 to 50 µM. The inset of each spectrum plots the Q-band 
absorbance versus the concentration of the Pc-CD in DMSO, and the line represents the 
best-fitted straight line. 
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In PBS the emission spectra of Pc-α-CD and Pc-γ-CDs demonstrated similar 
shapes with maximum emission bands respectively at 688 and 682 nm (Figure 6.11). In the 
same medium Pc-β-CD demonstrated a bathochromic shift with a maximum emission 
band at 717 nm. The spectral shape of the emission excitation spectra of all conjugates, in 
DMSO and in PBS, closely resemble the absorption spectra and therefore confirm the 
existence of single chemical species (data not shown). 
 
6.3.2 Solubility of the Pc-CD dyads 
 
The water solubility of the new PSs is a critical parameter for the photodynamic 
effect, as low solubility compromises their bio-distribution, uptake by the cells and ROS 
production.
25,26
 The solubility of Pc-CDs 6.1-6.3 in PBS (with <1% v/v DMSO) was 
investigated for different concentrations (Figure 6.13), in close resemblance conditions to 
those used in the in vitro PDT assays.  
The solubility of the Pc-CDs decreased in the order Pc-γ-CD ≈ Pc-α-CD > Pc-β-
CD in PBS buffer (<1% v/v DMSO). The Q absorption bands of Pc-α-CD and Pc-γ-CD 
were significantly broadened, but still followed the Lambert-Beer’s law, suggesting that 
solubility of these conjugates was not compromised under these conditions. However, the 
absorption spectra of Pc-β-CD indicated that the solubility of this compound is lower in 
PBS buffer (Figure 6.13) than in DMSO (Figure 6.12). The self-aggregation of Pc-β-CD 
can be a possible explanation for its lower water solubility when compared with Pc-α-CD 
and Pc-γ-CD. In fact, the self-aggregation of drug-loaded CDs in water is a well-known 
phenomenon,
27
 which can be caused by the self-aggregation tendency of β-CD native 
structure,
28
 since its molecular dimensions are optimal for the formation of an 
intramolecular hydrogen bond within the CD molecule, preventing its hydrogen bond 
formation with surrounding water molecules and reducing its solubility.
28
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Figure 6.13 UV-Vis spectra of A) Pc-α-CD 6.1, B) Pc-β-CD 6.2 and C) Pc-γ-CD 6.3 in 
PBS buffer (<1% v/v DMSO) at concentrations for Pc-α-CD 6.1 and Pc-γ-CD 6.3 from 0 
to 50 µM, and for Pc-β-CD 6.2 from 0 to 10 µM. The inset of each spectrum plots the Q-
band absorbance versus the concentration of the Pc-CD in PBS, and the line represents the 
best-fitted straight line. 
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6.3.3 Photostability and ability of the Pc-CD conjugates to generate 1O2  
 
Considering the potential application of Pc-CDs 6.1-6.3 as new PSs, their 
photostability and ability to generate 
1
O2 were determined. The photodegradation of PSs 
impairs their photodynamic effectiveness, as it causes the decrease of PS concentration. 
For the photostability assays, solutions of Pc-CDs 6.1-6.3 at 1 µM were freshly prepared in 
PBS buffer (with 0.5% v/v DMSO) and kept in the dark at room temperature. The 
photostability of Pc-CDs 6.1-6.3 were determined by monitoring the absorption Q-band 
intensity at different irradiation times. The irradiation experiments were performed in 
magnetically stirred cuvette solutions (with 2 mL of sample), over a period of 40 min with 
white (400-800 nm) and red light (620-750 nm) delivered by an illumination system (LC-
122 LumaCare, London) equipped with a halogen/quartz 250 W lamp coupled the selected 
interchangeable optic fibre probe (400-800 nm or 620-750 nm). The lights were delivered 
at an irradiance rate of 150 mW.cm
-2
, measured with an energy meter Coherent 
FieldMaxII-Top combined with a Coherent PowerSens PS19Q energy sensor. The 
absorbance at 640 nm (maximum absorption band in PBS) was determined at 0, 1, 3, 4, 5, 
10, 15, 20, 25, 30 and 40 min periods of time after irradiation. The results were expressed 
as follows: 
 
. 
 
The Pc-CD conjugates 6.1-6.3 exhibited similar photostability when compared to 
ZnPc over the investigated irradiation period (40 min; Table 6.3). These results 
demonstrated that the derivatization of Pc with α-, β- and γ-CDs did not compromise their 
photostability. 
It has been demonstrated that the ability of PSs to generate 
1
O2 is an important 
feature in the photosensitizing process, since this reactive oxygen specie is important in the 
induction of cell death pathways which will lead to the destruction of tumours.
8
 The ability 
of Pc-CD conjugates 6.1-6.3 to generate 
1
O2 was evaluated in DMF/H2O (9:1 v/v) and in 
DMSO. On these two solvents the three conjugates strictly followed the Lambert-Beer’s 
law between 0 to 50 µM (Figures 6.12 and 6.14), suggesting that the solubility of Pc-CD 
conjugates was not compromised during the study. 
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Table 6.3 Photostability of 1 µM of ZnPc and Pc-CDs 6.1-6.3 in PBS, after irradiation 
with white (400-800 nm) and red light (620-750 nm) at an irradiance rate of 150 mW.cm
-2
 
at different periods of time (0-40 min). 
Compounds Light Irradiation time (min) 
  0 1 3 4 5 10 15 20 25 30 40 
ZnPc
a
 white 100 99 98 97 97 96 94 93 92 91 90 
red 100 99 98 98 98 97 97 96 96 96 96 
Pc-α-CD white 100 99 98 98 98 97 97 96 95 95 95 
red 100 100 100 100 100 100 100 100 100 99 99 
Pc-β-CD white 100 97 95 95 94 94 94 94 94 94 94 
red 100 99 99 98 97 96 95 95 94 94 93 
Pc-γ-CD white 100 99 99 99 99 99 99 96 96 96 96 
red 100 99 99 99 99 99 99 99 99 98 98 
a
The photostability of ZnPc was determined in PBS buffer containing 20% of DMSO due to its low 
solubility in aqueous solution. The results in percentage are calculated by the ratio of residual 
absorbance at 640 nm at different periods of time and absorbance before irradiation. 
 
 
Figure 6.14 UV-Vis spectra of A) Pc-α-CD 6.1, B) Pc-β-CD 6.2 and C) Pc-γ-CD 6.3 in 
DMF/H2O (9:1 v/v) at different concentrations 0 to 50 µM. The inset of each spectrum 
plots the Q-band absorbance versus the concentration of the Pc-CD in DMF/H2O (9:1 v/v), 
and the line represents the best-fitted straight line. 
 
206 
The ability of Pc-CDs to generate
 1
O2, was performed by a steady-state method 
using 1,3-diphenylisobenzofuran (DPBF) as the 
1
O2 acceptor; the non-substituted ZnPc 
was used as the 
1
O2 generator reference.
29,30
 The decrease in the absorption of DPBF 
(monitored at 415 nm) was higher in the presence of all Pc-CDs (Figures 6.15 and 6.16) 
with the conjugates 6.1 and 6.3 showing similar ability to photooxidize DPBF when 
compared to ZnPc. These results demonstrated that ZnPc moiety did not lose its 
sensitizing properties after binding with α- and γ-CDs. Pc-β-CD demonstrated to be a 
much less efficient 
1
O2 generator, which could be partially explained by its low solubility 
in aqueous media like PBS (Figure 6.13). 
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Figure 6.15 Photo-oxidation of DPBF (33 µM) in DMF/H2O (9:1) with or without Pc-α-
CD 6.1, Pc-β-CD 6.2, Pc-γ-CD 6.3 or ZnPc at 0.33 µM, after irradiation with a LEDs 
array system emitting red light at a irradiance of 10 mW.cm
-2
. The DPBF absorbance was 
recorded at 415 nm. 
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Figure 6.16 Photo-oxidation of DPBF (33 µM) in DMSO with or without Pc-α-CD 6.1, 
Pc-β-CD 6.2, Pc-γ-CD 6.3 or ZnPc at 0.33 µM, after irradiation with a LEDs array system 
emitting red light at a irradiance of 10 mW.cm
-2
. The DPBF absorbance was recorded at 
415 nm. 
 
6.3.4 Human serum albumin interaction assays 
 
Knowing that human serum albumin (HSA) is able to bind anticancer drugs and 
deliver them to the target organs, the interaction of Pc-CDs 6.1-6.3 with the abundant 
plasma protein HSA was studied by fluorescence quenching of tryptophan residues in HSA 
solutions in the presence of increase concentration of Pc-CDs (0-10 µM in PBS <1% v/v 
DMSO).
29
 
For the determination of Pc-CDs interaction with HSA, 2 mL of HSA solution was 
titrated with increasing additions of Pc-CDs, keeping always the final amount of DMSO 
208 
below 1% (v/v). The fluorescence spectrum of the HSA´s tryptophan residues were 
acquired for the wavelength range between 300-450 nm upon excitation at 280 nm, 
showing a characteristic emission maximum band at 335 nm (Figure 6.17). The excitation 
and emission slits width were set at 2.0 nm. The fluorescence quenching curves were 
obtained by plotting the tryptophan residues quenching (in percentage) against conjugates 
concentration. The tryptophan residues quenching (in percentage) was calculated, as 
follows: 
 
 
 
The Ka and n values presented in Table 6.4 were determined by plotting the log((F0-F)/F) 
against log(Pc-CD concentration), giving a linear plot, where log(Ka) and log(n) are the 
ordinate at the origin and slope, respectively. 
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Figure 6.17 Emission spectra of HSA at 2 µM in PBS (λexc. at 280 nm). 
 
The effects of DMSO on HSA emission quenching were tested, since the stock 
solutions of the Pc-CDs were prepared in this organic solvent. Over a concentration range 
of 0-1% (v/v), DMSO did not quench HSA emission (data not shown). The addition of Pc-
CDs to HSA led to fluorescence quenching of tryptophan residues (Figure 6.18), which 
was lower for the compound 6.2 when compared with compounds 6.1 and 6.3. 
The binding constant (Ka) and the number of binding sites (n) of compounds 6.1-
6.3 were determined as described in the literature
29
 and compared with the ones obtained 
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for ZnPc (Ka = 7.3×10
3
 M
-1
 and n = 0.8). The Ka values of the Pc-CDs decreased in the 
order 6.3 (Pc-γ-CD) > 6.1 (Pc-α-CD) > ZnPc > 6.2 (Pc-β-CD) (Table 6.4). 
 
Table 6.4 Binding constant (Ka) and number of binding sites (n) of compounds 6.1-6.3 to 
HSA. 
Compound 
HSA interaction 
Ka (M
-1
) n 
Pc-α-CD (6.1) 3.0 × 10
5
 1.2 
Pc-β-CD (6.2) 1.1 × 10
2
 1.3 
Pc-γ-CD (6.3) 7.8 × 10
5
 0.9 
 
The number of binding sites indicates that there is only one binding site for the Pc-
CDs closes to the tryptophan residues of HSA (Table 6.4). The values of Ka obtained for 
Pc-CDs 6.1 and 6.3 are in accordance to the ones obtained for Pcs glycodendritic 
conjugates.
29 
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Figure 6.18 Emission quenching curves of 2 µM of HSA after addition of the Pc-CDs 6.1-
6.3 at concentrations ranging from 0 to 10 µM). Quenching % = (F0-F)/(F0)×100, where F0 
and F are the HSA emission intensities in the absence and presence of the Pc-CDs (λexc. = 
280 nm and λem. = 335 nm). 
 
Considering that Pc-CDs in PBS have an absorption band (Figure 6.11) in the 
region of the emission spectra of the HSA protein (Figure 6.17), two additional 
experiments demonstrates that HSA emission quenching was due to the interaction of HSA 
with Pc-CDs. On the first experiment, the emission spectra of Pc-CD solutions in the 
210 
presence and absence of HSA were recorded after excitation at 610 nm (Figure 6.19). HSA 
by itself did not produce a signal over the spectral region (data not shown). Note the large 
increase in emission spectra associated with combining the HSA and the photosensitizer. 
The emission and electronic absorption spectra of Pc-CDs were also recorded after 
addition of HSA at 2 µM, keeping always the final concentration of DMSO below 1% 
(v/v). The emission spectra of Pc-CDs were acquired for the wavelength range of 650-850 
nm. The excitation and emission slits width were set at 2.0 nm. 
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Figure 6.19 Emission spectra of Pc-CDs in PBS before and after addition of HSA (λexc. at 
610 nm). 
 
The increase of Pc-CD emission suggests the formation of a complex that 
substantially enhances the emission characteristics of the photosensitizer. On the second 
experiment, the absorption spectra of Pc-CDs were recorded upon addition of HSA protein 
(Figure 6.20). After addition of HAS, it was observed hypochromicity without any Q-band 
shift, which unequivocally confirms the existence of interaction between HSA and Pc-
CDs. The Pc-CD conjugates and their interaction with HAS are not comparing with ZnPc 
reference because this one aggregates in PBS. 
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Figure 6.20 Absorption spectra of Pc-CDs in PBS before and after addition of HSA. 
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6.3.5 In vitro photodynamic activities of Pc-CD conjugates 
 
The in vitro photosensitizing efficiency of Pc-CDs 6.1-6.3 was performed in the 
human bladder cancer cell line (UM-UC-3) derived from transitional cell carcinoma, which 
is the most common malignant tumour arising from the urothelium. The cytotoxicity of Pc-
CDs 6.1-6.3 was investigated in the presence and absence of light using 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) colorimetric assay (Figures 
6.21 and 6.22). 
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Figure 6.21 Dark toxicity of Pc-CDs 6.1-6.3 in UM-UC-3 bladder cancer cells. Cells were 
incubated in darkness with Pc-CDs at different concentrations (0, 0.05, 0.1, 0.5, 5 and 10 
µM in PBS buffer) for increasing uptake times (1, 2 and 4 h). Cytotoxicity was assessed 24 
h after treatment using the MTT colorimetric assay. The percentage of cytotoxicity was 
calculated relatively to control cells (cells incubated with PBS in darkness) at the 
respective uptake time. Data are the mean value ± S.D. of at least three independent 
experiments performed in triplicates. 
 
In this assay, the yellow colored MTT is reduced by mitochondrial dehydrogenases 
in living cells to a blue-colored formazan precipitate. The absorption of dissolved 
formazan correlates with the number of living cells. Pc-CDs solutions 6.1-6.3 were non-
toxic in the dark up to 10 µM and uptake time up to 4 h. For the PDT assays, the bladder 
cancer cells were incubated in darkness with Pc-CDs at different concentrations (0-1 µM) 
during 3 h and irradiated with a white (400–800 nm) or red (620–750 nm) light source, 
both at an irradiance rate of 50 mW.cm
-2
. Variable irradiation times of 20 and 40 min were 
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performed for giving a demonstration of irradiation-time dependence of cell killing. 
Compounds 6.1 and 6.3 demonstrated a phototoxic effect in a concentration- and 
irradiation time-dependent manner (Figure 6.22). 
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Figure 6.22 Photocytotoxic effects after PDT with Pc-CDs 6.1-6.3 in UM-UC-3 bladder 
cancer cells. Cells were incubated in darkness with Pc-CDs 6.1-6.3 at different 
concentrations (0, 0.005, 0.025, 0.1 and 1 µM in PBS) for 3 h and irradiated with red light 
(620-750 nm) for 20 min (A) and 40 min (B), or with white light (400–800 nm) for 20 min 
(C) and 40 min (D) at a potency of 50 mW.cm
-2
. Cytotoxicity was assessed 24 h after PDT 
using the MTT colorimetric assay. The percentage of phototoxicity was calculated 
relatively to control cells (cells incubated in darkness with PBS and then irradiated). Data 
are the mean value ± S.D. of at least three independent experiments performed in 
triplicates. *(p<0.05), **(p<0.001), ***(p<0.0001) significantly different from control 
cells. 
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The incubation concentration (IC50) values are summarized in Table 6.5, being 
estimated from Figure 6.22, and it is defined as the Pc-CD concentration required to kill 
50% of the UM-UC-3 bladder cancer cells. The data show that the cell photokilling is 
dependent of the Pc-CD, light wavelength range and irradiation time. In case of the white 
light, only a narrow region of the light was absorbed by the compounds to initiate the 
photodynamic action. Hence, the IC50 values were lower when it was used the red light 
source. The data showed interesting differences between the photoactivity of Pc-CDs that 
differ only in the CD nature. Compounds 6.1 and 6.3 are more phototoxic comparatively 
with compound 6.2, showing IC50 values in the range of 26-87 and 330-460 nM when cells 
are irradiated for 20 and 40 min with red and white lights, respectively. These IC50 values 
of Pc-CDs 6.1 and 6.3 were similar with the obtained for β-CD-conjugated silicon(IV) Pcs 
against human colorectal carcinoma and human hepatocarcinoma cells.
3
 The lower 
solubility and 
1
O2 production of Pc-β-CD 6.2 could explain the absence of phototoxic 
effect on UM-UC-3 cells (Figure 6.22). Meanwhile, it is well-known that aggregation can 
deactivate the excited electronic states of PSs and cause further loss of photoreactivity.
25
 
 
Table 6.5 IC50 values of Pc-CDs 6.1 and 6.3 against UM-UC-3 bladder cancer cells. 
 
Pc-CD 
Red light White light 
 20 min 40 min 20 min 40 min 
IC50 [CI95%] (nM) 
6.1 41 [27;64] 33 [23;47] 460 [290;730] 380 [220;660] 
6.2 n/d n/d n/d n/d 
6.3 87 [53;140] 26 [17;38] 430 [300;620] 330 [220;490] 
IC50: incubation concentration that inhibits the proliferation of cultures in 50%, after cells 
incubation with Pc-CD and irradiation for 20 or 40 min with white or red light; [CI95%]: 95% 
confidence interval; n/d: not determined. 
 
To account for the difference in photocytotoxicity, the intracellular production of 
ROS of these Pc-CDs was evaluated immediately after PDT using the probe 2´,7´-
dichlorodihydrofluorescein diacetate (DCFDA).
29,31
 This probe quantitatively reacts with 
several ROS to yield the fluorescent product 2´,7´-dichlorodihydrofluorescein (DCF). It 
was found that all the Pc-CDs are able to generate ROS upon irradiation with white or red 
light and the intracellular ROS production was higher for Pc-CD conjugates 6.1 and 6.3 
than for Pc-CD dyad 6.2 (Figure 6.23). This fact is in good agreement with the trend 
observed for their photocytotoxicity (Table 6.5). 
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Figure 6.23 Quantification of DCF fluorescence increase (as a measure of ROS 
production) after PDT. UM-UC-3 bladder cancer cells were incubated with 1 µM of Pc-
CD for 3 h in the dark. After PDT with red (620-750 nm) or white light (400-800 nm) 
during 40 min, it was detected an increase in intracellular oxidative stress observed by 
oxidation of the fluorescent probe H2DCFDA (5 µM in PBS). **Significantly different 
from irradiated-control cells (p<0.001), 
++
significantly different from cells incubated with 
Pc-α-CD and irradiated with red light (p<0.001), +significantly different from cells 
incubated with Pc-γ-CD and irradiated with red light (p<0.05). 
 
In addition to the cell viability studies, it was also investigated the intracellular 
uptake of Pc-CDs 6.1-6.3 in bladder cancer cells by fluorescence microscopy (Figure 
6.24). It is expected that CDs act as Pc carriers and that the hydrophilic (polar) CD exterior 
and lipophilic (nonpolar) Pc ring of Pc-CDs 6.1-6.3 resemble the structure of amphiphilic 
sensitizers. Uptake of these types of PSs by endocytosis has been previously reported.
5,32
 
On the other hand, it has been reported that CDs can perturb the lipophilic membrane 
barrier, enhancing the uptake of Pcs in cancer cells.
5
 
The results obtained by fluorescence confocal microscopy revealed that incubation 
of UM-UC-3 cells with the three Pc-CDs at 1 µM for 3 h (in the dark) led to cell 
incorporation of all compounds resulting in intracellular fluorescence. The fluorescence of 
all Pc-CDs was observed as bright and granular small spots through the cytoplasm 
indicating that there was substantial uptake of the dyes. There were marked differences in 
the cellular uptake of the compound 6.2 when compared with compounds 6.1 and 6.3, 
which might be due to its overall solubility and tendency to aggregation. While compound 
6.2 is poorly taken up by the cells, compounds 6.1 and 6.3 are accumulated inside the cells 
to a much higher extent. All these results suggest that the higher phototoxicity of 
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compounds 6.1 and 6.3 can be attributed to their higher cellular uptake and efficiency in 
generating intracellular ROS. 
 
 
Figure 6.24 Representative fluorescence images of UM-UC-3 bladder cancer cells after 
incubation with 1 µM of Pc-CDs 6.1-6.3 (red) for 3 h in the dark. Nucleus was stained with 
DAPI (blue). Control fluorescence images were acquired after cells incubation with PBS 
buffer for 3 h and staining the nucleus with DAPI (blue). Scale bars are indicated on 
images. Original magnification: 400x. 
 
6.4 Conclusions 
 
In conclusion, we have prepared and characterized three Pc-CD conjugates (Pc-α-
CD, Pc-β-CD, and Pc-γ-CD) and investigated their PS capabilities on UM-UC-3 bladder 
cancer cell line. The structures of the new Pc-CD conjugates were fully characterized by 
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MALDI-TOF-MS/MS tandem mass spectrometry, in which the observed fragmentation 
pathways were therefore relevant for the identification of such glycophthalocyanine 
derivatives. The MS/MS results demonstrated the main fragmentation pathways of [Pc-
CD+Na]
+
 ions studied that consist of consecutive loss of hexose residues (-162 Da) due to 
the rupture of O-C1,4 bond in the CD units. 
The new Pc-α-CD and Pc-γ-CD exhibited much higher water-solubility, 1O2 
production and intracellular ROS generation than Pc-β-CD, with consequently much 
higher UM-UC-3 bladder cancer cell line phototoxicity by the first two Pc-CDs and almost 
none phototoxicity by the Pc-β-CD. The lower photodynamic activity of the Pc-β-CD can 
be attributed to its lower solubility, lower accumulation in bladder cancer cells and lower 
intracellular reactive oxygen species generation. The promising photoactivity of Pc-α-CD 
and Pc-γ-CD ensure their potential as strong PDT drugs and it opens the possibility to 
explore these and many other bioconjugates of PcF16 in different directions. 
 
6.5 Experimental section 
6.5.1 General methods 
 
1
H and 
19
F NMR spectra were recorded on a Bruker Avance-300 spectrometer at 
300.13 and 282.38 MHz, respectively. Tetramethylsilane was used as internal reference. 
Absorption and fluorescence spectra were recorded using a Shimadzu UV-2501-PC and 
FluoroMax3 (Horiba JovinYvon), respectively. Analytical TLC was carried out on 
precoated silica gel sheets (Merck, 60, 0.2 mm). Column chromatography was carried out 
over silica gel (Merck, 63–200 mesh). Reverse phase column chromatography was carried 
out over Sep-Pak
®
Vac 35cc (10g) tC18 Cartridges and molecular exclusion column 
chromatography was carried out over Bio-beads
TM
 S-X1 Beads (200-400 Mesh, 100g), 
Bio-Rad Laboratories, Inc. 
The HPLC chromatograms were recorded on a Merck Hitachi L620A coupled to a 
detector Merck Hitachi, L4250 UV/Vis detector, set at 690 nm. 
MALDI-TOF-MS and MALDI-TOF-MS/MS mass spectra were acquired using a 
MALDI-TOF/TOF Applied Biosystems 4800 Proteomics Analyzer (Applied Biosystems, 
Framingham, MA, USA) instrument equipped with a nitrogen laser emitting at 337 nm. 
Prior to MALDI-TOF-MS analysis, 4 µL of matrix, dithranol (10 mg mL
-1
 in methanol / 
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0.1% TFA) were mixed with 2 µL of Pc-CD solution in methanol/ (10 µg mL-1) and 1 µL 
of this mixture was deposited on the MALDI plate and let to dry. MALDI-TOF-MS 
spectra were acquired in the positive ion reflector mode using delayed extraction in the 
mass range between 600 and 4500 Da with ca. 1500 laser shots. For the following 
acquisition of tandem mass spectra (MS/MS) a collision energy of 2 keV was used to 
induce fragmentation and compressed air was used as collision gas. 
 
6.5.2 Synthesis and characterization of Pc-CD dyes 6.1-6.3 
 
General procedure for the preparation of the Pc-CD derivatives 6.1-6.3: 
 
A mixture of hexadecafluorophthalocyaninatozinc(II) PcF16 (50 mg) and 1 
equivalent of the CD derivative (α-, β- and γ-CD) in dry DMSO (10 mL) was heated in the 
presence of an excess of K2CO3 for 16 h at 50 ºC, until no starting PcF16 could be detected 
in the TLC. Then, it was added to the reaction mixture chloroform and the obtained 
precipitate was filtrated and redissolved in THF/H2O (6/4). This crude mixture was first 
purified by silica gel column chromatography using a gradient of THF/H2O. Further 
purifications of the main product fractions were performed in a reverse phase column 
chromatography, using again a gradient of THF/H2O as eluent, and by molecular exclusion 
column chromatography using DMF as solvent. The desired products were then directly 
precipitated from chloroform. Typical yields were over 63%. The structures of 6.1-6.3 
were confirmed by NMR spectroscopy, UV–Vis and MALDI-TOF-MS. 
 
Phthalocyanine-α-cyclodextrin dyad (Pc-α-CD, 6.1): 
 
In a 25 mL round-bottom flask, to a mixture of PcF16 (50.0 mg, 0.058 mmol) and α-
CD (57.7 mg, 0.059 mmol, 1.0 equiv.) dissolved in DMSO (10 mL) was added K2CO3 
(62.5 mg, 0.45 mmol, 7.8 equiv.). The reaction mixture was then stirred for 16 h at 50 ºC. 
After the workup and the purification described above the product Pc-α-CD was 
crystalized from THF/H2O and obtained in 73% (76.8 mg) yield. 
19
F NMR (282 MHz, 
DMSO-d6): δ -178.86 to -175.51 (m, 8F, 8-α-F), -166.98 to -164.12 (m, 6F, 6-β-F). UV-
Vis (DMSO), λmax. (log ε): 694 (3.67). MALDI-TOF-MS: m/z 1821 [M+Na]
+
. 
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Phthalocyanine-β-cyclodextrin dyad (Pc-β-CD, 6.2): 
 
In a 25 mL round-bottom flask, to a mixture of PcF16 (52.0 mg, 0.059 mmol) and β-
CD (67.0 mg, 0.059 mmol, 1.0 equiv.) dissolved in DMSO (10 mL) was added K2CO3 
(68.5 mg, 0.50 mmol, 8.4 equiv.). The reaction mixture was then stirred for 16 h at 50 ºC. 
After the workup and the purification described above the product was crystalized from 
THF/H2O and obtained in 66% (77.2 mg) yield. 
19
F NMR (DMSO-d6, 282 MHz): δ -
178.30 to -175.26 (m, 8F, 8-α-F), -166.78 to -164.15 (m, 6F, 6-β-F). UV-Vis (DMSO), 
λmax. (log ε): 696 (3.03). MALDI-TOF-MS: m/z 1981 [M+Na]
+
. 
 
Phthalocyanine-γ-cyclodextrin dyad (Pc-γ-CD, 6.3): 
 
In a 25 mL round-bottom flask, to a mixture of PcF16 (50.8 mg, 0.058 mmol) and γ-
CD (77.4 mg, 0.060 mmol, 1.0 equiv.) dissolved in DMSO (10 mL) was added K2CO3 
(66.0 mg, 0.48 mmol, 8.2 equiv). The reaction mixture was stirred for 16 h at 50 ºC. After 
the workup and the purification described above the product was crystalized from 
THF/H2O and obtained in 63% (78.4 mg) yield. 
19
F NMR (DMSO-d6, 282 MHz): δ -
179.92 to -176.90 (m, 8F, 8-α-F), -167.16 to -165.02 (m, 6F, 6-β-F). UV-Vis (DMSO), 
λmax. (log ε): 699 (3.91). MALDI-TOF-MS: m/z 2143 [M+Na]
+
. 
 
6.5.3 Cell culture 
 
Human bladder transitional cell carcinoma cell line UM-UC-3, established from 
urinary bladder of a male with a grade 3 bladder carcinoma (World Health Organization 
grading system classification), was obtained from the American Type Culture Collection 
(ATCC
®
, Manassas, VA, USA). UM-UC-3 cells were grown in EMEM medium (ATCC) 
with Earle’s Balanced Salt Solution, nonessential amino acids, sodium pyruvate, 10% (v/v) 
of heat-inactivated Fetal Bovine Serum (FBS; Life Technologies, Carlsbad, CA, USA) and 
antibiotic/antimicotic containing 100 units.mL
-1
 penicillin, 100 µg.mL
-1
 streptomycin and 
0.25 µg.mL
-1
 amphotericin B (Sigma). 
 
219 
6.5.4 Determination of intracellular Pc-CD fluorescence by fluorescence 
microscopy 
 
The UM-UC-3 bladder cancer cells were plated in coverslips at a density of 0.9 × 
10
5
 cells per mL for 24 h before treatment. Cells were incubated with 1 µM Pc-CD in PBS 
buffer (10 mM NaH2PO4, 70 mM Na2HPO4 and 145 mM NaCl at pH 7.6) for 3 h in the 
dark. Immediately after incubation, cells were washed and fixed with 4% 
paraformaldehyde (PFA) (Merck, Darmstadt, Germany) for 10 min at room temperature. 
The samples were rinsed in PBS, mounted using VectaSHIELD (Vector Laboratories, CA, 
Burlingame) mounting medium with DAPI, sealed around the perimeter with nail polish 
and stored at 4 ºC until visualization under the confocal microscope (LSM 710, Carl 
Zeiss). 
 
6.5.5 Dark toxicity of Pc-CD dyads 
 
Cells were seeded (9.4 × 10
4
 cells.cm
-2
) in 96-well cell culture plates and 
maintained in culture medium under an atmosphere of air containing 5% CO2. After 
seeding the cells overnight, they were washed twice with PBS and incubated in darkness 
(at 37 ºC under an atmosphere of air containing 5% CO2) with solutions of Pc-CDs in PBS. 
The cells were then washed twice with PBS and covered with 100 µL of fresh medium. 
After uptake, cells were incubated in a humidified incubator in an atmosphere containing 
5% CO2 and 95% air. After 24 h, cell toxicity was determined by the MTT colorimetric 
assay, using 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide (MTT, yellow, 
Sigma). In this assay, the yellow colored MTT is reduced by mitochondrial 
dehydrogenases in living cells to a blue-colored formazan precipitate. The absorption of 
dissolved formazan correlates with the number of living cells. 
 
6.5.6 Phototoxicity of Pc-CD dyads 
 
Cells were seeded (9.4 × 10
4
 cells.cm
-2
) in 96-well cell culture plates and 
maintained in culture medium under an atmosphere of air containing 5% of CO2. After 
seeding the cells overnight, these were washed twice with PBS and incubated in darkness 
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(at 37 ºC under an atmosphere of air containing 5% of CO2) with solutions of Pc-CDs in 
PBS. The cells were then washed twice with PBS and covered with 100 µL of fresh 
medium. Cells were irradiated (using the illumination system referred above for the 
photostability assays) for 20 or 40 min with white (400-800 nm) and red light (620-750 
nm) at an irradiance rate of 50 mW.cm
-2
. After irradiation, cells were incubated in a 
humidified incubator in an atmosphere containing 5% of CO2 and 95% of air. After 24h of 
PDT, cell phototoxicity was determined by the MTT colorimetric assay using 3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide (MTT, yellow, Sigma). 
The IC50 values (i.e. concentration of PS required to reduce cell viability by 50% as 
compared to the control cells) were calculated using non-linear regression analysis the 
sigmoidal dose-response curves (using GraphPad Prism). 
 
6.5.7 Determination of Reactive Oxygen Species (ROS) after PDT 
 
Immediately after photodynamic treatment, cells were washed and incubated with 5 
μM of 6-carboxy-2',7'-dichlorodihydrofluorescein diacetate (H2DCFDA) from Invitrogen 
(Carlsbad, CA, USA) in PBS, for 1 h at 37 °C and protected from light. This probe 
quantitatively reacts with several ROS to yield the fluorescent product DCF. The cells 
were mechanically scrapped in 130 µL of 1% (m/v) sodium dodecyl sulphate (SDS from 
Sigma) solution in PBS (pH 7.0) and the plate was stirred on an automatic plate shaker in 
the dark at room temperature. Cell suspension (100 µL) was transferred into a 96-well 
black plate (Greiner Bio-One) and used for fluorescence measurements of DCF. The 
measurements were performed using a microtiter plate reader (Synergy HT, Biotek 
Instruments) with the excitation and emission filters set at 485/20 and 528/20 nm, 
respectively. It was used 25 µL of the cell suspension to determine the protein 
concentration using the Pierce
® 
BCA Protein Assay Kit (Pierce, Rockford, IL, USA). 
 
6.5.8 Statistical analysis 
 
GraphPad Prism (v.5.00, GraphPad Software) was used to perform the statistical 
analysis. The Mann-Whitney non-parametric test was applied to determine the differences 
between the selected two groups. Level of significance was set at p < 0.05. 
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Chapter 7 
General conclusions 
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7.1 Conclusions 
 
In summary, the global goal of this multidisciplinary project allowed the synthesis 
and characterization of remarkable compounds/materials based on neutral and cationic Pcs 
and to study their potential in electron donor-acceptor and biomedical areas. To this 
purpose, original Pc derivatives were prepared with appropriate groups on their periphery 
to investigate their supramolecular interactions with carbon nanostructures, and their use as 
PDT drugs against human bladder cancer cells and PDI agents against Gram-negative 
bacteria E. coli. 
Newly synthesized thiopyridylphthalocyanines 2.6-2.8, as novel electron accepting 
building blocks of variable strengths, showed great promise for the exfoliation of graphite 
via their immobilization onto the basal plane of graphene in DMF to afford single layer 
and turbostratic graphene based G2.6-G2.8. G2.6-G2.8 were fully characterized (AFM, 
TEM, Raman, pump probe transient absorption spectroscopy, etc.) and were studied in 
terms of electron donor-acceptor interactions in the ground and excited state. In the 
context, it was noted a photoinduced electron transfer from graphene to the electron 
accepting Pcs that was confirmed in a series of steady-state and time-resolved spectroscopy 
experiments. 
Following the use of thiopyridylphthalocyanines 2.6-2.8 and the corresponding 
thiopyridiniumphthalocyanines 3.1-3.3, it was evidenced the syntheses and full 
characterization of these Pc derivatives. The preliminary photophysical studies of Pcs 2.6-
2.8 evidence π-π interactions with SWNTs (∆λ = 17–24 nm) in DMF, were the SPy groups 
have ability to coordinate the metal of the macrocycle core of the neighbouring Pcs, 
approaching these molecules around the SWNTs surface. Cationic Pcs 3.1 and 3.2 presents 
also noncovalent interactions but with smaller intensity comparatively with the 
corresponding neutral Pcs 2.6 and 2.8. With regards to the electron donor/acceptor 
character of these assemblies more studies will be necessary, in order to take final 
conclusions. 
Thiopyridylporphyrins and RuPcs proved to be versatile building blocks of novel 
supramolecular arrays 4.10-4.12 by axial ruthenium coordination. The thiopyridyl groups 
placed at the bay region of the porphyrins coordinate the RuPc dye, showing notable 
heterochromophore structures that evidenced electron-donating/-accepting communication 
between both dyes in the supramolecular hybrids. Photophysical investigation by time-
228 
resolved transient absorption, mainly fluorescence and femtosecond spectroscopy, 
demonstrated efficient intermolecular energy transfer from the photoexcited central 
porphyrin to the peripheral RuPcs in the supramolecular multichromophore ensembles 
4.11 and 4.12. However, in case of the hybrid 4.10 occurs an unidirectional energy transfer 
from the Por to RuPc. The outcome forms the source to architect interesting materials in 
solar light converting systems. 
The new inverted pyridinone and pyridinium Pc derivatives 5.6-5.9 were 
structurally characterized by NMR spectroscopy and mass spectrometry, in which the 
observed data were therefore relevant for the identification of such pyridinone and/or 
pyridinium Pc derivatives. Moreover, derivative 5.9 proved to be an efficient PS against 
bioluminescent E. coli. Interestingly, PSs 3.1 and 3.2 have higher absorbance in the 
wavelengths where white light system emits compared with Pc 5.9; and the better 
performance of 5.9 under red light system can be due to its higher production of 1O2 and/or 
higher overlap with the absorbance spectrum of the red light, comparing to 
thiopyridiniumphthalocyanines 3.1 and 3.2. 
Three Pcs conjugated with α-, β- and γ-CDs were prepared and their application as 
PS agents assessed by photophysical, photochemical and in vitro photobiological studies. 
The photoactivity of Pc-α-CD and Pc-γ-CD ensure their potential as PDT drugs against 
UM-UC-3 human bladder cancer cells due to the higher water-solubility, 1O2 production 
and intracellular ROS generation than Pc-β-CD, with consequently much higher UM-UC-3 
bladder cancer cell line phototoxicity by the first two Pc-CDs and almost none toxicity by 
the Pc-β-CD. The promising photoactivity of Pc-α-CD and Pc-γ-CD ensure their potential 
as strong PDT drugs. 
 
